Rhabdovirus-induced microribonucleic acids in rainbow trout (<i>Oncorhynchus mykiss</i> Walbaum) by Bela-Ong, Dennis
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
General rights 
Copyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright owners 
and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these rights. 
 
• Users may download and print one copy of any publication from the public portal for the purpose of private study or research. 
• You may not further distribute the material or use it for any profit-making activity or commercial gain 
• You may freely distribute the URL identifying the publication in the public portal  
 
If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately 
and investigate your claim. 
   
 
Downloaded from orbit.dtu.dk on: Dec 20, 2017
Rhabdovirus-induced microribonucleic acids in rainbow trout (Oncorhynchus mykiss
Walbaum)
Bela-Ong, Dennis; Schyth, Brian Dall; Lorenzen, Niels
Publication date:
2014
Document Version
Peer reviewed version
Link back to DTU Orbit
Citation (APA):
Bela-Ong, D., Schyth, B. D., & Lorenzen, N. (2014). Rhabdovirus-induced microribonucleic acids in rainbow trout
(Oncorhynchus mykiss Walbaum). National Veterinary Institute.
  
 
Rhabdovirus-induced microribonucleic acids in 
rainbow trout (Oncorhynchus mykiss Walbaum)  
 
 
PhD Thesis 
 
 
Dennis Berbulla Bela-ong 
 
 
 
National Veterinary Institute, Technical University of Denmark  
 
and  
 
Department of Animal Science, University of Århus 
 
 
 
April 2014 
 
ii 
 
TABLE OF CONTENTS 
 
   Page 
    
Table of Contents ………………………………………………………………..    ii 
Preface…………………………………………………………………………… iii 
Acknowledgment………………………………………………………………... iii 
Abbreviations…………………………………………………………………… v 
Summary………………………………………………………………………… vi 
Sammendrag……………………………………………………………………... vii 
1 Introduction and Objectives………………..………………….. 
Background ……………………………….………………….. 
Viral hemorrhagic septicemia virus ……….………………….. 
DNA vaccine based on rhabdovirus G protein ……………….. 
Immune response to VHSV infection and vaccination with the 
VHSV-G-based DNA vaccine……………………………………. 
Microribonucleic acids (microRNAs; miRNAs) ………………… 
Cellular microRNAs in vertebrate animal host-virus 
interactions....................................................................................... 
MicroRNAs in immune responses ………………………………. 
MicroRNAs in teleost fish ……………………………………….. 
Do homologous miRNAs perform conserved functions across 
species? ………………………………………………………….. 
 
General discussion of the project ………………………………… 
1 
2 5 
     2.1 5 
     2.2 9 
     2.3  
10 
     2.4  14 
     2.5  
19 
     2.6 22 
     2.7 25 
     2.8  
29 
      
     2.9 
 
32 
  
References…………………………………………………………………………… 35 
Manuscript 1………………………………………………………………… 
Manuscript 2 ……………………………………………………………… 
55 
99 
Manuscript 3…………………………………………………………………… 136 
 
 
 
 
 
 
 
 
 
 
iii 
 
PREFACE  
     This thesis is submitted in partial fulfillment of the requirements for the Doctor of 
Philosophy (PhD) degree at the Technical University of Denmark. The work was 
carried out at the Fish Health Section, Department of Animal Science, Aarhus 
University (formerly the Fish Host-Pathogen Interactions Laboratory, National 
Veterinary Institute, Technical University of Denmark), under the supervision of Dr. 
Niels Lorenzen (main supervisor) and Dr. Brian Dall Schyth (co-supervisor). The 
project was funded by the Danish Technical Research Council Grant 247-08-0530 (Co-
evolution), the European Economic Community (EEC) Sixth Framework Programme 
(Food Quality and Safety) Improved Immunity of Aquacultured Animals 
(IMAQUANIM) Contract No. 007103, and the European Union Network of Excellence 
EPIZONE Contract No. FOOD-CT-2006-016236. 
     The thesis is based on studies on microRNA expression profiles in a teleost fish in 
the contexts of lethal rhabdovirus infection and vaccination with a DNA vaccine 
encoding an antigenic protein of the virus. Chapter 1 briefly introduces the thesis and 
describes its objectives. Background information is presented in Chapter 2. The major 
studies are described in Manuscript 1 and Manuscript 2. A review paper, Manuscript 3, 
is likewise included. 
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SUMMARY 
This thesis deals with microribonucleic acid (microRNA; miRNA) expression during 
rhabdovirus infection and upon immunization with a DNA vaccine expressing the 
rhabdovirus glycoprotein in teleost fish. MicroRNAs are conserved, small, endogenous, 
non-coding regulatory RNAs that modulate gene expression at the post-transcriptional 
level. The genes whose expression they control are involved in numerous aspects of an 
organism’s biology in which abnormal miRNA expression is associated with 
pathologies. 
In this thesis, the upregulation of two clustered miRNAs was observed in rainbow trout 
infected with the fish rhabdovirus, viral hemorrhagic septicemia virus (VHSV) and in 
fish immunized with a DNA vaccine encoding the glycoprotein of VHSV. It was shown 
that the two miRNAs, known so far only in teleost fishes, are orthologues of an ancient 
vertebrate miRNA cluster, which in humans are involved in the regulation of the cell 
cycle and have been associated with various types of cancers. Interferon (IFN)-related 
regulatory sequences were found in the promoter of the teleost fish miRNA cluster and 
its expression was induced by IFNs and IFN-related mechanisms. It was further 
demonstrated that these teleost miRNAs may participate in the IFN-mediated antiviral 
response.    
IFN-induced miRNAs contributing to the antiviral effects of type I IFN have been 
demonstrated and an increasing number of cellular miRNAs have been shown to be 
involved in the antiviral response against different viruses in mammalian cells. The 
findings in this thesis represent the first report to address the expression of particular 
miRNAs in response to rhabdovirus infection and to anti-rhabdovirus DNA vaccination 
in teleost fish, as well as the first teleost fish IFN-elicited miRNAs that could 
potentially be involved in teleost immune responses. Thus, RNA interference 
mechanism mediated by cellular miRNAs might play an important role in innate 
antiviral immune responses in teleost fish. An update on the antiviral roles of miRNAs 
in mammalian cells and potentially in vertebrate cells is included in a review paper as 
part of the thesis.   
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SAMMENDRAG 
Nyere forskning har vist, at reguleringen af hvor kraftigt gener i dyr og menneskers 
celler udtrykkes ikke kun foregår i cellekernen. Man har således tidligere antaget at det 
især var i omskrivningen af cellekernens DNA til budbringer RNA (messenger RNA 
eller mRNA) at geners aktivitet blev styret. Det har imidlertid vist sig at små RNA 
molekyler, kendt som mikroRNA, ude i cellens cytoplasma kan parre sig med bestemte 
mRNA molekyler og dermed blokere for oversættelsen af disse til protein. 
Mekanismen, der betegnes RNA-interferens er meget velbevaret op igennem dyreriget 
og bruges ikke kun til at regulere kroppens egne gener, men også som forsvar mod fx 
virusinfektioner. I dette projekt har fokus været at analysere og karakterisere 
regnbueørredens mikroRNA-reaktion på infektion med en smitsom virus. To 
mikroRNA molekyler, som tidligere har været beskrevet hos blandt andet zebrafisk, 
blev meget kraftigt aktiveret. Nærmere analyse af deres regulering viste at blandt andet 
interferon, som er kroppens vigtigste akutte forsvarskomponent mod virusinfektioner, 
styrer aktiveringen af de to RNA molekyler. Selvom de to mikroRNA molekyler ikke 
direkte er beskrevet hos mennesker, viste en sammenlignende gensekvensanalyse at 
mennesker og andre varmblodede dyr besidder nogle meget tæt beslægtede, men mere 
originale varianter. Hos fisk er de to mikroRNA´er sandsynligvis blevet specialiserede 
til at indgå i forsvarsmekanismerne mod virusinfektioner. Forsøg hvor fisk blev smittet 
med virus efter aktivering af interferon viste nemlig at beskyttelsen mod 
virusinfektionen blev nedsat, når de to mikroRNA´er forinden blev blokeret. 
Resultaterne bidrager til vores samlede forståelse af hvordan dyr og mennesker 
forsvarer sig mod virusinfektioner og kan på sigt bidrage til udvikling af nye metoder til 
sygdomsforebyggelse og –behandling. 
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1 INTRODUCTION AND OBJECTIVES 
     Microribonucleic acids (microRNAs or miRNAs) are a class of evolutionarily 
conserved, short (roughly 22 nucleotides (nt) in length), endogenously expressed non-
coding RNAs. MicroRNAs control the expression of genes post-transcriptionally by 
negatively regulating transcript levels or inhibiting protein synthesis (Bartel, 2004). 
They play crucial regulatory roles in multiple biological processes including 
development, metabolism, immune responses, and host-pathogen interactions. 
Dysregulated expression of miRNAs is linked to several pathological conditions, such 
as cancer, which underscores the essential functions of miRNAs in various normal 
physiological contexts.   
 
     Viral hemorrhagic septicemia virus (VHSV) is a rhabdovirus that causes viral 
hemorrhagic septicemia (VHS), infecting several freshwater and marine fish species. 
The virus was first identified from farmed rainbow trout (Oncorhynchus mykiss) in 
Denmark in 1965 and since then has been known to occur widely in the marine waters 
of the Northern Hemisphere. VHS has a major impact on commercial production of 
rainbow trout because of huge economic losses that result from very high mortality 
rates (Olesen, 1998).  
 
     The disease has long been eradicated in aquaculture farms in Denmark. 
Nevertheless, the existence of a wild marine reservoir of VHSV threatens the increasing 
production of rainbow trout in sea farms with potential VHS outbreaks.  This 
necessitates improved disease management/prevention approaches in order to alleviate 
the impact of potential VHS outbreaks in rainbow trout marine production systems.  
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     A DNA vaccine based on the glycoprotein G gene of VHSV has been demonstrated 
to protect fish from lethal infection under experimental conditions (Lorenzen and 
LaPatra, 2005; Lorenzen, 1998). The DNA vaccine stimulates an immune response that 
includes early, non-specific, and short-term protection, and subsequently by specific, 
long-term immunity (Kurath, 2008; Lorenzen and LaPatra, 2005). Even though the 
exact protective mechanism is not completely known, it is believed that non-specific 
and specific immune mechanisms complement each other to contribute to the high 
efficiency of the DNA vaccine (Lorenzen and LaPatra, 2005).    
 
     Immune responses involve cell activation, proliferation, and differentiation. During 
these cellular processes, cell phenotypes are altered, accompanied by gene expression 
changes such that genes characteristic of particular (immune) cell types are expressed. 
Gene expression is a highly regulated process and employs several mechanisms that 
operate at various levels. The discovery of miRNAs as major players in controlling 
gene expression at the post-transcriptional level adds to the molecular diversity of the 
gene regulatory machinery.  
 
     Therefore, miRNA expression profiles were investigated during lethal infection with 
VHSV in the teleost fish rainbow trout (O. mykiss) and in fish vaccinated with a DNA 
vaccine encoding the glycoprotein of VHSV.  
 
     Strong expression of a miRNA cluster comprising miR-462 and miR-731 (herein 
referred to as the miR-462/731 cluster), miRNAs which are described thus far only in 
teleost fishes, was observed in the liver of O. mykiss infected with VHSV. The presence 
of immunologically-relevant gene regulatory sequences found proximal to the miR-
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462/-731 locus suggests the potential involvement of these two miRNAs in interferon 
(IFN)-mediated anti-viral immune responses. Furthermore, nucleotide sequence 
analysis indicates that miR-462 and miR-731 are orthologues, respectively, of miR-191 
and miR-425 (herein referred to as the miR-425 cluster), which are ancestral miRNAs 
found in genomes of cartilaginous fish and higher vertebrates, including humans 
(Manuscript 1). 
 
     The miR-462 cluster was also found to be very highly induced in the skeletal muscle 
(site of vaccine administration) and the liver of O. mykiss injected with the VHSV 
glycoprotein gene-based DNA vaccine. The expression of miR-462 and miR-731 was 
elicited by both type I and type II IFNs in both the site of injection and liver in fish 
injected with plasmid constructs encoding IFN 1 and IFN-γ. Finally, antagonizing miR-
462/731 with intraperitoneally-injected, saline-formulated anti-miR-462 and anti-miR-
731 oligonucleotides in poly I:C-treated rainbow trout fingerlings followed by VHSV 
challenge reduced the protective effect of poly I:C and caused higher mortalities. By 
counteracting poly I:C-induced miR-462/-731 expression with specific synthetic 
inhibitory oligonucleotides, results indicate that the upregulation of these two miRNAs 
and their activities are involved in IFN-mediated protection of trout against VHSV 
(Manuscript 2).  
 
     RNA-based antiviral responses in which virus-derived small interfering (si-)RNAs 
are used by the RNA interference machinery to target and inhibit virus RNAs are well-
established in invertebrates and plants. A similar mechanism has recently been shown 
to operate in a context-dependent manner in mammalian cells and in mice. It is also 
believed that mammalian cells (or potentially vertebrate cells) employ miRNAs in an 
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RNAi-based antiviral strategy. The involvement of miRNAs in antiviral responses in 
mammals has been the subject of intense research efforts in recent years. Inhibitory 
miRNAs that directly target virus RNAs and those that target host mRNAs involved in 
host-pathogen interactions and immune responses have been reported in numerous 
studies. To date, no teleost fish miRNA has been implicated in these processes, 
although many mammalian miRNAs with such functions have homologues in teleost 
fishes. Manuscript 3 updates on the current knowledge of RNA-based antiviral 
mechanisms in vertebrates.  
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2 BACKGROUND 
     This chapter reviews literature that provides fundamental scientific background 
knowledge pertaining to the experimental work described in the manuscripts contained 
herein. 
 
2.1 Viral hemorrhagic septicemia virus 
     Viral hemorrhagic septicemia virus (VHSV) is a rhabdovirus (Gr. rhabdos = rod) 
with a bullet-shaped, enveloped virus particle (virion), possessing a negative sense 
single stranded RNA genome (Figure 2). It belongs to the genus Novirhabdovirus of the 
Rhabdoviridae family (ICTV, 2012; Van Regenmortel et al., 2000) and is the 
aetiological agent of the disease called viral hemorrhagic septicemia (VHS) (Jensen, 
1965; Jørgensen, 1974). The novirhabdovirus genome comprises six open reading 
frames that codes for the following proteins: the nucleoprotein (N), polymerase-
associated phosphoprotein (P), matrix protein (M), glycoprotein (G), non-virion protein 
(NV) and the large RNA-dependent RNA polymerase (L) protein (Walker et al., 2000; 
Schutze et al., 1999).  The G protein has been shown to be the target of protective 
neutralizing antibodies (Lorenzen et al., 1999; Lorenzen et al., 1990).  
 
     Typical clinical signs in infected fish are the extensive hemorrhaging in external and 
internal organs that varies among fish species, ascites, exopthalmia, and skin darkening. 
Histopathological features include necrotic changes in the liver, spleen, hematopoietic 
tissue, and pancreatic acini in numerous fish species (Kurath and Winton, 2008; Isshiki 
et al, 2001).  
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Figure 2. Schematic representation of rhabdovirus virion which is enveloped and bullet-
shaped and contains a negative sense, single stranded RNA genome. The genome 
encodes both structural and non-structural proteins. 
(http://viralzone.expasy.org/all_by_species/2.html) 
      
 
 
     VHSV can infect numerous species of both freshwater and marine fish. The virus 
was first isolated and identified from farmed rainbow trout (Oncorhynchus mykiss) in 
Denmark in 1965(2?) (Jensen, 1965; Jørgensen, 1974) and was thought to infect only 
European freshwater salmonid species until 1988 (Einer-Jensen, 2013). To date, VHSV 
is known to occur widely in the marine environment, having been identified in the 
waters of North America (Hedrick et al., 2003), Japan (Takano et al., 2000), and 
continental Europe (Skall et al., 2005; Mortensen et al., 1999; Olesen, 1998). At least 
28 species of wild fish in the North American Great Lakes are vulnerable to VHSV 
infection (USDA-APHIS, 2008a, b). VHS is a highly significant virus disease of 
salmonid fish in European aquaculture, with major impact on commercial production of 
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rainbow trout, resulting in up to 90% mortality (Olesen, 1998) causing massive 
economic loss.  Apart from rainbow trout (Smail, 1999), VHS also seriously impacts 
culture of turbot (Scophthalmus maximus) (Ross et al., 1995), and Japanese flounder 
(Paralichthys olivaceus) (Isshiki et al, 2001).  
 
     It is believed that VHSV originated from marine waters (Dixon, 1999) and the virus 
may have changed hosts several times. A close genetic linkage between marine VHSV 
and rainbow trout VHSV from European farms has been demonstrated (Einer-Jensen et 
al., 2004). Likewise, data also indicated that adaptation of VHSV to rainbow trout has 
taken place a number of times in the past 50 years in European rainbow trout 
aquaculture (Einer-Jensen et al., 2004). Several studies also corroborate the hypothesis 
that the origin of VHSV is the marine environment (Pierce and Stepien, 2012; 
Thompson et al., 2011; Snow et al., 2004).  
 
     Four main VHSV genotypes (I, II, III, and IV) are recognized, which cluster based 
on geographical location instead of serotypes or host species (Pierce and Stepien, 2012; 
Einer-Jensen et al., 2004; Snow et al., 1999). Genotypes I-III are found in Europe while 
genotype IV is found in Asia (Japan and Korea) and North America (Einer-Jensen et al., 
2004; Kim et al., 2011; Snow et al., 1999).  
 
    European freshwater strains consisting of rainbow trout-adapted VHSV belong to 
genotypes I and III (Einer-Jensen et al., 2004; Dale et al., 2009), whereas strains 
isolated from marine fish species have been assigned to the four genotypes. Marine 
VHSV strains either do not cause disease or are very weakly pathogenic to rainbow 
trout (Skall et al., 2004). Nonetheless, marine strains comprise the bulk of genetic 
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diversity (Einer-Jensen et al., 2004) and because single-stranded RNA (ssRNA) viruses 
like VHSV exhibit very high mutation rates (Domingo, 2000; Domingo and Holland, 
1997), the prospect of evolving from non-pathogenic to pathogenic forms is extremely 
high, particularly when permitted contact with a new host (species barrier crossing).  
 
     Outbreaks of VHS have occurred in rainbow trout sea farms in Finland (Husu-Kallio 
& Suokko 2000; Raja-Halli et al. 2006), Sweden (Nordblom 1998; Nordblom & Norell 
2000), and Norway (Dale et al. 2009). In these cases, it is very likely that VHSV from 
marine wild fish shifted hosts due to repeated introduction of marine VHSV strains into 
farmed rainbow trout.  
 
     VHS outbreak strains in Norway showed the closest genetic relatedness to marine 
VHSV isolates from neighboring marine waters (Einer-Jensen et al., 2004; Dale et al., 
2009), as were the Finnish and Swedish isolates. Such outbreaks are most probably due 
to host changes from wild marine fish and adaptation to farmed rainbow trout 
(Schonherz et al., 2012). This indicates that non- or less pathogenic marine VHSV 
strains can give rise to new pathogenic strains and that the marine environment harbors 
a circulating marine wild reservoir of VHSV capable of rapid genetic change and high 
evolutionary adaptation.  
 
     Such evolutionary potential for marine VHSV strains is a cause for a real concern in 
Scandinavia where sea-farming of rainbow trout is expanding. Shifting production from 
freshwater to marine aquaculture systems, fish is reared in open sea-floating net cages. 
While within the confines of these cages, cultured fish shares the water environment 
with wild marine fish, which are potential carriers of the virus and therefore the threat 
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of VHS outbreaks. This poses danger of host shifts from wild fish to naïve maricultured 
trout and the prospect of disease outbreaks in sea farms is highly possible. 
It is therefore imperative that disease management/prevention strategies be developed to 
mitigate the impact of potential VHSV outbreaks in sea-reared rainbow trout. Such 
approaches include vaccine development, breeding for disease-resistant fish stocks, and 
immunostimulatory feed additives.  A better understanding of host defenses involved is 
important in the development of such disease protection measures.   
 
2.2 DNA vaccine based on rhabdovirus G protein 
     A DNA vaccine based on the surface glycoprotein of VHSV (Figure 3) has been 
shown to be successful against VHSV and confers an early cross-protective anti-viral 
response upon vaccination followed by specific, long-lasting protection (Kurath, 2008; 
Lorenzen and LaPatra, 2005; Lorenzen et al., 2002; Lorenzen et al., 1998). The 
complementary activities of non-specific and specific defense mechanisms most likely 
contribute to the high efficiency of fish rhabdovirus vaccines (Lorenzen and LaPatra, 
2005), although the exact protective mechanism has yet to be clarified (Kurath, 2008; 
Lorenzen et al., 2002). While the early protection correlates with upregulation of the 
IFN-induced antiviral protein Mx, neutralizing antibodies probably contributes to the 
later specific immunity. However, even in the late/long-lasting protection phase, the 
protective effect of the vaccine does not always correlate with virus-specific antibody 
titers (Kurath et al., 2006; McLauchlan et al., 2003; Lorenzen et al., 1999), implying the 
involvement of other immune mechanisms such as cytotoxic cells (Utke et al., 2008).  
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Figure 3. Schematic diagram of (A) a rhabdovirus particle, (B) the DNA vaccine, and 
(C) the rhabdovirus surface glycoprotein (G). The DNA vaccine is a plasmid containing 
the gene encoding the rhabdovirus envelope glycoprotein under the transcriptional 
control of a eukaryotic promoter. The G protein is a transmembrane protein found on 
the surface of the virus particles and on infected cell surfaces. It is stabilized by 
disulfide bridges (S-S) and contains oligosaccharide side chains. Following DNA 
vaccination, the G protein is expressed and will be present in the cell interior and on the 
cell surface, mimicking the natural virus infection  (Lorenzen and LaPatra, 2005).  
 
 
 
 
 
2.3 Immune response to VHSV infection and vaccination with the VHSV-G-based 
DNA vaccine 
     The fish rhabdovirus glycoprotein has been known to be a potent elicitor of the IFN 
response and is systemically induced following vaccination with recombinant 
rhabdovirus G protein or G-protein based DNA vaccine (Byon et al., 2006; Purcell et 
al., 2006; Byon et al., 2005; Chen et al., 2012; Verjan et al., 2008; Lorenzen et al., 
2002; LaPatra et al., 2001). 
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     Consequently, infection with fish rhabdoviruses stimulates the IFN response and 
induces the expression of both type I and type II IFN (IFN-γ) genes (Verrier et al., 
2011; Lopez-Munoz et al., 2009; Purcell et al., 2009; Zou et al., 2007; Bernard et al., 
1985), providing transcriptional data on the production of IFNs that has been 
demonstrated by earlier studies (de Kinkelin et al., 1982; de Kinkelin and Le Berre, 
1974; de Kinkelin and Dorson, 1973). IFN-like activity was earlier reported in the sera 
of infected fish and inhibited virus replication (de Kinkelin et al., 1982; de Kinkelin and 
Le Berre, 1974; de Kinkelin and Dorson, 1973). IFN-containing supernatants and 
recombinant type I IFNs have also been shown to prevent fish rhabdovirus replication 
(reviewed by Purcell et al., 2012), Whereas type II IFNs show variable activities against 
rhabdoviruses (Zou et al., 2007), the protective effect of IFN-γ has been demonstrated, 
as well as its ability to induce antiviral responses, expression of antiviral IFN-
stimulated genes (ISGs) and pro-inflammatory cytokines, and increase the expression of 
type I IFNs (reviewed by Purcell et al., 2012).   
 
     Infection with rhabdoviruses or G-protein-based vaccination elicits the expression of 
a ―core‖ set of conserved IFN-stimulated genes (ISGs) that are typically highly induced 
in viral infections, as well as novel antiviral genes (Verrier et al., 2011; Byon et al., 
2006; Purcell et al., 2006; Byon et al., 2005; reviewed by Purcell et al., 2012). One such 
ISG is the type 1 IFN-inducible myxovirus resistance (Mx) gene, which encodes a non-
specific antiviral protein in vertebrates including teleost fishes (Verhelst et al., 2013; Jin 
et al., 1999; Trobridge and Leong, 1995), and is upregulated in fish injected with 
rhabdovirus G-expressing plasmids (Kim et al., 2000; Boudinot et al., 1998). In teleost 
fishes, the expression of Mx is stimulated by IFN-α (a type I IFN) (Berg et al., 2009; 
Robertsen et al., 2003) and by IFN-γ (Sun et al., 2011). The transcriptional response 
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kinetics post-vaccination correlates with the early nonspecific protection from lethal 
rhabdovirus infection (Lorenzen et al., 2002, LaPatra et al., 2001). Therefore, the 
antiviral activities of the IFNs, Mx, and other ISGs can partly account for the short-
lived non-specific protective mechanisms (Lorenzen et al., 2002; Lorenzen et al., 2000).  
 
     In rhabdovirus infected fish, a similar response that correlates with virus titers is 
observed, but IFN and ISG induction is not associated with protection (Peñaranda et al., 
2009; Purcell et al., 2009; Purcell et al., 2004), which could be due to the fast 
replication rate of fish rhabdoviruses enabling them to outpace/overtake the distribution 
of innate immune effectors (Purcell et al., 2012).  
 
     Specific and long-lasting adaptive immunity against fish rhabdoviruses requires the 
crucial involvement of infection- or vaccination-induced neutralizing and protective 
antibodies (Lorenzen and LaPatra, 1999). These antibodies target the rhabdovirus G 
protein (Lorenzen et al., 1999, 1990) and numerous studies have repeatedly 
demonstrated the protective effect of these antibodies (Kurath et al., 2006; Garver et al., 
2005; McLauchlan et al., 2003; Corbeil et al., 2000; LaPatra et al., 2012; Traxler et al., 
1999; Boudinot et al., 1998; Lorenzen et al., 1998). Nevertheless, titers of virus-specific 
antibodies and the protective effect of the vaccine do not always correlate (Kurath et al., 
2006; McLauchlan et al., 2003; Lorenzen et al., 1999), hence other immune 
mechanisms such as cellular responses involving T cells and NK cells most likely also 
play a role.   
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     The involvement of NK cells in the immune response against rhabdovirus infection 
was demonstrated in which peripheral blood leukocytes (PBLs) isolated from rainbow 
trout infected with VHSV or from fish vaccinated with the DNA vaccine encoding the 
glycoprotein of VHSV exhibited cytotoxic activity against VHSV-infected MHC I-
mismatched xenogeneic target cells (Utke et al., 2008; Utke et al., 2007). In contrast, 
PBLs from fish vaccinated with the VHSV-N DNA vaccine did not kill xenogeneic 
cells, suggesting that only the G protein elicits an NK cell response (Utke et al., 2008).  
 
     T lymphocyte activity against a fish rhabdovirus is suggested by T cell clonal 
expansion elicited by VHSV infection and DNA vaccination (Boudinot et al., 2004, 
2001). The G protein appears to contain the key T cell epitopes, as suggested by the 
TCR-β chain complementarity-determining region 3 profiles shared between DNA 
vaccination and virus infection (Purcell et al., 2012).  Furthermore, specific cell-
mediated cytotoxicity was demonstrated in isogenic fish and class I major 
histocompatibility complex (MHC I) matched cell lines. Peripheral blood mononuclear 
cells (PBMCs) from VHSV-infected rainbow trout killed MHC I-matched VHSV-
infected target cells but not VHSV-infected xenogeneic cells (Utke et al., 2007). 
Likewise, PBMCs from fish immunized with VHSV G- or VHSV N-based DNA 
vaccines exhibited cytotoxic activity against MHC I-matched VHSV-infected target 
cells (Utke et al., 2008).  
 
     The immune responses to fish rhabdoviruses are reviewed in detail by Purcell and 
co-authors (2012). 
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 2.4  Microribunucleic acids (microRNAs; miRNAs)  
     MicroRNAs are a class of evolutionarily conserved, short (~22 nt in length), 
endogenously expressed non-coding RNAs that have come to be recognized as key 
regulators of gene expression. MicroRNAs control the expression of genes post-
transcriptionally by negatively regulating target gene transcript levels. They do so by 
binding imperfectly to the 3’ untranslated region (UTR) of specific mRNA targets to 
reduce mRNA stability through deadenylation and mRNA decay (Schier and Giraldez, 
2006) or repress (block) translation (Bartel, 2004; Filipowicz et al., 2008). They also 
interact with the translation machinery to decrease protein synthesis (Gu and Kay, 
2010).  
 
     Initially identified as a key regulator of development in the nematode 
Caenorhabditis elegans (Wightman et al, 1993; Lee et al., 1993), miRNAs have been 
demonstrated to play crucial regulatory roles in a broad spectrum of biological 
processes including cellular differentiation, proliferation, apoptosis, developmental 
timing (Stefani and Slack, 2008; Bushati and Cohen, 2007; Ambros, 2004; He and 
Hannon, 2004), metabolism (Moore, 2013) signal transduction (Zhao et al., 2013; Inui 
et al., 2010; Mudhasani et al., 2008), host-virus interactions (Ghosh et al., 2009; 
Gottwein and Cullen, 2008). Misexpression of miRNAs is linked with several 
pathological conditions (Mendell and Olson, 2012; Tsai and Yu, 2010; Croce 2009; 
Soifer et al., 2007). Likewise, natural variants of miRNA-encoding genes or target sites 
in mRNAs (Saunders et al., 2007) may be responsible for phenotypic differences (Gong 
et al., 2014; Hu et al, 2014; Wojcicka et al., 2014; Jovelin and Cutter, 2011; Clop et al, 
2006).  All these emphasize the crucial functions of miRNAs in normal physiological 
activities.   
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     MicroRNAs are encoded in ―intergenic‖ or ―intragenic regions‖ in the genome and 
are transcribed by RNA polymerase II into 1-3 kb primary transcripts called primary 
miRNAs (pri-miRNAs) (Lee et al., 2004). Pri-miRNAs are 5’-capped and poly-A tailed 
and folds into one or more hairpin structures, each hairpin consisting of a ~32- bp 
imperfect stem and a terminal loop (Skalsky and Cullen, 2010).  The pri-miRNAs are 
processed by Drosha (a type III RNase) and its co-factor, the double-stranded RNA-
binding protein Pasha (DiGeorge Syndrome Critical Region 8 Protein, DGCR8), into 
70-100 nt stem-loop structures bearing 2 nt 3’ overhangs called pre-miRNAs (Gregory 
et al., 2004; Lee et al., 2003). The pre-miRNAs are transported from the nucleus into 
the cytoplasm by Exportin 5 (Bohnsack et al., 2004). The pre-miRNAs are further 
processed by Dicer (another type III RNase) together with TRBP (Tar RNA binding 
protein), removing the terminal loops to generate ~22-bp dsRNAs with 2 nt 3’ 
overhangs (Skalsky and Cullen, 2010). One of these two strands (guide strand) becomes 
the mature miRNA incorporated into the RNA-induced silencing complex (RISC), a 
protein complex comprising of an argonaute (Ago) protein and a GW182 protein 
(Hammond et al., 2000). The strand with less stable base pairing at its 5’ end is 
selectively loaded into the RISC complex (Tomari et al., 2007). The other strand (the 
passenger strand or miRNA*) is usually degraded but can also regulate miRNA 
homeostasis or have downstream regulatory activities (Bartel, 2009; Suzuki and 
Miyazono, 2011). The mature miRNA guides the RISC complex to complementary 
sites usually located in the 3’ untranslated regions (UTRs) of target mRNAs. Matching 
between the miRNA seed region (nucleotides 2-7 or 8) and the target mRNA results in 
mRNA degradation and/or translational inhibition/repression (Bartel, 2009). Perfect 
complementarity between the seed sequence and the mRNA target site generally results 
in endonucleolytic cleavage of the mRNA by Ago, and eventually mRNA degradation 
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(Cullen, 2011). Imperfect or partial matching results in repression of mRNA translation, 
followed by retargeting of RISC-bound mRNAs to translationally inactive processing 
bodies (P bodies) in the cytosol (Cullen, 2011) containing exonucleases and proteins 
implicated in mRNA remodeling, decapping, and deadenylation (Skalsky and Cullen, 
2010). The efficiency of inhibition of mRNAs with imperfectly matched target sites 
depends on mRNA to miRNA expression ratio (Cullen, 2011). MiRNA biogenesis is 
schematically shown in Figure 1.   
 
     Each miRNA can potentially target several mRNAs and one mRNA can be targeted 
by multiple miRNAs (Bartel, 2009; Friedman et al., 2009; Brennecke at al., 2005; 
Lewis et al., 2005). Computational prediction identified >45 000 miRNA target sites in 
the 3’ UTRs of human mRNAs and over 60% of protein-coding genes were found to be 
conserved targets (Friedman et al., 2009).  
 
     MiRNAs control gene expression in a cell type- or tissue- and/or time-specific 
fashion (Bartel 2004; Lagos-Quintana et al., 2002). They may operate in an intricate 
web of combinatorial controls, with a single miRNA regulating multiple targets and/or 
one target having many miRNA-binding sites (Bushati and Cohen 2007), thus 
potentially significantly affecting networks of gene expression. Because miRNAs may 
have considerable influence on gene expression networks, expression profiles of a few 
or maybe even a single miRNA may reveal changes in the expression of many mRNAs.  
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Figure 1. Biogenesis of and post-transcriptional gene silencing by miRNAs. Genes 
encoding miRNAs may be present in non-protein coding regions, in between protein-
coding genes, or within introns. These are transcribed by RNA polymerase II (not 
shown) into primary miRNA transcripts (here, the miRNA is located within an intron), 
which Drosha processes into precursor miRNA (pre-miRNA).  The pre-miRNA is 
subsequently exported into the cytoplasm via exportin-5. Dicer cleaves the pre-miRNA 
to double-stranded siRNA intermediates. The strands of the siRNA duplexes are 
separated during incorporation into miRNP/RISC. The mature miRNAs bound to Ago 
proteins guide the RISC to find cognate target mRNAs for cleavage or  translational 
suppression depending on the level of target complementarity. (Modified from Umbach 
and Cullen, 2009).   
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     Since they affect virtually all aspects of the biology of organisms, miRNAs have 
been studied intensively, resulting in the understanding of the aspects of the functions 
of miRNAs and the role of miRNA-mediated gene regulation in various physiological 
contexts. The breadth of the impact of these small non-coding RNAs on virtually all life 
processes in both normal and diseased states is so vast that they are investigated not 
only to elucidate cellular and organismal functions but are also being explored in the 
diagnosis and treatment of human diseases (Esau and Monia, 2007). The potential use 
of miRNAs as diagnostic and prognostic markers is being actively explored 
(Schwarzenbach et al., 2014; Wu et al., 2014; Zhu et al., 2014; Devaux et al., 2013; Liu 
et al., 2013; Madhavan et al., 2013), serving as bases for microRNA-based disease 
diagnostics and therapeutics. Results of studies on specific miRNAs have allowed the 
discovery of miRNAs with therapeutic value that have reached clinical trials (Mirna 
Therapeutics Press Release, 2013; Janssen et al., 2013; Lanford et al., 2010). Currently, 
the most clinically advanced miRNA-based therapeutic has been developed to treat 
Hepatitis C virus (HCV) infections (Janssen et al., 2013). The cellular liver-specific 
miRNA miR-122 has been known to be used by HCV to promote its own replication 
(Jopling et al., 2005). Miravirsen is a locked nucleic acid (LNA)-modified DNA 
phosphorothioate antisense oligonucleotide that antagonizes miR-122 (Janssen et al., 
2013). The latest phase 2a clinical trial has demonstrated a dose-dependent efficacy of 
Miravirsen in reducing HCV RNA levels in patients with chronic HCV infection and 
the absence of signs of viral resistance and adverse effects (Janssen et al., 2013).    
 
     The first miRNA to be identified was a small RNA encoded by the lin-4 gene in C. 
elegans (Lee et al., 1993). Since then and the initial identification of gene silencing by 
RNA interference (RNAi) (Fire et al., 1998), thousands of genes encoding miRNAs 
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have been identified in plant (Reinhart et al., 2002), animal (Ambros 2004), and viral 
(Cullen 2006; Kincaid and Sullivan, 2012) genomes. Thus far, over 30 000 miRNAs 
have been identified and annotated in 206 species, which are deposited in miRBase 
(miRBase Release 20; http://www.mirbase.org/) (Kozomara and Griffiths-Jones, 2011). 
miRBase is a comprehensive online database of miRNA sequences and annotations 
across a wide range of organisms and is an authority on miRNA terminology and 
nomenclature. Formerly called microRNA Registry (Griffiths-Jones, 2004), it is a 
repository of miRNA sequences, both of pre-miRNAs and those of their derivative 
mature miRNAs. It also provides links to online resources for miRNA target prediction 
and a web interface to RNA sequencing data stored in the public functional genomics 
data repository, Gene Expression Omnibus (GEO) of the National Center for 
Biotechnology Information (NCBI) (http://www.ncbi.nlm.nih.gov/geo/) (Barrett et al., 
2013; Edgar et al., 2002). The latest version (Release 20) of miRBase contains 30, 424 
mature miRNA sequences derived from (24, 521) hairpin precursors representing 206 
species. Evidence for many of these miRNAs comes from cloning and sequencing data, 
whereas others have been identified based on sequence similarity/homology to verified 
sequences from other organisms already listed in miRBase.  
 
2.5 Cellular microRNAs in vertebrate animal host-virus interactions  
     Both the animal host and the virus encode miRNAs that participate as key players in 
the complex web of host-virus interactions. Viral miRNAs have so far been shown to 
play crucial roles in the establishment of long-term infection such as regulating the shift 
to the lytic state, host immune response evasion, and extending the life of infected cells. 
Viral miRNAs are also postulated to act as cellular miRNA mimics that could target 
host mRNAs (Kincaid and Sullivan, 2013). This section focuses on animal cellular 
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miRNAs and the roles that have been ascribed to them thus far. For virus-encoded 
miRNAs, the reader is referred to recent reviews (Kincaid and Sullivan, 2013; 
Grundhoff and Sullivan, 2011). 
 
     Some virus infections have been shown to alter the expression pattern of cellular 
miRNAs (Fu et al., 2014; Zhang et al., 2014; Hicks et al., 2013; Tambyah et al., 2013; 
Buggele et al. 2012; Cameron et al., 2008; Pepini et al., 2010; Houzet et al., 2008; 
Varnholt et al., 2008), revealing an essential function for miRNAs in the interactions of 
the hosts with viruses.  
 
     Cellular miRNAs have been shown to positively or negatively impact virus 
infection. For instance, miR-122 has been shown to stabilize hepatitis C virus (HCV) 
genome, protect it from exonuclease degradation, enhance its replication and to 
stimulate protein synthesis (Conrad and Niepmann, 2013; Li et al., 2013; Wilson and 
Huys, 2013; Jopling et al., 2005). Epstein-Barr virus (EBV) and enterovirus induce 
specific host miRNAs which enable them to replicate (in culture) by targeting mRNAs 
of proteins which may function in anti-viral defense (Ho et al., 2011; Linnstaedt et al., 
2010).  
 
     On the other hand, several studies have reported that mammalian cellular miRNAs 
directly target virus sequences and inhibit their replication (Zheng et al., 2013; Huang et 
al., 2007; Otsuka et al., 2007; Pedersen et al., 2007; Lecellier et al., 2005; see also 
review by Russo and Potenza, 2011). For example, mouse miR-24 and miR-93 target 
Vesicular stomatitis virus genes encoding the large (L) protein and phosphoprotein (P) 
(Otsuka et al., 2007). A number of IFN-β-induced miRNAs in human cells have been 
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shown to target Hepatitis C virus (HCV) sequences and  inhibit HCV replication in 
vitro, thus contributing towards the antiviral properties of IFN-β (Pedersen et al., 2007). 
Other mammalian miRNAs regulate the expression of host genes that either directly or 
indirectly negatively impact virus infection (Gao et al., 2013; Zhang et al., 2013; Terrier 
et al., 2013; Smith et al., 2012; Wang et al., 2009; Triboulet et al., 2007). Such cellular 
miRNAs may potentially be used as antiviral effectors in mammalian cells (discussed in 
review Manuscript 3). 
      
     The importance of cellular miRNAs as antiviral effectors in mammalian cells is 
suggested by observations that miRNA production is impaired in Drosha- or Dicer-
deficient mice and cultured cells, which boosted viral replication and increased 
susceptibility to infection (Otsuka et al., 2007; Triboulet et al., 2007). Furthermore, 
some mammalian viruses have the ability to suppress RNAi mechanisms. For instance, 
influenza A virus has been shown to target Dicer (Matskevich and Moelling, 2007), 
whereas HIV-1 has been reported to actively suppress the expression of a cellular 
miRNA that regulates the expression of a host gene whose protein product benefits 
HIV-1 (Triboulet et al., 2007). 
 
     It is believed that since cellular miRNAs are evolutionarily conserved (Bartel, 2009), 
it is probable that viruses would evolve ways to circumvent inhibition by endogenous 
cellular miRNAs, although how they do this is currently not understood. Cullen (2013) 
proposed a number of possible mechanisms that viruses might employ in order for 
viruses to evade inhibition by cellular miRNAs. These include 1) blocking miRNA 
function; 2) mutating in the 3’ UTR targets complementary to cellular miRNAs; 3) 
evolving very short 3’ UTRs which may allow translating ribosomes to remove mRNA-
22 
 
bound RISC; and 4) having structured (with ―high level‖ of secondary structures) long 
UTRs which restrict RISC recruitment (Cullen, 2013).  
 
2.6 MicroRNAs in immune responses 
     Dicer and the cellular RNAi machinery have been shown to influence the 
proliferation, survival, lineage choice, and cytokine production during T cell 
differentiation (Muljo et al., 2005). Mice with conditional Cre-mediated dicer 1 deletion 
had reduced T cell numbers in peripheral lymphoid organs. CD4+ T cells had defective 
miRNA processing and showed impaired development and abnormal cytokine 
production (Muljo et al., 2005). 
 
     A number of microRNAs are known to modulate various features of mammalian 
immunity, ranging from immune cell development and differentiation, hematopoiesis, 
proliferation, cell fate establishment and maintenance, Toll-like receptor (TLR) 
signaling and cytokine production, antigen presentation, antibody switching, and T cell 
receptor signaling (Baltimore et al., 2008; Lindsay, 2008; Sonkoly et al., 2008), all of 
which contribute to infectious disease outcomes, as well as to the advance of immune-
relevant disorders.  
 
     Differential expression of specific miRNAs influence immune cell phenotypes. For 
instance, B lymphocytes in mouse bone marrow selectively upregulate miR-181 and 
miR-223, but not undifferentiated progenitor cells, which reflects their role in 
regulating lineage differentiation (Chen et al., 2004). Peripheral blood mononuclear 
cells and T lymphocytes in humans afflicted by autoimmune and inflammatory diseases 
likewise differentially express particular miRNAs (Liu et al., 2012; Stagakis et al., 
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2011; Li et al., 2010; Pan et al., 2010; Pauley et al., 2008; Stanczyk et al., 2008). In B 
cell malignancies, miR-155 has been shown to be present in high levels in B 
lymphocytes (Costinean et al., 2006; Eis et al., 2005; Kluiver et al., 2005; Metzler et al., 
2004; reviewed by Lindsay, 2008). All these indicate the crucial role of miRNAs in 
shaping and maintaining the proper functions of immune cells and the development of 
immunological disorders when miRNA expression becomes abnormal.  
 
     Other studies have shown that activation of innate immune signaling alters the 
expression of specific miRNAs, which modulate acute inflammatory responses by 
controlling the production of inflammatory cytokines or targeting innate immune 
signaling proteins (reviewed by Lindsay, 2008). For example, exposure to IL-1β and 
TNF-α or stimulation of TLR-2, -4, and -5, upregulate miR-146a in macrophages and 
alveolar/bronchial epithelium, which consequently negatively regulates innate immune 
responses (Perry et al., 2008; Taganov et al., 2006). Likewise, innate immune response 
activation induces the expression of miR-155, which suppresses the release of 
inflammatory mediators (reviewed by Lindsay, 2008). 
 
     Whereas specific miRNAs exert activities in particular contexts, a single miRNA, 
miR-155, plays versatile roles in regulating numerous immune functions, both innate 
and adaptive. It has been shown to regulate members of the tumor-necrosis factor 
family receptors and their ligands (Tili et al., 2007; Costinean et al., 2006). Apart from 
its involvement in B cell lymphomas as mentioned earlier, it has been shown to be 
critical for normal T cell and B cell differentiation and antibody production since 
knockout mice show impaired B and T cell function (Rodriguez et al., 2007; Thai et al., 
2007; Vigorito et al., 2007). The activity of miR-155 is needed to produce 
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immunoglobulin class-switched plasma cells (Vigorito et al., 2007). By modulating 
cytokine production, miR-155 regulates T helper cell differentiation and germinal 
center reaction to promote the development of an optimal T cell-dependent antibody 
response (Thai et al., 2007). Its role in DC function is suggested by observations that 
miR-155-deficient DCs are inefficient antigen presenters (Rodriguez et al., 2006). It 
controls differentiation of helper T cells into its various subsets (O’Connell et al., 2010; 
Vigorito et al., 2007; Rodriguez et al., 2006) and influences of regulatory T cell 
development (Kohlhaas et al., 2009). It is highly upregulated in activated mouse 
cytotoxic T cells (CTLs) and in antigen-specific effector CTLs (Gracias et al., 2013) 
and was essential for optimum CTL responses against pathogens and for generating 
pathogen-specific CTL memory (Dudda et al., 2013; Gracias et al., 2013). It has also 
been shown to play a role in CTL proliferation and in regulating CTL responsiveness to 
type I IFN (Gracias et al., 2013). It has also been shown to positively regulate IFN-γ 
production in human NK cells (Trotta et al., 2012). Furthermore, miR-155 
overexpression has been observed in virus-infected cells, in which it suppresses 
apoptosis and promotes proliferation of HCV-infected hepatocytes (Zhang et al., 2012) 
and reduces NF-κB signaling, contributes to immortalization of EBV-infected B cells, 
and inhibits innate immune response to latent EBV infection (Lu et al., 2008). 
Therefore, a tight regulation of miR-155 expression is vital in order to ensure normal 
immune cell functions and prevent disease development. This also makes miR-155 as a 
good therapeutic target in numerous immune-related and infectious diseases. 
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2.7 MicroRNAs in teleost fish 
     Genes encoding miRNAs have been identified in teleost fish genomes (in silico 
prediction based on sequence homology) (Yang and He, 2014; Barozai, 2012; Loh et 
al., 2011), as well as conserved 7-mer sequences in the 3’ UTR of teleost fish genes 
identical to recognized miRNA-binding sites (Andreassen et al., 2009). MiRNAs have 
been demonstrated as crucial regulators of gene expression during in zebrafish 
development, indicating the presence of functional RNAi pathway that operates in 
teleost fish as it does in other organisms (Giraldez et al., 2006). The use of zebrafish as 
a model to study the role miRNAs play during vertebrate development has contributed 
significantly towards revealing some common themes in vertebrate miRNA functions 
(Takacs and Giraldez, 2010).  
 
     With about 23, 000 teleost fish species (http://fishbase.org/home.htm Accessed 10 
April 2014), teleost fishes comprise almost half of the extant vertebrate lineage. 
Teleosts exhibit astonishing variability in different aspects of biology from genomes to 
ecology and inhabit diverse aquatic environments of the world (Nelson, 2006). 
Therefore, they are good subjects for research on various biological aspects especially 
those pertaining to evolution.  
 
     Despite the enormous species diversity and the economic and cultural importance of 
fish in both wild fisheries and aquaculture, teleost fish miRNAs are currently 
underrepresented in the miRNA repository miRBase (http://mirbase.org), being limited 
to 8 species (miRBase release 20, accessed 25 April 2014). Among others, these include 
miRNAs identified in the model species zebrafish (Danio rerio) and medaka (Oryzias 
latipes) and the aquaculture fish species common carp (Cyprinus carpio) and Channel 
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catfish (Ictalurus punctatus).  A total number of 1250 teleost fish pre-miRNA hairpin 
sequences and 1044 mature miRNAs are currently listed in mirBase (http://mirbase.org, 
accessed 25 April 2014) and are summarized in Table 1. Zebrafish miRNAs are 
currently the most numerous teleost miRNAs in miRbase. 
 
Table 1. MicroRNA entries for teleost fish species held in Release 20 of miRBase 
(accessed 25 April 2014). 
Fish species Common name Sequences available 
in miRbase 
Reference(s) 
Oryzias latipes Medaka 168 precursors, 146 
mature 
Li et al., 2010; Tani 
et al., 2010 
Fugu rubripes Fugu 129 precursors, 108 
mature 
miRBase 
(communicated by)  
Mihaela Zavolan 
Tetraodon 
nigroviridis 
Pufferfish 132 precursors, 109 
mature 
miRBase 
(communicated by)   
M. Zavolan 
Danio rerio Zebrafish 346 precursors, 255 
mature 
Chen et al., 2005; 
Kloosterman et al., 
2006 + many others 
Cyprinus carpio Common carp 134 precursors, 146 
mature 
Zhu et al., 2012; 
Yan et al., 2012 
Paralichthys 
olivaceus 
Japanese flounder 20 precursors, 38 
mature 
Fu et al., 2011 
Hippoglossus 
hippoglossus 
Atlantic halibut 40 precursors, 37 
mature 
Bizuayehu et al., 
2012 
Ictalurus punctatus Channel catfish 281 precursors, 205 
mature 
Xu et al., 2013  
 
 
     The usefulness of zebrafish as a model to investigate miRNA functions in vertebrate 
embryogenesis allowed the elucidation of the mechanisms by which target mRNAs are 
regulated (Takacs and Giraldez, 2010; Morton et al., 2008; Giraldez et al., 2006; Schier 
and Giraldez, 2006;). Accordingly, many of these teleost miRNAs have been identified 
in studies that analyzed miRNAs profiles in different zebrafish developmental stages 
and in selected zebrafish cell lines (Wei et al., 2012; Chen et al., 2005), as well as in 
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general sequencing activities (Soares, 2009; Kloosterman et al., 2006). Indeed, many of 
the studies undertaken on teleost fish miRNAs focused on developmental profiling. 
Apart from zebrafish, miRNA developmental profiles have also been carried out on 
another model fish species medaka (Tani et al., 2012), and in the aquaculture fish 
Atlantic halibut (Bizuayehu et al., 2012).  
 
      MiRNAs from a few other fish species which await inclusion in miRbase are also 
available in literature, which include those identified from sequencing experiments and 
those predicted in silico (Table 2). While many of these miRNAs are evolutionarily 
conserved and are thus homologous to previously identified miRNAs from other 
organisms including other fishes, unique new miRNAs have been characterized (e.g. in 
Atlantic salmon) (Andreassen et al., 2013; Bekaert et al., 2013).  
     In functional terms, teleost fish miRNAs are less characterized compared with their 
mammalian homologues. Functional investigation has lagged behind the increasing 
reports on miRNA discovery and profiling in different biological settings. Apart from 
the activities of zebrafish miRNAs in different aspects of embryonic development 
(Tacaks and Giraldez, 2010), involvement of teleost fish miRNAs has been investigated 
in various physiological contexts in different species such as muscle growth and 
development (Yan et al., 2013), vitellogenesis (Cohen and Smith, 2013), oogenesis 
(Juanchich et al., 2013), aging (Terzibasi-Tozzini et al., 2014), liver-specific 
metabolism (Mennigen et al., 2014a,b), osmotic regulation and osmotic stress response 
(Yan et al., 2012a,b), organ regeneration (Yin et al., 2012; Thatcher et al., 2008; Yin et 
al., 2008), and immune responses to bacterial infection (Ordas et al., 2013; Wu et al., 
2012; Xia et al., 2011).   
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Table 2. Teleost fish species in which microRNAs have been identified other than those 
included in miRBase. 
Fish species Common name Reference(s) 
Gadus morhua Atlantic cod Johansen et al., 2011 
Ictalurus punctatus Channel catfish Barozai, 2012 
Lates calcarifer  Asian seabass Xia et al., 2011 
 Megalobrama 
amblycephala 
Blunt snout bream Yi et al., 2013 
Nothobranchius 
furzeri 
Turquoise killifish Terzibasi-Tozzini et al., 2014 
Oncorhynchus 
mykiss 
Rainbow trout Mennigen et al., 2014a,b; Juanchich et 
al., 2013; Mennigen et al., 2013; 
Trattner and Vestergren, 2013; Yang 
and He, 2014; Ma et al., 2012; Salem et 
al., 2010; Ramachandra et al., 2008 
Oreochromis 
niloticus 
Nile tilapia Xiao et al., 2014; Tang et al., 2013; Yan 
et al. 2013; Huang et al., 2012; Yan et 
al., 2012a,b,c  
Paralichthys 
olivaceus 
Japanese flounder Fu et al., 2011 
Salmo salar Atlantic salmon Andreassen et al., 2013; Bekaert et al., 
2013; Barozai, 2012; Reyes et al., 2012 
Hypophthalmichthys 
nobilis  
Bighead carp Chi et al., 2011 
Hypophthalmichthys 
molitrix  
Silver carp Chi et al., 2011 
Various cichlid 
species 
Lake Malawi 
cichlids 
Loh et al., 2011 
 
     Of the teleost miRNAs, those from zebrafish have the most functional data and 
validated targets (Takacs and Giraldez, 2010). In tilapia, miRNAs with experimentally 
validated targets have also been reported (Yan et al., 2013; Yan et al., 2012a,b). These 
include miR-206, which targets insulin-like growth factor 1 (IGF-1) mRNA to regulate 
growth in tilapia (Yan et al., 2013); miR-30c, which modulates the expression of heat 
shock protein 70 (HSP70) and consequently regulates responses to osmotic stress in the 
kidney (Yan et al., 2012); and miR-429, which silences the osmotic stress transcription 
factor 1 (OSTF1) and affects osmosensory signal transduction in the gill epithelium 
(Yan et al., 2012).  
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     Having a fully sequenced genome and being a model for functional genomics 
research, computationally predicted targets for zebrafish miRNAs are also available and 
can be obtained from TargetScanFish (http://www.targetscan.org/fish_62/) (Ulitsky et 
al., 2012). The role of the majority of teleost fish miRNAs and their targets is currently 
unknown. 
 
     The miRNAs identified and characterized from other teleost species (Table 2), 
pending their inclusion in miRBase, will greatly expand the number of annotated teleost 
fish miRNAs which would be a valuable resource for functional genomic studies and 
future research (explore evolution of fishes and vertebrates in general), especially 
studies dealing with the role of miRNA-mediated gene control in the expression of 
economically important traits. The lack of functional data for many of the teleost fish 
miRNAs currently offers a vast opportunity for scientific investigation. Functional 
studies will shed light on whether the many of the roles of these teleost miRNAs are 
conserved among teleosts and their mammalian homologues. MiRNAs most likely 
influence the expression of numerous mRNAs in different cell and tissue types in 
diverse biological contexts in fish, as do many miRNAs whose functions have been 
elucidated in other organisms.  
 
2.8  Do homologous miRNAs perform conserved functions across species? 
     It is interesting to look into the functional conservation of homologous miRNAs 
across the vertebrate lineage. The high degree of conservation of miRNAs among 
distantly related vertebrate species implies involvement in generic biological processes 
and functional conservation. Accordingly, miRNAs are identified by numbers in a 
continuous numbering system across all living species. A three-letter prefix is used to 
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indicate the species in which the individual miRNA was found. Functional conservation 
across multiple species may be valuable when working with model organisms to 
unravel miRNA functions in various aspects of vertebrate biology. 
 
     For example, miR-146a and miR-146b are highly conserved between humans and 
teleost fishes. In mammals, the expression of these two members of the miR-146 family 
is stimulated by bacterial lipopolysaccharide (LPS) and the inflammatory cytokines 
interleukin-1 (IL-1) and tumor necrosis factor-α (TNF-α) (Taganov et al., 2006) and by 
bacterial (Nahid et al., 2011) and viral (Ho et al., 2014) infections. They act in the 
negative feedback regulation of TLR signalling by targeting the TLR signalling 
intermediates IL-1 receptor-associated kinase (IRAK) and TNF receptor-associated 
factor 6 (TRAF6) (Boldin et al., 2011; Curtale et al., 2010; Bhaumik et al., 2008; 
Taganov et al., 2006). Mir-146a has also been shown to target the transcription factors 
IFN regulatory factor 5 (IRF-5) and sugnal transducer and activator of transcription 1 
(STAT-1), thus inhibits IFN signalling (Tang et al., 2009). Because innate immune 
signalling pathways are evolutionarily conserved among the vertebrates (van der Vaart, 
et al., 2012; Aoki et al., 2008; Purcell et al., 2006), and the teleost fish orthologues of 
IRAK and TRAF6 (Phelan et al., 2005) also possess miR-146 putative target sites 
(Ordas et al., 2013), the functional conservation of miR-146 feedback control of TLR 
signalling between mammals and teleost fish may be rationally anticipated. In 
zebrafish, miR-146a/b orthologues have been shown to be upregulated following 
bacterial infection (Ordas et al., 2013). 
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      Likewise, the liver-specific miR-122 is conserved among the vertebrates and 
participates in modulating numerous hepatic processes including the metabolism of fat 
and cholesterol in mammals (Hsu et al., 2012; Hu et al., 2012; Tsai et al., 2012). A 
study in rainbow trout indicated that miR-122 may have a conserved function in 
postprandial lipogenesis in the liver in mammals and in fish and may have evolved in 
vertebrates to play a role in liver-specific metabolic activities (Mennigen et al., 2014).  
 
     However, while the induction of miR-146a/b in bacteria-infected zebrafish embryos 
suggests an association with innate immune responses, knockdown of miR-146a/b did 
not strongly affect the induction of teleost irak1, irf5, stat1, and traf6 transcripts (Ordas 
et al., 2013). Whereas protein levels of IRAK1, IRF5, STAT-1, and TRAF6 were not 
checked and miR-146a/b may function by translational suppression (Ordas et al., 2013), 
it is also possible that miR-146a/b have different mRNA targets between fish and 
mammals.       
 
     Likewise, miRNAs may show quantitative variation in function and different target 
mRNA repertiore among vertebrate species, as indicated for miR-122 (Mennigen et al., 
2014).  
 
     Recent reports also demonstrated that differences in miRNA expression pattern and 
hence variation in regulation and function, increases with larger physiological 
differences among vertebrate species (Ason et al., 2006) Consequently, evolvability of 
miRNA target sites between fish and humans is higher compared with that between 
chimpanzee and human (Xu et al., 2014). Thus, despite the highly conserved sequences, 
homologous miRNAs may evolve specialized functions in different species. This 
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implies that evolution of RNAi takes place at the 3’ UTR miRNA recognition region of 
the regulated mRNAs rather than in the miRNA seed region. This may reflect some 
unique features of their physiology arising from the need to diversify physiological 
strategies to adapt to the various lifestyles and environments.   
 
2.9  General discussion of the project 
     The fundamental role of miRNAs in virtually all biological activities and the 
numerous gaps in the current knowledge of their exact roles in these various processes 
in organisms necessitate continued scientific research on the involvement of miRNAs in 
every biological problem of interest. In this thesis, the potential role of miRNAs in 
rhabdovirus infection in rainbow trout and in fish responses to vaccination with a DNA 
vaccine based on the fish rhabdovirus glycoprotein was investigated.  
 
     Although virus infection in mammals and bacterial infection in teleost fish have 
been shown to modulate the expression of cellular miRNAs, studies on miRNA 
expression profiling following virus infection and/or vacination in teleost fish are 
presently limited. Identification of IFN-induced miRNAs in response to both VHSV 
infection and VHSV-G-based DNA vaccination reflects the ability of the virus and the 
glycoprotein to stimulate fish innate immune responses, particularly IFN and IFN-
induced mechanisms. 
 
     As reported in Manuscript I, the induction of the clustered miRNAs miR-462 and 
miR-731 by IFNs can be accounted for by an IFN-stimulated response element (ISRE) 
and gamma IFN activation site (GAS) in the promoter sequences upstream of the miR-
462/731 locus. It was also found that the teleost miR-462/731 cluster is an orthologue 
33 
 
of an ancestral miR-191/425 cluster in vertebrates, which is known to be involved in 
cell cycle control in humans. Functional specialization between the teleost miR-462/731 
and human miR-191/425 clusters is a consequence of a change in detailed genome 
position and mode of regulation, presumably along with evolution of the 3’ UTR 
miRNA recognition sites in the mRNA. Accordingly, in silico analysis indicates very 
dissimilar target profiles between fish and humans, which reflects evolution of diverse 
species-specific functions of orthologous miRNAs among vertebrates. 
 
     In manuscript II, the IFN-dependent expression of miR-462/731 was confirmed and 
was shown to be induced also by the natural infection-mimicking VHSV-G-based DNA 
vaccine, demonstrating a common miRNA response to both infection and vaccination. 
These results further demonstrated that the two miRNAs may be involved in IFN-
mediated antiviral activities, acting as antiviral effectors thereby contributing to the 
early protective effect of the DNA vaccine.  
 
     Finally, manuscript III (review) provides a state-of-the-art update on the roles of 
miRNAs in antiviral defense in vertebrates. 
 
     The findings in this thesis add up to the knowledge on the functional characterization 
of miRNAs in the context of host-virus interactions in teleost fishes and should 
stimulate interest among scientists to pursue research in this new and interesting area of 
fish biology where potential research opportunities abound and is relatively 
underexplored. The two IFN-induced miRNAs identified in the project may be novel 
components of the antiviral response in teleost fishes. Their potential use as biomarkers 
of virus infection or vaccine-induced immunity should be explored along with the 
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search for genetic variability related to disease immunity. They may also be potential 
targets for therapeutic intervention against viral diseases in aquaculture.  
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Short title: Regulation and evolution of two vertebrate microRNAs in Rainbow trout 
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Significance: MicroRNAs (miRNAs) are important regulators of gene expression 
involved in virtually all biological processes. Two clustered miRNAs, miR-462 and 
miR-731, identified thus far only in teleost fishes, lack functional characterization. 
Here, we found a strong induction of miR-462/731 in virus-infected fish, correlating 
with interferon sensitive promoter elements. The miR-462 and miR-731 were shown to 
be orthologues of the ancestral miRNAs, miR-191 and miR-425, respectively, which in 
humans are involved in cell cycle control. The findings demonstrate that some miRNAs 
despite high conservation have evolved into specialized functions in different vertebrate 
lineages. This is the first report on the presence of interferon-inducible miRNAs in 
teleost fish. We speculate that RNA interference might play an important role in innate 
antiviral immunity in fish. 
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Abstract: MicroRNAs (miRNAs) are ~22 base-pair long non coding RNAs which 
regulate gene expression in the cytoplasm of eukaryotic cells by binding to specific 
target regions in mRNAs thereby mediating transcriptional blocking or mRNA 
cleavage. Of the more than 1000 human miRNAs which have been described so far, 
more than 50% are conserved across vertebrate species. Through their fundamental 
roles in cellular pathways, gene regulation mediated by miRNAs has been shown to be 
involved in many physiological processes such as embryonic development, 
toxicological response, tumour formation, and immunological reactions.  The miRNAs 
miR-462 and miR-731 have so far only been identified in teleost fishes without data on 
functional aspects. We here report a strong upregulation in rainbow trout following 
inoculation with the highly virulent rhabdovirus viral hemorrhagic septicaemia virus. 
Gene synteny analyses along with gene sequence conservation suggested that the teleost 
fish miRNAs have evolved from an ancestral miRNA cluster known as miR-191/425. 
In humans, the genes encoding these miRNAs are found in an intron of the DALDR3 
gene and functionally associated with cell cycle regulation. In contrast to this, we found 
the teleost miR cluster in an intergenic position with upstream IFN-related regulatory 
elements. Stimulation of fish cell cultures with the TLR3 ligand poly I:C accordingly 
induced upregulated expression of the teleost miRs 462/731 while no stimulatory effect 
on miRNA-191/425 expression was seen in human cell lines. Despite high sequence 
conservation, evolution has thus resulted in different functional roles of these 
orthologous miRNA clusters in different vertebrate lineages.   
 
Keywords: MicroRNA; Regulation; Fish; Rhabdovirus; Interferon response; miR-462; 
miR-731; miR-191 cluster; Evolution 
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Introduction: 
MicroRNAs are small non-coding RNA molecules (22-25 nucleotides long) that 
modulate gene expression in the cells by pairing with complementary mRNAs whereby 
they inhibit translation of genes into proteins (1). Following their first description in 
1993 in invertebrates (2), it has been found that these molecules are remarkably 
conserved within vertebrates and as a statement of their importance, it has been 
estimated that more than 60% of human protein coding genes are targets of miRNAs 
(3). New miRNAs are continuously being discovered, identified by a continuous 
numbering system in miRBase (4). In humans, animals, and plants, more than 20000 
unique miRNAs have been described and related to a range of different functions. The 
complexity of miRNA regulation is increased by the fact that each miRNA often 
appears to target several genes, often involved in the same pathway or the same overall 
phenotype, thereby reinforcing their functionality (5). In this study, we have observed a 
very strong induction of two clustered miRNAs, miR-462 and miR-731 (herein referred 
to as the miR-462/731 cluster), in the liver of a teleost fish, the rainbow trout 
(Oncorhynchus mykiss), following infection with the fish rhabdovirus viral 
hemorrhagic septicaemia virus (VHSV). Analysis of regulatory sequences surrounding 
the miR-462/731 locus revealed interferon (IFN) inducible and other immune-related 
promoter elements, suggesting involvement of the miRs in anti-viral immune responses. 
By gene synteny and sequence homology analysis, we found that the teleost miR-462 
and -731 are orthologues of miR-191 and -425, respectively, found in mammals as well 
as in the ancestral elephant shark belonging to cartilaginous fishes. Despite high 
sequence conservation of miRs across vertebrate species, data on the functional role of 
miRs in terms of which genes they target and how they are regulated have appeared to 
be less consistent and dependent the physiological specialization of the individual 
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vertebrate lineages (6, 7). Here we describe how these two teleost miRNAs differ from 
their human orthologues in terms of genome position and regulation and discuss how 
these differences may reflect functional specialization.  
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Results: 
Identification of regulated miRNAs in the liver of VHSV infected fish  
Microarray-based examination of miRNA regulation in the liver tissues from VHSV 
infected as compared to non-infected control fish using 1492 unique miRNA specific 
probes detected 120 miRNAs expressed significantly above the background level 
determined as a mean of all probe signals. Of these, 13 showed more than two-fold up 
regulation in infected compared to control fish (Fig. 1A) and among these, miR-462 and 
-731 were particularly upregulated (>50-fold). The strong expression levels of the two 
miRNAs were confirmed by qPCR, showing that miR-462 was upregulated ~20-fold 
and miR-731 ~15-fold (Fig. 1B).    
Identification and characterization of an immune induced polymerase II specific 
promoter upstream miR-462 and 731 in fish 
     We found miRNAs miR-462 and miR-731 particularly interesting as both were 
highly regulated in the liver of VHSV-infected fish. miR-462 and miR-731 have been 
described so far only in teleost fish and the mirBase currently lists only miR-462 and 
miR-731 as identified in zebrafish (Danio rerio) (8, 9), medaka (Oryzias latipes) (10) 
and channel catfish (Ictalurus punctatus) (where only miR-462 has been identified so 
far; (11).   
     A search in Ensembl database (http://www.ensembl.org/index.html) further showed 
that these miRNAs are found as an intergenic miRNA cluster between the housekeeping 
genes inosine monophosphate dehydrogenase 2 (IMPDH2) and DALR anticodon 
binding domain containing 3 (DALRD3) on chromosome 8 in the zebrafish genome and 
that the two miRNAs comprising the miR-462 cluster are separated by 125 nucleotides. 
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Available genomes of fish and higher vertebrates were searched for the IMPDH2 and 
the DALRD3 genes and we found evolutionary variants of the two miRNAs in the 
region of these genes for the various genomes. In the teleost fish genomes the mature 
miR-462 and -731 were found to be fully conserved in both seed sequence and genome 
location. We aligned the upstream sequence from IMPDH2 to the miRNA cluster and 
the downstream cluster until DALRD3 using the BLAST bl2seq option at NCBI 
Genbank (http://www.ncbi.nlm.nih.gov/genbank/) and found some sequence motifs, 
which were conserved in teleost fish. We used the conserved sequence motifs together 
with conserved sequences in the premature miRNAs to sequence a 1000 bp long stretch 
of the rainbow trout genome flanking the 5´-side of the cluster from the last part of the 
miR-731 hairpin gene (Fig. 2). In order to look for indications of a promoter upstream 
of the miRNA cluster, we searched this sequence using the Transcription Element 
Search System (TESS; http://www.cbil.upenn.edu/tess) and BIOBASE immune specific 
binding sites prediction (http://www.biobase.de). In this way, we identified an 
interferon (IFN)-stimulated response element (ISRE), G/A/T + GAAANNGAAA + 
G/C + A/T/C, (12-15) 828 bp upstream the start of the mature miR-462 (Fig. 2), 
indicative of type I interferon inducibility. This motif is 100% conserved among teleost 
fishes, indicating conserved regulation (Fig. S1). Another motif, the purine box 1 
(PU.1: GAGGAAGT) involved in the development of granulocytes, macrophages, and 
lymphocytes in jawed vertebrates (16-17) was conserved among teleosts (Fig. S1). In 
the rainbow trout sequence we further identified the TATA element (18), indicative of 
RNA polymerase II-dependent expression and a motif which was repeated twice and 
resembled the gamma interferon activated site (GAS) element (IFN-gamma activated 
sequence; TTN CNN NAA; (19-21). In addition, a sequence from the rainbow trout 
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GGTTTTTTC was found to be conserved in the other fish as well, but we were not able 
to identify this as any known promoter motif (Fig. 2).  
Identification of miR-462 and miR-731 orthologues in mammalian genomes 
     Synteny analysis between the zebrafish and human genomes showed the two 
intergenic/non-intronic miRNAs, miR-191 and miR-425, within the region flanked by 
DALRD3 and IMPDH2 instead of miR-462 and miR-731 present in teleost fish 
genomes (http://www.ensembl.org/index.html) (Fig.3 A-B). Alignment of miR-191 and 
miR-425 with miR-462 and miR-731, respectively, showed high homology especially 
in the antisense strand and a full conservation in the seed area (Fig.3 C). Furthermore, 
by aligning the fish and the human DALRD3 sequences, we found that the miR-191/425 
cluster sequences were absent in the fish DALRD3 locus (data not shown). Together, 
these findings suggest that the intragenic teleost fish miR-462/731 cluster is 
phylogenetically related to the miR-191/425 cluster. Interestingly, while comparing 
several mammalian genomes from the Ensembl database, we noted that whereas the 
human, macaque, and mamorset miR-191 cluster is present intragenically in an intron 
of DALRD3 (Fig 3 A-B), this is not the case for all mammalian genomes.   
Stimulation of miRNA expression in cell culture 
Stimulation of rainbow trout liver cells (RTL-W1) with the TLR3 ligand poly I:C 
upregulated the expression of the miR-462/731 cluster (Fig. 4A&B). On the other hand, 
infection of RTL-W1 cells with VHSV did not stimulate an upregulation of the 
miRNAs but rather a tendency was seen for downregulation (Fig. S3). The presumed 
miRNA promoter sequence was checked for its ability to promote the expression of the 
green fluorescent protein (GFP) in rainbow trout macrophage cell line (RTS-11) 
transfected with a GFP reporter plasmid construct carrying the suspected miRNA 
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promoter sequence upstream the GFP gene. Flow cytometry analysis confirmed that 
these cells could be stimulated by poly I:C to produce GFP, while the IFN-γ-stimulating 
ligand phytohemagglutinin (PHA) failed to induce GFP expression (Fig. 4C-G).  
     Subsequent stimulation of HeLa cells with poly I:C induced the expression of the 
IFN-induced gene ISG12 but not miR-191 and miR-425  (Fig. S4). We used HEK293T 
cells as control as these are known not to be poly I:C inducible due to lack of TLR3 
expression (22, 23) and showed neither ISG12 regulation nor significant regulation of 
the examined miRNAs.   
Phylogenetic analysis 
    Based on the high homology of the seed regions in the non-teleost miRNA-191/425 
and teleost miRNA-462/731 clusters (Fig. 3C), conserved clustering pattern, related 
genomic location as well as lack of genomic co-existence, we hypothesized these 
miRNA clusters to represent evolutionary orthologues. We therefore performed 
phylogenetic analysis based on the mature sequences of the miR-191 and miR-462 
cluster miRNAs retrieved from miRbase to elucidate their evolutionary history in 
vertebrates.  
    Unrooted neighbor-joining (NJ) bootstrapped distance trees (1000 replicates) for both 
miR-191 and miR-462 cluster miRNAs showed that the miRNAs of teleosts and those 
of a cartilaginous fish (elephant shark; Callorhinchus milii) clustered within distinct 
clades (Fig. 5A-B). The teleost clade is separated with large genetic distances from 
those of the cartilaginous fish and higher vertebrates, with the largest genetic distance 
from the latter. On the other hand, miRNAs of diverse higher vertebrates all clustered 
together and were thus almost identical.   
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Discussion:  
The data presented here are the first functional and evolutionary analyses of a cluster of 
two virus induced microRNAs (miR-462/731) only found in teleost fishes. MicroRNAs 
are endogenous small RNA molecules which have appeared to play an important role in 
posttranscriptional regulation of protein expression in many living organisms (1, 24). 
Their high level of conservation across vertebrate species suggests involvement in 
generic biological processes, but this is not consistently supported by currently 
available data (6, 7). We report here that the miR-462/731 cluster in teleost fishes is 
orthologous to the miR-191/425 cluster present in other vertebrates, but differ in gene 
regulation and detailed genomic position. The results suggest that the miRNA clusters 
has evolved different functional roles in different vertebrate lineages.      
   Based on teleosts belonging to an evolutionary early vertebrate lineage, we initially 
thought that the miR-462/731 cluster represented an ancestral form of the mammalian 
miR-191/425 cluster. However, the recently discovered presence of the miR-191 cluster 
in the cartilaginous fish C. milii, which has the slowest evolving genome of all known 
vertebrates (25), suggested that the miR-191 cluster has existed in the common ancestor 
of cartilaginous fishes and bony vertebrates. The probability of convergent evolution of 
two miRNAs is considered to be small (26-27) and animal miRNAs generally exhibit a 
low rate of secondary loss (28). Together with their consistent position relative to the 
DALRD3 locus as well as the association of the two miRNAs comprising the given 
miRNA cluster in all genomes analyzed, this further supports the genetic relation of the 
miR-462 and miR-191 clusters. 
     Phylogenetic analysis accordingly demonstrated that the teleost fish miRNA cluster 
represented a distinct subclade within their non-teleost homologues. This basically 
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suggests that the fish miRs 462 and 731 should be considered as homologues of the 
non-teleost miRs 191 and 425, respectively. The large genetic distance that according to 
the phylogenetic analysis (Fig. 5) separates the teleost fish miRNA cluster from those of 
other vertebrates indicates that teleost miRNAs in relative terms have undergone 
accelerated changes but is based on a very high conservation in the seed region among 
the non-teleosts in combination with a few changes in the teleost nucleotide sequence 
outside of the seed region. The most important evolutionary adaptation within the 
teleost fish thus appeared to be the local regulatory elements outside the miRNA 
cluster.   
     All available teleost fish genomes have the miR462 and miR-731 positioned in a 
region between the DALRD3 and IMPDH2 loci whereas humans and some other 
mammals have the homologous miR-191 cluster in an intron in the DALRD3 gene. The 
intergenic position of the miR-191cluster in the genome of the primitive cartilaginous 
fish, C. milii (25) suggests that a translocation of the miR-191 locus into the DALDR3 
intron has occurred during vertebrate evolution in the primate lineage including human, 
macaque, and marmoset.  
     Our search for regulatory elements upstream the teleost miR-462 cluster supported 
the involvement of the miRNAs in innate immune functions. Presence of ISRE and 
GAS elements suggested that their expression can be enhanced by the binding of IFN-
induced transcription factors while the TATA-box indicated that the expression of miR-
462 and miR-731 is steered by a polymerase type II promoter as reported for other 
miRNAs (29). We found an ISRE element, which itself shows a remarkable 
conservation among vertebrates (15) and is a binding site for IFN-regulatory factors 
(IRFs) and IFN-stimulated gene factor 3 (ISGF3). Upregulation of the miR-462/731 
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cluster in fish RTL-W1 cells stimulated with the TLR3 ligand poly I:C supported that 
the expression of the miRNAs was related to IFN induction (Fig. 4A&B). The observed 
downregulation of miR-462/731 cluster in VHSV-infected RTL-W1 cells (Fig. S3) was 
contradictory to what was observed in the fish, but correlated with a lack of IFN 
induction in the RTL-W1 cells following VHSV infection and could thus reflect that 
VHSV is able to suppress IFN induction (30) in this cell line.   
     The presence of the GAS element indicates IFN-γ-regulated transcription. However, 
attempts to induce miR-462/miR-731 expression by stimulation of RTS-11 cells with 
PHA or LPS gave only weak signal in immunofluorescence microscopy (not shown) 
and could not be shown by flow cytometry (Fig. 4G). These cells have been shown to 
upregulate levels of IFN-γ-inducible protein 10 (IP-10), as well as the key IFN-γ 
intracellular signalling molecule STAT 1 in response to PHA stimulation (31) and our 
findings might thus reflect that the cloned promoter region is incomplete in terms of 
IFN-γ sensitive motifs.  Like the ISRE and GAS motifs, the leukocyte differentiation 
related transcription factor (PU.1) binding sequence also appeared to be a conserved 
immune-related regulatory element in teleost genomes (16-17; 32-33) upstream of the 
miR-462 cluster. In rainbow trout, PU.1 is known to be upregulated tissue specifically 
in the muscle, liver, intestine, brain, head kidney, and in macrophages in primary cell 
culture following LPS stimulation (32).    
     While IFN induced expression of other miRNAs as well as the involvement of 
miRNAs in antiviral immune mechanisms has been described earlier (34-35), this is to 
our knowledge the first report describing the involvement of the teleost miR-462/731 
cluster in response to virus infection. In contrast, the expression of the human miR-191 
cluster has not been directly associated with immune responses. Accordingly, we were 
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not able to induce miR-191 nor miR-425 in poly I:C-stimulated human cell lines HeLa  
and  HEK-293T despite the high up-regulation in HeLa cells of the IFN-stimulated gene 
ISG-12. In addition, the miR-191/425 cluster was not among the many inducible 
miRNAs found in a virus replicon-bearing human hepatoma cell line, nor were they 
upregulated by the addition of ribavirin and/or IFN-β to these cells (36). The regulation 
of the intragenic miR-191 cluster in humans appears to be different, possibly controlled 
by various sequence elements such as estrogen response elements (37-38), among other 
regulatory elements (39-40), and by epigenetic mechanisms (41). Furthermore, the 
implication of the human miR-191 cluster in various physiological processes (42-46) 
and in a number of pathologies and human neoplasias (37-41; 47-48) indicate a wide 
and diverse expression pattern, target repertoire, and regulatory roles in diverse 
processes in multiple organs and tissues.  As discussed by Ason at al. (7), differences in 
miRNA expression profiles – and thereby differences in regulation – between vertebrate 
species increases with increased physiological differences. Accordingly, Xu et al. (6) 
found a very high evolvability of miRNA target sites between fish and humans and low 
evolvability between chimpanzee and human using cross-linking immunoprecipitation 
data.          
     In conclusion, our study showed that the IFN-regulated miR-462/731 cluster in 
teleost fishes is an orthologue of the ancestral vertebrate miR-191/425 cluster (present 
in a wide range of non-teleost vertebrates from primitive cartilaginous fish to humans) 
but that the teleost variant has evolved differently with respect to functional roles. In 
contrast to the miR-462/731 cluster in teleost genomes, the human miR-191/425 cluster 
does not appear to be involved in immunological functions. Thus, the regulatory 
changes through evolution of the orthologous miRNA clusters have resulted in their 
functional specialization/diversification in different vertebrate lineages. This was 
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supported by our in silico target prediction analysis suggesting very different target 
profiles in fish and humans (Tables S2-S5) but requires further functional analysis as 
well as 3´UTR target sequence validation. Our findings support earlier analyses 
showing that miRNA sequence conservation among distantly related species may not 
necessarily imply functional conservation and that higher miRNA expression variation 
reflects functional diversity associated with larger differences in physiology (7). The 
evolution of IFN-related response elements associated with the miR-462 cluster in 
teleost fishes seems to reflect some unique features of the innate immune response in 
teleost fishes. Specialization in the function of these miRNAs across this highly diverse 
vertebrate group could have resulted from the need to diversify innate immune defence 
strategies as an adaptation to the aquatic environments with varying temperatures and 
frequent exposure to water borne viruses.  Further functional studies are expected to 
reveal how the teleost miR-462 and -731 are involved in the response to virus infection.  
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Materials and methods: 
Total RNA purification from liver of diseased trout 
Total RNA from the liver was isolated and purified using the miRNeasy Mini kit 
(Qiagen cat.no. 217004), quantified, and quality tested by using the nanodrop system 
(Thermo Scientific, USA) measuring RNA at OD 260 nm and impurities by the OD 
260nm / OD 280 nm ratio followed by stabilization in RNA stable (Biomatrica, USA) 
according to the manufacturers protocol. A description of the viral challenge 
experiment is presented in supplementary Text S1.  
Expression analysis of miRNAs and ISG-12 gene 
qPCR for miRNAs was performed using the sequences of the mature dre-miR-462, dre-
miR-731, and hsa-miR-191 as forward primers together with the universal primer from 
the kit used to prepare cDNA (Text S1). The mature miRNA sequences can be found in 
the miRBase at http://www.mirbase.org/ (49). For detection of human ISG12 mRNA 
transcripts, human ISG12 sequence was used as forward primer together with the 
universal primer from the kit, as above. 
     Real-Time PCR reactions were run on a Mx3000P machine (Agilent Technologies, 
CA, USA) in reaction volumes of 25 μl containing a master mix solution (Brilliant® 
SYBR
®
 Green QPCR Master Mix cat. no. 600548, Agilent Technologies, CA, USA), 
specific primers, ROX, water, and 5 μl of cDNA template (prepared as described in 
Text S1) diluted x100. The program was set to 10 min at 95C, 40 cycles of 20 sec at 
94C and 1 min at 60C with collection of fluorescent data. Melting curves were 
determined by denaturing PCR products for 1 min at 95˚C followed by a ramp down to 
55˚C for 30 sec followed by a gradual 0.2˚C/sec climb to 95˚C continuously recording 
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fluorescence. Transcript levels were measured as Ct values and normalized to trout 
snoRNA-U23, miR-16, let-7a, or snoRNA U6 for miRNAs and to the housekeeping gene 
18S rRNA for human ISG-12 mRNA. PCR Primers for both miRNA and mRNA 
detection are listed in Table S1. Values presented are means of normalized Ct values 
from 3 cell culture wells + SD. The sizes of all PCR products were verified by 
inspection of the dissociation curve and by gel electrophoresis. 
Genomic localisation of the miR-462 cluster and upstream region in sequenced 
fishes 
The gene cluster containing miR-462 and miR-731 was localised on the chromosome 8 
of the zebrafish genome in Ensembl release 48 (50). Synteny analysis was used to find 
homologous miRNA genes in all teleost fish genome assemblies present in Ensembl as 
well as in selected genomes of higher vertebrates including human. This was done by 
searching these genomes for the genes IMPDH2 and DALRD3 flanking the miR-462 
cluster in the zebrafish chromosome 8. The miRNAs were localized using the mature 
miRNA sequences and the NCBI 2seq blast algorithm. Upstream of these miRNAs,  
immunological relevant promoter motifs were found by the use of the on-line database 
search tools Transcription Element search System (TESS; 
http://www.cbil.upenn.edu/tess) and BIOBASE (www.biobase.de) as well as blast 
(bl2seq) (http://www.ncbi.nlm.nih.gov/genbank/)  alignments for previously published 
motifs from fish. All searches were performed on the 1000 nt upstream of the miR-462 
locus. Selected vertebrate miR-191 and miR-425 sequences were aligned with the 
zebrafish miR-462 and miR-731, respectively, in the CLC main Workbench (CLC, 
Denmark) multiple alignment using default settings.   
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Cloning and sequencing of the premature miR-462 cluster and its 5'- flanking 
region: 
Two PCR amplicons generated (Text S1) were cloned into the TOPO TA Cloning Kit 
vector 
®
 (Invitrogen). Plasmids were transformed in DH5α cells and cultured in LB 
medium with ampicillin (100 μg/ml) and screened for inserts by T7-M13 primers as 
specified by Invitrogen. Plasmids of positive clones were purified using the Plasmid 
DNA Purification kit (Qiagen). Inserts were verified by gel electrophoresis of 5' EcoRI 
and 3' XbaI double digests. Confirmed clones were sequenced commercially (DNA 
Technology, Denmark) using the cloning primers.  
Construction of a plasmid containing the 5’-flanking region and a reporter gene 
EGFP  
The 5'-flanking region of the miRNA cluster was amplified using a forward primer 
composed on the 5' side by an inserted restriction site for BglII (underlined) followed 
by the sequence of the ISRE element containing region roughly 1000 nt upstream the 
miRNA cluster, 5'-GGAGATCTAGAAGTGAAAGTGAAATACA-3' in combination 
with a reverse primer flanked on its 5' side by a XbaI restriction site (underlined), 5'-
CGCTCTAGA TACCCGCTAACACCACTACTGAGT-3'. For the amplification of the 
presumed promoter area the following conditions were used: 1 cycle of 94°C for 3 min, 
14 cycles of 94°C for 60 sec, 54°C decrease 0.5ºC per cycle for 60 sec and 68°C for 2 
min, 19 cycles of 94°C for 60 sec, 46°C for 60 sec and 68°C for 1 min, with a terminal 
step of 5 min at 68°C. The PCR product (838 bp) was digested by BglII and XbaI after 
gel purification and cloned into pcDNA3.1/CT-GFP (Invitrogen) in which the CMV 
promoter had been excised by BglII and XbaI digestion. The presence of the presumed 
ISRE promoter in the pcDNA3.1/CT-ISREprom-GFP plasmid was confirmed by 
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restriction enzymes and by bidirectional sequencing (DNA Technology, Denmark). 
Concentrations of plasmids were determined by Nanodrop spectrophotometry (Thermo 
Fisher Scientific, Germany). 
Cell culture transfection and ligand stimulation studies 
For flow cytometry studies of promoter activation, 10
6
 RTS-11cells (51) were 
electroporated with 2µg pcDNA3.1/CT-ISREprom-GFP plasmid using the 
Microporator MP-100 system (Invitrogen, USA) for 24 well plates and 10µl tips using 
two pulses of 1300 volts at a pulse width of 20. Immediately following electroporation, 
either 100µg/ml poly I:C (Sigma-Aldrich GmbH, Steinheim, Germany; CAS # 42424-
50-0) formulated 1:2 in DOTAP as previously described (57) or 20 µg/ml 
phytohaemagglutinin (PHA) was added directly to the medium. As controls, mock cells 
or cells transfected with plasmids without the presumed ISRE promoter or plasmid 
without EGFP were used. Following 48 hrs of stimulation at 15
0
C, cells were 
trypsinized and detached from plates, stained with CELL LAB ApoScreen™ Propidium 
Iodide (PI) (Beckman Coulter, USA) and run in a Beckman Coulter FC-500 flow 
cytometer. Graphs were prepared in the Kaluza software (Beckman Coulter, USA) 
gating out PI stained dead cells. Rainbow trout RTL-W1 cells (52) and human HeLa 
and HEK293T cells stimulated with poly I:C or inoculated with VHS virus (fish cells 
only) were examined for miRNA and gene expression as described above. 
Bioinformatics analysis  
     Mature miRNA sequences of miR-191/425 and miR-462/731 were retrieved from 
miRbase. Elephant shark miR-191/425 stem-loop sequences were accessed from NCBI 
Nucleotide database (http://www.ncbi.nlm.nih.gov/nuccore/). Multiple sequence 
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alignment was carried out using Clustal Omega through the European Molecular 
Biology Laboratory-European Bioinformatics Institute (EMBL-EBI) server 
(http://www.ebi.ac.uk/Tools/msa/clustalo/) (53). The aligned sequences were then 
analysed by Neighbour-Joining method using Jukes-Cantor nucleotide distance measure 
and 1000 replicates using CLC Genomic Workbench 7.0.3.  The trees were 
subsequently visualised as unrooted neighbor joining (NJ) trees.  Putative targets of 
miR-191 and miR-462 were predicted with the TargetScanHuman Release 6.2 
algorithm, which predicts target mRNAs in vertebrate genomes 
(http://www.targetscan.org/vert_61/) (3). Determination of the potential targets of 
teleost fish miR-462 and miR-731 was performed using the TargetScanFish Release 6.2 
algorithm, which predicts target mRNA in the zebrafish genome 
(www.targetscan.org/fish_62/) (54).  
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Figures 
 
              
 
Fig. 1: miR-462 and miR-731 are highly up-regulated in the liver of rainbow trout 
infected with viral hemorrhagic septicaemia virus (VHSV). (A) The data presented are 
from a microarray experiment where the Ncode V2 probeset covering miRBase v.9 was 
used to detect up-(blue) and down-regulated (red) miRNAs in liver samples from 
diseased rainbow participating in an infection trial (shown in insert). Fold regulation 
was calculated by dividing the mean intensity of arrays with RNA from diseased fish 
with the mean of arrays with RNA from control fish. Up-regulated miRNAs are shown 
as blue bars and down regulated miRNAs as red bars. Probes are denoted according to 
convention and as in miRBase. Organisms: dre = Danio rerio , hsa = Homo sapiens and 
dme = Drosophila melanogaster. (B) qPCR validation of miR-462 and miR-731 
expression in the liver of VHSV-infected rainbow trout. Fold regulation was calculated 
from the mean values of duplicate measurements using the ΔΔCt method, where 
Relative Expression = 2
−ΔΔC
t and ΔΔC
t
 = (Ct infected − Ct reference gene) − (Ct non-infected − Ct 
reference gene). The reference gene used for normalization was omy-snoRNA U23. miRNA 
expression was analyzed in 6 VHSV-challenged fish relative to 6 unchallenged fish.  
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Fig. 2: Potential miRNA promoter area in rainbow trout. The conserved motif 
sequences ISRE and PU.1 found upstream of the two miRNAs (Fig. S1) together with 
the miRNA sequences allowed design of primers for sequencing of the area from the 
ISRE element to the end of the mature miR-731. Several motifs known from 
immunologically relevant promoters were identified in this sequence. Element key 
colors: Red: ISRE element of fish according to Castro et al. 2008 (15); Orange: The 
PU.1 element (17); Brown: The TATA-box; Yellow: consensus GAS elements (15); 
Blue: mature miRNAs up-regulated during VHSV infection; Green: unknown 
conserved sequence. Based on these motifs the upstream sequence is presumed to be an 
IFNγ regulated class 2 polymerase promoter. The identified sequence is part of the 
intergenic area between the genes dalrd3 and impdh2 in the trout genome and 
comprises 1119 bp. The location between dalrd3 and impdh2 was also conserved in the 
other fish.  
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Fig. 3: miR-462 and miR-731 in fish are orthologous of miR191 and miR-425 in higher 
vertebrates. (A-B) Diagram of the location of the miR-462731 cluster in zebrafish and 
the miR-191/425 cluster in humans. (C) Alignment of pre-miRNA sequences from 
various vertebrate species. Highlighted below the alignments is the location of the 
mature antisense miRNA. hsa = Homo sapiens (human), bta = Bos taurus (cow),  rno = 
Rattus norvegius (rat), mmu = Mus musculus (mouse), mdo = Monodelphis domestica 
(opossum), xtr = Xenopus tropicalis (frog), and dre = Danio rerio (Zebrafish). See 
Figure S2 for an alignment including more species.  
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Fig. 4: The promoter steering expression of miR462 and miR731 can be activated by 
poly I:C. (A-B) Trout liver cells RTL-W1 in culture up-regulated miR-731 and -462 
following stimulation with poly I:C. (C-G) Using various  plasmid constructs  
transfected into rainbow trout  RTL-W1 cells  followed by stimulation with poly I:C, 
some cells showed higher levels of green fluorescence compared to controls and non-
transfected cells indicating activation of the suspected miRNA promoter by poly I:C. 
Blue circles in flow cytometry diagrams indicate cells with green fluorescence higher 
than the gated negative cells. Cells transfected with a positive control plasmid 
containing the CMV promoter followed by the GFP reporter and a negative control 
plasmid containing only the GFP reporter without any promoter were used to gate for 
GFP positive cells (quadrant A4) and GFP negative cells (quadrant A3) respectively. 
Red dots indicate dead cells according to their staining above background with 
propidium iodide (quadrant A1 and A2). Such cells were not considered in the analysis. 
Using the same experiment we were not able to show up regulation in cells following 
stimulation with the TLR-4 ligand phytohemoglutanin (I).    
 
 
 
 
 
 
 
 
84 
 
 
 
Fig. 5: Phylogenetic analysis of (A) miR-191 and miR-462 and (B) miR-425 and miR-
731. Unrooted neighbor-joining (NJ) trees with bootstrap values from 1000 replicate 
analysis indicated at the nodes as percentage values. In 4B, high similarity among the 
sequences originating from higher vertebrates makes the end nodes appear overlapping, 
thereby mimicking a single node.      
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Supplementary Information 
Table S1. Primers used in qPCR experiments.  
Gene name* Accession number Primer sequence (5’ 3’)a 
dre-miR-462 MIMAT0001855 TAACGGAACCCATAATGCAGCT 
dre-miR-731 MIMAT0003761 AATGACACGTTTTCTCCCGGATCG 
omy-snoRNA U23 AJ009730 GCCCATGTCTGCTGTGAAACAAT 
hsa-miR-191 MIMAT0000440 CAACGGAATCCCAAAAGCAGCTG 
hsa-miR-425 MIMAT0003393 AATGACACGATCACTCCCGTTGA 
hsa-miR-16 MIMAT0000069 TAGCAGCACGTAAATATTGGCG 
hsa-let-7a MIMAT0000062 TGAGGTAGTAGGTTGTATAGTT 
hsa-ISG-12 X67325.1 CAAATTCTGCATCTCCAGAGG 
hsa-18S rRNA K03432.1 TTCCGTAGGTGAACCTGCGGA 
 
*dre = Danio rerio (zebrafish); hsa = Homo sapiens (human); omy = Oncorhynchus 
mykiss (rainbow trout) 
a
 All primers are forward primers used together with a universal reverse primer supplied 
in the QuantiMir RT Kit 
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Figure S1. Conservation of specific sequence motifs upstream miR-462 and miR-731. 
The area upstream of the two miRNAs (-1000nt ) were retrieved from selected fish 
genomes in the UCSC database. By alignment of these sequences conserved motifs 
were found which were later identified as ISRE and PU.1.  
 
Figure S2. Alignment of dre-miR462/731 with higher vertebrate miR-191/425 stem 
loops (referring to Figure 3). 
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Figure S3. Rainbow trout liver cells RTL-W1 in culture did not up-regulate miR-731 
and -462 24, 48 and 72 hrs. following infection with VHS virus.   
                      
Figure S4. Human miR-191 and -425 regulation is not steered by an poly I:C activated 
promoter. (A-C) Immune stimulation by poly I:C does not induce up regulation of 
neither miR-191 in human Hela cells. Normalization to miR-16 (A) showed a tendency 
towards regulation following polyI:C stimulation, but it was not significant. 
Normalizations of the same data to other commonly used normalization genes Let-7a 
(B) and snoRNA U6 (C) did also not show any significant changes. Cells were either 
mock treated with DOTAP or treated with DOTAP formulated poly I:C at 5 or 10 ug/ml 
concentrations. The negative control (NK) refers to untreated cells to which the other 
group-data were normalised. Standard deviations are shown.  (D) Despite that there was 
no significant up-regulation of hsa-miR191 following polyI:C stimulation it was 
verified that the polyI:C treatment did indeed induce a strong concentration dependent  
interferon response, as shown by up regulation of ISG12, in the Hela cells. Note that the 
values on the y-axis in (D) are much higher than in (A-C). The samples were also 
checked for the regulation of miR-425 by PCR which also showed no significant 
regulation (data not shown). Human embryo kidney cells HEK293t cells were used as 
negative control cells because  an innate cellular response in these cells cannot be 
induced by poly I:C. Accordingly these did neither regulate ISG12 nor  any of the 
miRNAs (data not shown).  
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Table S2. Selected putative targets of miR-191 in vertebrate genomes predicted using the TargetScan Release 6.2 algorithm and ranked by their 
probability of conserved targeting (PCT). (Only top-ranked targets are shown.) 
Target 
Gene 
Representative 
transcript Gene name 
 
Vertebrates whose miR-191have predicted targets in human mRNA orthologues 
             
   Rat Frog Cow Opossum Rhesus Dog Chimpanzee Mouse Platypus Horse 
BDNF NM_001143805 brain-derived neurotrophic factor + + + + + + + + + + 
CASK  NM_001126054  
calcium/calmodulin-dependent 
serine protein kinase (MAGUK 
family) 
+ + + + + + + + + + 
TMOD2 NM_001142885  tropomodulin 2 (neuronal) + - - + + + + + - + 
IFFO2  NM_001136265  
intermediate filament family 
orphan 2 
+ - + - + + + + - + 
NEURL4 NM_001005408  neuralized homolog 4 (Drosophila) + - + + + + + + - - 
ZNF362  NM_152493  zinc finger protein 362 - - + + + + + - + + 
CDK6  NM_001145306  cyclin-dependent kinase 6 - - + - + + + + - + 
MAPRE3  NM_012326  
microtubule-associated protein, 
RP/EB family, member 3 
+ - + + - + - + + + 
RCC2  NM_001136204  
regulator of chromosome 
condensation 2 
+ - - + + + + - - + 
AMMECR1  NM_001025580  
Alport syndrome, mental 
retardation, midface hypoplasia 
and elliptocytosis chromosomal 
region gene 1 
+ + + + + + + + + + 
MSI1  NM_002442  musashi homolog 1 (Drosophila) - - + - + + + - - + 
NFIA  NM_001134673  nuclear factor I/A + + + + - + + + + + 
WIZ  NM_021241  
widely interspaced zinc finger 
motifs 
+ - - - + + + + - + 
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SLC12A5  NM_001134771  
solute carrier family 12 
(potassium/chloride transporter), 
member 5 
- - - - + + + + - + 
GAP43  NM_001130064  growth associated protein 43 + + + + + + + + + + 
AJAP1  NM_018836  
adherens junctions associated 
protein 1 
- - + + + + + + + + 
FZD5  NM_003468  frizzled family receptor 5 + - + - + + + + - - 
ATP2B2  NM_001001331  
ATPase, Ca++ transporting, 
plasma membrane 2 
+ - + - + + + + - + 
ZCCHC24  NM_153367  
zinc finger, CCHC domain 
containing 24 
+ - - - + + + + - + 
RNF139  NM_007218  ring finger protein 139 + - + + + + + + - + 
FUBP3  NM_003934  
far upstream element (FUSE) 
binding protein 3 
- + + + + + + + + + 
 
 
 
 
 
 
 
 
 
90 
 
Table S3. Putative targets of miR-425 in vertebrate genomes predicted using the TargetScan Release 6.2 algorithm and ranked by their probability of 
conserved targeting (PCT).  
Target 
Gene 
Representative 
transcript Gene name 
Vertebrates whose miR-425 have predicted targets in human mRNA orthologues 
             
   
Rat Frog Cow Opossum Rhesus Dog Chimpanz
ee 
Mouse Platyp
us 
Horse 
NUFIP2 NM_020772 
nuclear fragile X mental 
retardation protein interacting 
protein 2 
+ - - - + + + + + - 
FOXJ3  NM_001198850  forkhead box J3 + + - - + + + + + - 
C11orf41 NM_012194  
chromosome 11 open reading 
frame 41 
- - - - + - + - - - 
STRN NM_003162  
striatin, calmodulin binding 
protein 
- - - - + + + - - - 
ZAK  NM_133646  
sterile alpha motif and leucine 
zipper containing kinase AZK 
- - - - - + + - + - 
ATP5G3  NM_001002258  
ATP synthase, H+ transporting, 
mitochondrial Fo complex, 
subunit C3 (subunit 9) 
+ - - - + + + + - - 
FAM135B  NM_015912  
family with sequence similarity 
135, member B 
+ - - - + + + + - - 
CBL  NM_005188  
Cas-Br-M (murine) ecotropic 
retroviral transforming 
sequence 
- - - - + + + - + - 
WWC3 NM_015691  WWC family member 3 - - - - + + + - + - 
RALGAPA
2 
NM_020343  
Ral GTPase activating protein, 
alpha subunit 2 (catalytic) 
- - - - + - + - - - 
DUSP16  NM_030640  dual specificity phosphatase 16 + - - - + - + - - - 
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CSNK1G1  NM_022048  casein kinase 1, gamma 1 + - - - + + + + + - 
HLF NM_002126  hepatic leukemia factor - - - - - + + - - - 
FBXO41  NM_001080410  F-box protein 41 - - - - + + + - - - 
KLF3  NM_016531  Kruppel-like factor 3 (basic) + - - - + + + - - - 
ANTXR1  NM_032208  anthrax toxin receptor 1 - - - - + - + + - - 
FAM133B  NM_001040057  
family with sequence similarity 
133, member B 
- - - - + + + - - - 
IGF1  NM_000618  
insulin-like growth factor 1 
(somatomedin C) 
+ - - - + - + + - - 
TLK1  NM_001136554  tousled-like kinase 1 - - - - + - + - + - 
MPP5  NM_022474  
membrane protein, 
palmitoylated 5 (MAGUK p55 
subfamily member 5) 
- - - - + + + - - - 
CPLX2  NM_001008220  complexin 2 - - - - - + + - - - 
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Table S4. Putative targets of miR-462 in the zebrafish genome predicted using the TargetScanFish Release 6.2 algorithm and ranked by their 
probability of conserved targeting (PCT).  
Target gene Representative 3’ UTR Transcript name 
si:ch211-241b2.1 ENSDARG00000044845.1 Novel protein annotated by Havana 
IL1RAP ENSDARG00000091088.1 uncharacterized protein 
TRAF2 (1 of 2) ENSDARG00000078378.1 TNF receptor-associated factor 2 
CABZ01038499.1  ENSDARG00000088258.1 chromosome 16 open reading frame 52 
ABTB1 ENSDARG00000063354.1 ankyrin repeat and BTB (POZ) domain containing 1 
anks1b ENSDARG00000003512.1 ankyrin repeat and sterile alpha motif domain containing 1B 
ampd2  ENSDARG00000029952.1 adenosine monophosphate deaminase 2 (isoform L) 
CABZ01045212.1  ENSDARG00000087525.1 Uncharacterized protein  
fermt2  ENSDARG00000020242.1 fermitin family homolog 2 (Drosophila) 
cdk12  ENSDARG00000063726.1 cyclin-dependent kinase 12 
elp3 ENSDARG00000042005.1 elongation protein 3 homolog (S. cerevisiae) 
arntl1b  ENSDARG00000035732.1 aryl hydrocarbon receptor nuclear translocator-like 1b 
adcy7 ENSDARG00000060070.1 adenylate cyclase 7 
SNX19 (1 of 2) ENSDARG00000079931.1 Uncharacterized protein 
SGSM2  ENSDARG00000063307.1 small G protein signaling modulator 2 
ZNF507  ENSDARG00000052164.1 Uncharacterized protein 
pex19 ENSDARG00000004891.1 peroxisomal biogenesis factor 19 
tgfb1a ENSDARG00000041502.1 transforming growth factor, beta 1a 
fam69b  ENSDARG00000059881.1 family with sequence similarity 69, member B 
ZEB1 (2 of 2) ENSDARG00000016788.1 zinc finger E-box binding homeobox 1a 
ERBB4 (3 of 5) ENSDARG00000090408.1 v-erb-b2 avian erythroblastic leukemia viral oncogene homolog 4 
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uhmk1  ENSDARG00000059575.1 U2AF homology motif (UHM) kinase 1 
scpp1  ENSDARG00000090416.1 secretory calcium-binding phosphoprotein 1 
CU856539.3 ENSDARG00000058949.1 spindlin family, member 2B 
sall1a ENSDARG00000074319.1 sal-like 1a (Drosophila) 
nbeal2 ENSDARG00000057508.1 neurobeachin-like 2 
mtx3  ENSDARG00000030390.1 metaxin 3 
mtx3  ENSDARG00000090195.1 metaxin 3 
C1H4orf27 ENSDARG00000057114.1 chromosome 4 open reading frame 27 
mxd  ENSDARG00000023369.1 myxovirus (influenza virus) resistance D 
gba2 ENSDARG00000061472.1 glucosidase, beta (bile acid) 2 
psmb5  ENSDARG00000075445.1 proteasome (prosome, macropain) subunit, beta type, 5 
bckdha ENSDARG00000040555.1 branched chain keto acid dehydrogenase E1, alpha polypeptide 
kbtbd5 ENSDARG00000039052.1 kelch-like 40a (Drosophila) 
C5H9orf86 (2 of 
2) 
ENSDARG00000079046.1 RAB, member RAS oncogene family-like 6 
FP236334.1  ENSDARG00000095664.1 Uncharacterized protein  
lamp2  ENSDARG00000014914.1 lysosomal membrane glycoprotein 2 
CR407701.1 ENSDARG00000089094.1 Uncharacterized protein  
tpd52 ENSDARG00000061713.1 tumor protein D52 
tmem2  ENSDARG00000061600.1 transmembrane protein 2 
zbtb22b  ENSDARG00000003251.1 zinc finger and BTB domain containing 22b 
arl3l1 ENSDARG00000028846.1 ADP-ribosylation factor-like 3, like 1 
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Table S5. Putative targets of miR-731 in the zebrafish genome predicted using the TargetScanFish Release 6.2 algorithm and ranked by their 
probability of conserved targeting (PCT).  
Target Gene Representative 3’ UTR Transcript name 
   
NBL1 ENSDARG00000031898.1 neuroblastoma 1, DAN family BMP antagonist 
pfdn5 ENSDARG00000035043.1 prefoldin 5 
ANK1 (1 of 
2)|ank1  
ENSDARG059093|092143.1 
not present in the current release of the Ensembl database 
rab23 ENSDARG00000004151.1 RAB23, member RAS oncogene family 
UBAC2 (1 of 2) ENSDARG00000060581.1 UBA domain containing 2 
CABZ01045212.1  ENSDARG00000087525.1 Uncharacterized protein 
pob ENSDARG00000020607.1 ER membrane protein complex subunit 3 
XPR1 (1 of 2) ENSDARG00000062449.1 xenotropic and polytropic retrovirus receptor 1 
si:dkeyp-120h9.1 ENSDARG00000020278.1 si:dkeyp-120h9.1  
BX248318.1 ENSDARG00000022570.1 Uncharacterized protein 
shpk ENSDARG00000002355.1 sedoheptulokinase 
cdc42l2  ENSDARG00000057869.1 cell division cycle 42 like 2 
dcp1a  ENSDARG00000003323.1 DCP1 decapping enzyme homolog A (S. cerevisiae) 
gpm6aa  ENSDARG00000055455.1 glycoprotein M6Aa 
UBAC2 (2 of 2) ENSDARG00000093065.1 UBA domain containing 2 
CABZ01079302.1  ENSDARG00000091604.1 Uncharacterized protein 
VAMP5  ENSDARG00000068262.1 vesicle-associated membrane protein 5 
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ldb2a ENSDARG00000019579.1 LIM-domain binding factor 2a 
whsc1l1 ENSDARG00000062765.1 Wolf-Hirschhorn syndrome candidate 1-like 1 
apeh  ENSDARG00000008703.1 acylpeptide hydrolase 
si:ch211-22n13.1 ENSDARG00000070528.1 calcium channel, voltage-dependent, T type, alpha 1H subunit b 
lipea  ENSDARG00000063037.1 lipase, hormone-sensitive a 
si:ch211-
124k10.1 
ENSDARG00000068731.1 
relaxin/insulin-like family peptide receptor 2, like 
IPO11  ENSDARG00000054224.1 importin 11 
cttnbp2nl ENSDARG00000056091.1 CTTNBP2 N-terminal like 
onecutl ENSDARG00000040253.1 one cut domain, family member, like 
smtnl1  ENSDARG00000041257.1 smoothelin-like 1 
bcas3  ENSDARG00000090764.1 breast carcinoma amplified sequence 3 
FUT11  ENSDARG00000057727.1 fucosyltransferase 11 (alpha (1,3) fucosyltransferase) 
rab34b  ENSDARG00000010977.1 RAB34, member RAS oncogene family b 
mpg  ENSDARG00000069729.1 N-methylpurine-DNA glycosylase 
slc4a4a ENSDARG00000013730.1 solute carrier family 4, member 4a 
ccdc6a  ENSDARG00000043334.1 coiled-coil domain containing 6a 
fam155a  ENSDARG00000075858.1 family with sequence similarity 155, member A 
erbb4a  ENSDARG00000063207.1 v-erb-a erythroblastic leukemia viral oncogene homolog 4a (avian) 
si:ch211-
217k17.10 
ENSDARG00000079345.1 si:ch211-217k17.10 
tom1  ENSDARG00000043638.1 target of myb1 (chicken) 
CR848759.2 ENSDARG00000079119.1 si:ch211-229d2.5 
PACS1 (1 of 3) ENSDARG00000019800.1 phosphofurin acidic cluster sorting protein 1 
birc7 ENSDARG00000058082.1 baculoviral IAP repeat-containing 7  
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Text S1. Supplementary Materials and Methods 
 
Viral challenge experiment 
Two groups of 2x20 5g disease-free rainbow trout were kept in aquaria at 12˚C 
(experimental temperature). Each aquarium contained 8 litres of water, which was 
continuously renewed by a water flow-through system. The water flow-through was 
stopped and VHSV isolate DK-3592B (55) was added to one of the experimental 
aquaria (the other serving as negative control) to give a final concentration of 
approximately 10
5 
TCID50/ml. After one hour of viral challenge the water flow-through 
was restarted. Throughout the next week, dead fish were daily removed from the 
challenge-aquarium, counted, examined for external signs of disease such as bleedings 
in eyes and skin, swollen belly, swollen eyeballs, and dark skin. Liver samples for RNA 
purification were taken from fish with external signs of disease day 7 (5 fish) and day 8 
(4 fish). Both days the same number of fish was sampled from the negative control 
aquarium. Prior to sampling, fish were anaesthetized in benzocaine (ethyl p-
aminobenzoate; Sigma; cat.no.E-1501) diluted to 0.01%. Verification of VHSV 
infection in the diseased fish was carried out by the use of a previously published 
ELISA on organ samples (55). 
 
Microarray analysis of miRNA regulation 
Before the microarray analysis RNA samples were quality tested by verifying the 
presence of 28s rRNA, 18s rRNA and tRNA fractions after running for 1-2 hours (70 
volts) in a 1% agarose gel containing 2% formaldehyde and stained using SyberGold 
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(Invitrogen, USA). Furthermore, quantities and purity of samples were re-measured by 
nanodrop as described above. The microarray for detecting miRNA levels was run by a 
microarray profiling service (Ocean Ridge Biosciences, USA) using the Ncode Version 
2.0 probe set (Invitrogen) containing 1492 unique probes including 218 zebrafish 
probes (35-44-mer oligoes spotted in triplicates) for detection of all miRNAs in the 
Sanger Institute database miRBase version 9.0 (Nov´06). Two hundred ng RNA from 
each sample labeled by ligation of DNA dendrimer containing 15-fluorophores to 3´-
OHs of microRNAs (Genisphere, USA). One-way ANOVA was used to assure that the 
overall intensity difference between infected and non-infected fish was significant. Raw 
data were log2 transformed and normalized to the mean signal of all detected probes 
(120 probes which were detectable both among the infected and control samples. 
Triplicate spots were averaged throwing out flagged spots. Data from infected versus 
control samples for the 120 probe spots were compared using the NIA Array Analysis 
Software (56).  
 
cDNA synthesis 
1 μg of total RNA was used for cDNA synthesis by the QuantiMir Synthesis Kit 
(System Biosciences, USA, cat. no. RA420A-1) following manufacturer’s instructions. 
Briefly, RNAs were poly-A tailed using poly-A polymerase. The poly-A tail allows for 
the binding of an oligo-dT adaptor, which contains a universal reverse primer site. 
Following reverse transcription from this adaptor, a cDNA pool was generated, which 
contains strands complementary to various RNAs in the original samples and the 
universal reverse primer site at the distal 3´end. 
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Genomic DNA extraction and generation of PCR products for sequencing 
Genomic DNA was extracted from the liver tissue of disease-free rainbow trout using 
DNeasy Blood & Tissue Kit (Qiagen, Germany) following manufacturer’s instructions. 
The DNA was eluted in AE Buffer (10 mM Tris·Cl, 0.5 mM EDTA, pH 9.0.) and 
stored at -20 °C. Three conserved sequences were found by aligning fish genomic 
sequences, and used to design primers to generate two PCR products. The primer pair 
used for PCR product 1: forward primer, 5'-GTAACGGAACCCATAATGCAGCT-´3 
and reverse primer 5'- CTTGGCTGACACGAAITTCCCGGT-'3. PCR product 2 was 
amplified with forward primer, 5'- AGAAGTGAAAGTGAAA-3' and reverse primer 5'- 
CAGCTGCATTATGGGTTCCGTTAC- 3'. 
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ABSTRACT 
     Mechanisms that account for the high protective efficacy of a DNA vaccine 
expressing the glycoprotein (G) of Viral hemorrhagic septicemia virus (VHSV) are 
thought to involve early innate immune responses mediated by interferons (IFNs). In 
order to reveal the complex web of interactions involved in the underlying immune 
response, key factors must be identified. Microribonucleic acids (miRNAs) are a 
diverse class of small (18-22 nucleotides) endogenous RNAs that potently mediate 
post-transcriptional silencing of a wide range of genes and are emerging as critical 
regulators of cellular processes, including immune responses. We have recently 
reported that two miRNAs, miR-462 and miR-731, which have been only described in 
teleost fish, were induced in rainbow trout infected with VHSV. In this study, we 
analyzed the expression of these miRNAs in fish following administration with the 
DNA vaccine.  
     Quantitative RT-PCR analysis revealed the increased levels of miR-462, and miR-
731 in the skeletal muscle tissue at the site of vaccine administration and in the liver of 
vaccinated fish relative to empty plasmid backbone-injected controls. The increased 
expression of these miRNAs in the skeletal muscle correlated with the increased levels 
of the type I interferon (IFN)-inducible Mx gene, the vaccine gene (G), type I IFN and 
IFN-γ genes at the vaccination site. Intramuscular injection of fish with either type I 
IFN or IFN-γ construct resulted in the upregulation of miR-462 and miR-731 in the site 
of injection relative to controls, further suggesting that the induction of these miRNAs 
is elicited by IFNs. Silencing miR-462 and miR-731 with specific anti-miRNA 
oligonucleotides in poly I:C-treated rainbow trout fingerlings followed by VHSV 
challenge demonstrated faster disease development and higher mortalities in anti-miR-
injected fish relative to controls. Counteracting poly I:C-induced miR-462/731 
102 
 
expression and protective effect by specific anti-miRNAs indicates that miR-462/731 
may be involved in IFN-mediated protection conferred by poly I:C and the rhabdovirus 
G-based DNA vaccine and in the antiviral response in teleosts in general. 
 
Keywords: microRNA, Viral hemorrhagic septicemia virus (VHSV), DNA vaccination, 
interferons, rainbow trout 
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INTRODUCTION 
 
     Viral hemorrhagic septicemia caused by the fish rhabdovirus viral hemorrhagic 
septicemia virus (VHSV) results in mortality as high as 90% in farmed fish (Olesen, 
1998), causing huge economic loss. The presence of a marine wildlife reservoir of 
VHSV poses a potential threat to sea-farmed fish and necessitates the development of 
effective disease management strategies. Fish rhabdovirus DNA vaccines encoding the 
glycoprotein G of VHSV and infectious hematopoietic necrosis virus (IHNV) have 
been previously shown to confer efficient protection against lethal virus challenge 
under laboratory conditions (Lorenzen and LaPatra, 2005; Lorenzen et al., 1998). The 
immune response elicited by these vaccines involves early, non-specific, and short-term 
immunity, followed by specific, long-lasting protection (Kurath, 2008; Lorenzen and 
LaPatra, 2005). Neutralizing antibodies as well as cytotoxic cells are believed to be 
involved in the specific protection (Utke et al., 2008; Lorenzen and LaPatra, 2005; 
Boudinot et al., 1999). The early protection correlates with upregulation of the 
interferon (IFN)-induced antiviral myxovirus resistance Mx protein but the exact 
protective mechanism remains to be elucidated (Kurath, 2008; Kurath et al., 2006; 
McLauchlan et al., 2003; Lorenzen et al., 2002; Lorenzen et al., 1999).  Type I IFN 
responses implicate an activation of an array of innate antiviral defense mechanisms 
and recent reports suggest that these also include small regulatory RNAs known as 
microRNAs (miRNAs) (Sisk et al., 2013; Russo and Potenza, 2011; Pedersen et al., 
2007).   
     MicroRNAs are small (19-25 nucleotides), endogenously expressed single-stranded 
RNAs that post-transcriptionally regulate gene expression (Bartel, 2004). By repressing 
translation and/or degrading target mRNAs, miRNA-mediated RNAi results in altered 
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mRNA and protein expression profiles (Bartel, 2004).  Each miRNA is believed to 
regulate multiple genes (Creighton et al., 2012; Bonci et al., 2008), and as such could 
steer different mechanisms in various cell and tissue types, modulating diverse 
pathways for fine-tuning physiological conditions and defining distinct cell types 
(Smigielska-Czepiel et al., 2014; Allantaz et al., 2012; Chen et al., 2004).  By targeting 
numerous mRNAs (Friedman et al., 2009; Lim et al., 2005), miRNAs can control a 
broad spectrum of cellular processes, ranging from cell differentiation and development 
to immune responses, thus providing an additional layer to the molecular variety of 
gene regulatory mechanisms.  
     Whereas the exact global functional outcomes of the expression of a particular 
miRNA often remains to be determined, they have been shown to be involved in 
development and function of immune cells (Wu et al., 2007) and host-pathogen 
interactions (Staedel and Darfeuille, 2013; Swaminathan et al., 2013; Zhang and Li, 
2013; Eulalio et al; 2012; Skalsky and Cullen, 2010; Ghosh et al., 2009).  
     We have recently reported that two miRNAs known only in teleost fishes, miR-462 
and miR-731, were the most highly induced miRNAs in the liver of rainbow trout 
following VHSV infection (Schyth et al., manuscript  submitted). Here, we report the 
upregulation of these two miRNAs in fish immunized with a VHSV glycoprotein-
expressing DNA vaccine and determined the kinetics of expression following 
vaccination. We show that the expression of these miRNAs is elicited by IFN induction. 
Finally, inhibition of these two miRNAs in fish treated with the TLR3 agonist and IFN 
inducer, poly I:C, reduced the ability of poly I:C to protect fish against lethal VHSV 
infection.  
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MATERIALS AND METHODS 
 
Fish and virus. Outbred rainbow trout eggs were obtained from a commercial fish farm 
certified as disease-free. Fish were hatched from disinfected eggs and kept in pathogen-
free aquarium facilities until injection experiments and infection trials. Fish were 
acclimatized to laboratory conditions several weeks prior to the experiments. 
Throughout the experiments, fish were maintained in 8 L aquaria at 10 ± 2 °C supplied 
with flow through partly deionized water. The VHSV isolates DK-3592B (Lorenzen et 
al., 1993) or  a Norwegian isolate were used in the infection trials. 
DNA vaccine. The DNA vaccine (pcDNA3-vhsG) consists of the VHSV glycoprotein 
gene inserted under the control of the cytomegalovirus (CMV) promoter at a multiple 
cloning site in a commercially available plasmid, pcDNA3 (Invitrogen) as described 
previously (Lorenzen et al., 1998). Control fish were injected with either pcDNA3 
(empty vector) diluted in 0.9% NaCl (physiological saline) or physiological saline only. 
IFN-expressing plasmids. The IFN constructs consist of the IFN gene under the 
control of the cytomegalovirus (CMV) promoter at a multiple cloning site in a 
commercially available plasmid, pcDNA3.1/3.3 (Invitrogen) and were kindly supplied 
by Dr. J. Zou (Zou et al., 2007; Zou et al., 2005). The constructs are herein referred to 
as pcDNA3.3-IFN 1-13, and pcDNA3.1-IFN-G. Control fish were injected with 
pcDNA3.1 (empty vector) dissolved in 0.9% NaCl (physiological saline) or with 
physiological saline only. 
Poly I:C and anti-miRNAs. Polyinosinic: polycytidylate sodium salt (Poly I:C; CAS # 
42424-50-0) was purchased from Sigma-Aldrich GmBH (Steinheim, Germany). The 
anti-miR-462 and anti-miR-731 and their corresponding mismatch controls were 
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unconjugated 2’-O-methylated Locked Nucleic Acid (LNA)-based oligonucleotide 
probes synthesized by RiboTask (Langeskov, Denmark). The anti-miRs were designed 
as complete anti-sense sequences of the mature zebrafish miRNA sequences, whereas 
the corresponding mismatch anti-miRNA controls differed from the anti-miRNAs by 
two nucleotides (underlined bases) within the anti-seed region (Table 1). Positions in 
which the control anti-miRNAs differed from the anti-miRNAs are underlined and are 
located in positions complementary to that of the seed sequence in the mature miRNAs. 
2’-O-methylated positions are indicated/preceded by the letter m, while the LNA 
coupled positions are indicated by the letter I.  
   
Table 1. Anti-miRNAs and mismatched controls used in the experiments. 
Name Sequence (5’3’) 
dre-anti-miR-462 
probe 
mA mU IT mA mU IG mG mG IT mU mC IC mG mU IT mA 
dre-anti-miR-731 
probe 
mG mA IG mA mA IA mA mC IG mU mG IT mC mA IT mU 
dre-anti-miR-462 
mismatch probe 
mA mU IT mA mU IG mG mG IA mU mC IA mG mU IT mA 
dre-anti-miR-731 
mismatch probe 
5’mG mA IG mA mA IA mA mC IC mU mG IA mC mA IT 
mU 
 
 
Vaccination and injection with IFN constructs. Fish anaesthetized with 0.01% 
benzocaine were injected with 10 µg of pcDNA3-vhsG or 10 µg of pcDNA3 empty 
vector plasmid backbone in 20 µL phosphate buffered saline (PBS) or PBS only in the 
right, epaxial muscle in front of the dorsal fin as described by Lorenzen et al. (2009). 
For injection with IFN-expressing plasmids, benzocaine-anaesthetized fish were 
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injected with 10 µg of each of the above-mentioned constructs in 20 µL PBS, or 5 µg 
poly I:C (Sigma) in 20 µL PBS. Negative controls were injected with 10 µg of the 
empty vector in 20 µL PBS or 20 µL PBS alone.  
     At 1, 4, 7, and 21 days post-vaccination (dpv), muscle tissue  from the injection site 
and liver from 6 fish were sampled for each group. Muscle tissue was immediately 
processed for RNA isolation while liver samples were stored at -80C in RNALater until 
needed. 
RNA Isolation and cDNA Synthesis. Total RNA was isolated and purified from tissue 
samples using the miRNeasy Kit spin column purification (cat. # 217004, Quiagen SA 
Biosciences, Hilden, Germany), following manufacturer’s protocol for animal tissues 
with DNase treatment (Quiagen RNase-free DNase Set, cat. # 79254).   
     For miRNA expression studies, total RNA (1 µg) was used to reverse transcribe and 
convert small non-coding RNAs into quantifiable cDNAs with the QuantiMiR RT Kit 
Small RNA Quantitation System (cat. # RA420A-1, System Biosciences, SBI, 
Mountain View, CA, USA) following manufacturer’s instructions. For mRNA (Mx, 
IFN-1, IFN-G) expression analyses, 1 µg RNA was used to make cDNA using iScript 
cDNA synthesis kit from BioRad (cat. # 170-8891, Hercules, CA, USA) following 
manufacturer’s instructions.   
Quantitative RT-PCR for miRNAs and mRNAs. MicroRNA-specific forward 
primers together with a 3’ Universal reverse primer (supplied in the QuantiMiR RT Kit; 
designed to hybridize with the anchor tail in the oligo-dT adaptor used in cDNA 
synthesis) were used in quantitative real time PCR to detect miRNA expression. 
Forward miRNA-specific primers were exact mature sequences of the zebrafish 
miRNAs of interest converted to DNA. The transcript levels of the IFN-induced anti-
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viral protein Mx, type I IFN, IFN-gamma were also quantified. The miRNA expression 
levels were normalized to that of the internal control dre-snoU23 transcript, whereas the 
level of Mx mRNA was normalized to the level of acidic ribosomal protein (ARP) 
mRNA in the same sample. Primer sequences for both miRNA and mRNA expression 
analysis are given in Table 2.  
     Reactions were run on an Mx3005P machine (Stratagene) in final reaction volumes 
of 15 µL containing 5 μl diluted cDNA template (1:100), 333 nM miRNA-specific 
forward primer, 167 nM universal reverse primer, ROX reference dye, water, and 
7.5 μL of SYBR Green PCR master mix (Brilliant SYBR Green qPCR Master Mix, Cat. 
No. 600548, Stratagene, La Jolla, CA, USA).  The program was set to an initial 
denaturation step for 5 minutes at 95
0
C and 40 cycles of denaturation for 20 seconds at 
95
0
C and annealing/extension for 20 seconds at 65
0
C, with fluorescent data collection. 
To get melting curve data, PCR amplicons were denatured for 1 minute at 95
0
C 
followed by a ramp down to 55
0
C for 30 seconds and then a gradual increase to 95
0
C at 
0.2
0
C/second, with continuous fluorescence recording for making a dissociation curve. 
Transcript levels were measured as quantification cycle (Cq) values and normalized to 
that of the corresponding internal reference genes. Values presented are normalized Cq 
values from 6 fish. Negative control (without template) reactions were also carried out 
for each primer pair. The relative quantity values of miRNA or mRNA expression 
signals were calculated from the mean values of duplicate measurements using the 
ΔΔCt method, where Relative Expression = 2
−ΔΔC
t and ΔΔC
t
 = (Ct experimental − Ct reference 
gene) − (Ct control − Ct reference gene). The sizes of all PCR amplicons were verified by 
inspection of the dissociation curve and/or by agarose gel electrophoresis.  
     Efficiency of amplification was determined for each primer pair using 2-fold 
dilutions (100, 200, 400, 800, and 1600). A sample from the serial dilution was resolved 
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on an agarose gel and visualized under UV light after staining with ethidium bromide, 
to verify the amplification of a single band of the correct size. 
 
Table 2. Primers used in real time PCR analysis 
Gene name Accession 
number 
Primer sequence (5’ 3’) 
dre-miR-462 MIMAT0001855 Forward TAACGGAACCCATAATGCAGCT 
dre-miR-731 MIMAT0003761 Forward AATGACACGTTTTCTCCCGGATCG 
dre-snoU23 AJ009730 Forward GCCCATGTCTGCTGTGAAACAAT 
omy-Mx3 U47946 Forward GCAGAGGGAGATGCTTCAGA 
Reverse  CGATGTCAAAGTCCTCCTTCA 
omy type I IFN AY788890.1 Forward GAAAAGGACTGGGGCATTCT 
Reverse GAATACCTTTCCCTGCTGGAC 
IFN Gamma AY795563 Forward AAGGGCTGTGATGTGTTTCTG 
Reverse TGTACTGAGCGGCATTACTCC 
omy-ARP  Forward TCTACAACGAGCTGCGAGTG 
Reverse  GGGGTGTTGAAGGTCTCAAA 
 
 
Anti-miRNA injection and virus challenge experiments: Experiment 1. All groups 
were in duplicate aquaria (17-21 fish/aquarium). Rainbow trout fingerlings (approx. 1 
g) were anaesthetized in water with benzocaine. Based on the treatment groups, fish 
were injected intra-peritoneally (IP) with dre-anti-miR-462/dre-anti-miR-731 probe mix 
(0.5 µg/g of each anti-miR in 20 µL TE buffer per fish), dre-anti-miR-462/dre-anti-
miR-731 mismatch probe mix (0.5 µg/g of each anti-miR in 20 µL TE buffer per fish), 
5 µg poly I:C in 20 µL TE buffer (control), or 20 µL of TE buffer only (control). Water 
flow was discontinued 24 hours after anti-miRNA administration and the day of virus 
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challenge. Depending on the virus challenge group, VHSV isolate DK-3592B (high 
virulence strain; Lorenzen et al., 1993) or Norwegian VHSV isolate NO-2007-50-385 
NR1 (semi-virulent strain) was added to each experimental aquarium to a final titer of 
approximately 10
4
 tissue culture infectious dose50 (TCID50)/mL per aquarium. Virus 
challenge lasted for 2 hours, after which water flow was restarted. Unchallenged 
controls consisted of a mix of fish from each of the treatment groups. Disease 
development in each aquarium was monitored daily for 14 days post-challenge (dpc) for 
the group challenged with the high virulence strain or 32 dpc for the group challenged 
with the semi-virulent strain. Moribund/dead fish were terminated, removed, registered, 
examined for external manifestations of disease (skin darkening, bleeding, ascitis or 
swollen belly, exopthalmia or swollen eyeballs) and frozen (for virological 
examination).          
Anti-miRNA injection and virus challenge experiments: Experiment 2. All groups 
were in duplicate aquaria (18-27 fish/aquarium). In contrast to experiment 1, fish were 
treated with poly I:C prior to anti-miRNA administration. Rainbow trout fingerlings 
(approx. 0.5 g) anaesthetized in benzocaine were injected IP with 5 µg poly I:C in 20 
µL physiological saline or physiological saline only (control). 24 hours post-poly I:C 
treatment or saline injection, fish grouped accordingly were injected IP with a first dose 
of dre-anti-miR-462/dre-anti-miR-731 probe mix (1 µg/g of each anti-miR in 20 µL TE 
buffer per fish), dre-anti-miR-462/dre-anti-miR-731 mismatch probe mix (1 µg/g of 
each anti-miR in 20 µL TE buffer per fish), or TE buffer only (control). A second dose 
of anti-miR mix, mismatch control mix, or TE buffer (same dose as the first) was 
administered IP 24 h post-first dosing. Water flow was discontinued 24 hours after the 
second treatment dose and the day of virus challenge. Only VHSV isolate DK-3592B 
(Lorenzen et al., 1993) was used for virus challenge in this experiment, which was 
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added to each experimental aquarium to a final titer as in experiment 1. Virus challenge 
was done for 2 hours and water flow was subsequently restarted. Unchallenged controls 
consisted of a mix of fish from each of the treatment groups. Disease development in 
each aquarium was monitored daily for 14 dpc. Moribund/dead fish were handled as 
described earlier.          
Virological examination. Fish organs (brain, head kidney, and spleen pooled according 
to treatment group and aquarium) were homogenized with a tissue lyser. The 
homogenates were treated with gentamycin (25 μL mL−1) and kept overnight at 4 °C, 
after which were centrifuged at approximately 16 000 xg for 15 min. Three-fold 
dilutions (1 × 3
−1
 to 1 × 3
−3
) of the resulting supernatant were prepared and inoculated 
onto BF2 cell monolayers grown to 60–80% confluence in 24-well plates and incubated 
at 15 °C. After 7 days, supernatants were sampled and analyzed by a VHSV-specific 
enzyme-linked immunosorbent assay (ELISA) (Mortensen et al., 1999). Samples giving 
reactions of 3 times the background levels (cell culture supernatant from non-inoculated 
cells) were considered positive.    
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RESULTS 
miR-462 and miR-731 were upregulated in pcDNA3-vhsG-vaccinated rainbow 
trout 
     The expression levels of these two microRNAs were upregulated (relative to empty 
vector-injected controls) in the skeletal muscle (at site of vaccination) and in the liver of 
rainbow trout following vaccination with pcDNA3-vhsG (Figure 1A and 1B). Levels of 
miR-462 and miR-731 expression increased 4 days post-vaccination (dpv), which 
continued to 3 weeks. The expression of the two miRNAs in both tissues showed a 
similar kinetics (Figure 1A and 1B). 
     Transcript levels of the type 1 IFN-inducible myxovirus resistance (Mx) gene also 
increased in both the site of vaccination and in the liver at 4 dpv (Figure 2A). Mx 
expression levels decreased with time but remained upregulated up to the final sampling 
time point (21 dpv) (Figure 2A). Likewise, the levels of type I IFN and IFN-γ 
transcripts were also found to increase at the vaccination site (Figure 2B).  
 
miR-462 and miR-731 were induced in fish injected with type I and type II IFN-
expressing plasmid constructs 
      Increased expression of miR-462 and miR-731 in the skeletal muscle tissue (at 
injection site) was also observed in fish injected with plasmid constructs encoding a 
type I IFN (pcDNA3-IFN 1-13) or IFN-γ (pcDNA3-IFN-G) relative to controls (Figure 
3A). As positive control, the general IFN stimulator and TLR3 agonist poly I:C, 
upregulated miR-462/731 expression (Figure 3A). The levels of Mx transcripts were 
likewise induced in the injection site following administration with the IFN constructs 
and poly I:C (Figure 3B). 
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Effects of miR-462 and miR-731 inhibition with specific anti-miRNAs in fish 
     Inhibitory Locked Nucleic Acid (LNA) antagomiR (anti-miR)-462 and anti-miR-
731, anti-sense oligonucleotides that hybridize with miR-462 and miR-731, 
respectively, were designed in order to determine the potential role of these miRNAs in 
the interaction between the fish host and VHSV. The LNA oligonucleotides did not 
stimulate the IFN response (data not shown).  
Anti-miRNA injection followed by lethal virus challenge did not show significant 
effect on the development of disease and mortality. In a first experiment, fish were 
injected IP with anti-miRNAs followed by challenge with highly virulent or semi-
virulent VHSV strains. Injection with anti-miRs, mismatch controls, or with saline/TE 
showed similar cumulative mortality profiles reaching 90% 14 days post-challenge 
(dpc) with the highly virulent DK3592 VHSV strain (Figure 4A). On the other hand, 
poly I:C injection resulted in lower mortality (~40% mortality 14 dpc), indicating the 
protective effect of poly I:C (Figure 4A).  
     Challenge with the semi-virulent Norwegian VHSV strain showed slow disease 
progression and resulted in generally low mortalities. The groups injected with poly I:C, 
anti-miR mismatch controls, or with saline/TE showed similar mortality curves, 
whereas the group injected with anti-miRNAs showed higher mortality, although still 
low at 16% 32 dpc (Figure 4B).  
Anti-miRNA treatment of poly I:C-treated fish accelerated disease progression and 
increased mortality. In the second experiment, fish pre-treated with poly I:C were 
injected with anti-miRNAs or mismatch controls and subsequently challenged with the 
highly virulent VSHV strain. Injection with poly I:C gave protection by slowing down 
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the development of disease  and decreasing mortality (60% mortality, compared with 
almost 100% cumulative mortality 21 dpc in fish that did not receive poly I:C) (Figure 
5). Administration with a mixture of anti-miR-462/731 to poly I:C-treated fish hastened 
disease progression and increased mortality compared to the poly I:C-treated group that 
was not injected with anti-miRNAs. In fish that did not receive poly I:C treatment, 
injection with anti-miRNAs only or with mismatch controls only showed similar 
disease development and mortality profiles with the group injected only with saline/TE. 
     The mortality among fish injected with mismatch anti-miRNA controls following 
poly I:C treatment varied significantly between the replicate aquaria, with only one 
moribund fish in one replicate. 
 
Virological examination 
     Dead/moribund from challenge experiments as well as surviving fish from 
unchallenged controls were examined for the presence of VHSV by cell culture 
inoculation followed by ELISA on cell culture supernatants harvested 7 days post-
inoculation. 
     In experiment 1, homogenates from pools of organs from  dead/moribund fish from 
the challenged groups all tested positive for VHSV in ELISA (Tables 3). In experiment 
2, tissue homogenates from dead/moribund fish all tested positive for VHSV in ELISA 
(Table 4).  
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Table 3. Virological analysis of organs from fish injected with anti-miRNAs and 
challenged with VHSV (experiment 1). 
  
No 
challenge 
 
Challenge 
DK-3592B Isolate Norwegian isolate 
TE- 
Saline 
mismatch 
controls  
anti-miRs Poly I:C TE- 
Saline 
mismatch 
controls  
anti-miRs Poly I:C 
Moribund/ 
dead fish 
(%) 
Repl. 1; 
Repl. 2 
 
0;  
0 
 
89.5;  
84.2 
 
94.7;  
84.2 
 
100;  
89.5 
 
47.4;  
52.6 
 
0;  
14.3  
 
5.0;  
17.6 
 
21.1;  
11.1 
 
15.8; 
 5.3 
ELISA for 
VHSV 
Repl. 1; 
Repl. 2 
 
Neg; 
Neg 
 
Pos; 
Pos 
 
Pos; 
Pos 
 
Pos; 
Pos 
 
Pos; 
Pos 
 
Neg; 
Pos 
 
Pos; 
Pos 
 
Pos; 
Pos 
 
Pos; 
Pos 
 
Table 4. Virological analysis of organs from poly I:C pre-treated fish injected with anti-
miRNAs and challenged with VHSV (experiment 2).  
  
Unchallenged 
Treatments 
+ poly I:C - poly I:C 
TE- 
Saline 
mismatch 
control  
anti-
miRNAs 
TE- 
Saline 
mismatch 
control  
anti-
miRNAs 
Moribund/dead fish 
(%) 
Repl. 1; Repl. 2 
0; 
0 
54.5; 
60.7 
5; 
38.1 
100; 
86.4 
100; 
94.4 
100; 
96 
100; 
100 
ELISA for VHSV 
Repl. 1; Repl. 2 
Neg; 
Neg 
Pos; 
Pos 
Pos; 
Pos 
Pos; 
Pos 
Pos; 
Pos 
Pos; 
Pos 
Pos; 
Pos 
 
Neg = negative for VHSV in ELISA 
Pos = positive for VHSV in ELISA 
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DISCUSSION 
      We have recently reported that the clustered miRNAs miR-462 and miR-731 known 
so far only in teleost fishes (Xu et al., 2013; Li et al., 2010; Kloosterman et al., 2006; 
Chen et al., 2005) were the most highly upregulated miRNAs in rainbow trout liver 
infected with VHSV (Schyth et al., manuscript submitted). In this study we report that 
miR-462 and miR-731 are also highly induced in fish immunized with the protective 
VHSV glycoprotein-based DNA vaccine, pcDNA3-vhsG, and that the two miRNAs 
contribute to the protective mechanisms induced by the IFN stimulator poly I:C. 
     The parallel miR-462 and miR-731 induction and expression kinetics in both 
vaccination site and the liver reflects their genome organization. The two miRNAs are 
members of a cluster (miR-462/731 cluster) located in an intergenic region flanked by 
inosine monophosphate dehydrogenase 2 (IMPDH2) and DALR anticodon binding 
domain 3 (DALRD3) genes in teleost fish genomes, including rainbow trout (Schyth et 
al., manuscript submitted). The miRNAs in the cluster are most likely expressed as part 
of a polycistronic transcript, as are other clustered miRNAs. 
     The induction of miR-462 and miR-731 following the administration of the DNA 
vaccine (this study) and in VHSV-infected fish (Schyth et al., manuscript submitted) 
may be attributed to the stimulation of the IFN response elicited by immunization with 
the VHSV-G-based DNA vaccine (Byon et al., 2006; Byon et al., 2005) as well as by 
VHSV infection (Verrier et al., 2011; Bernard et al., 1985), respectively. Fish 
rhabdovirus glycoproteins, including VHSV-G, has been known to be a potent elicitor 
of the IFN response (Chen et al., 2012; Verjan et al., 2008; Acosta et al., 2006; 
Lorenzen et al., 2002; LaPatra et al., 2001). This was here confirmed by the increased 
levels of type I IFN and IFN-γ transcripts at the vaccination site (Figure 2B). 
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     Induction of the two miRNAs in both the site of vaccination and in the liver also 
correlated with increased transcript levels of the type 1 IFN-inducible Mx gene, which 
remained upregulated to the final sampling time point (21 dpv) (Figure 2A). The Mx 
protein is known as a non-specific antiviral protein in mammals (Jin et al., 1999) and in 
other vertebrates, including teleost fishes (Verhelst et al., 2013; Trobridge and Leong, 
1995) and has earlier been shown to be upregulated in fish injected with the plasmids 
mediating the expression of the rhabdovirus G protein (Kim et al., 2000; Boudinot et 
al., 1998). In teleost fishes, the expression of Mx is stimulated both by IFN-α (a type I 
IFN) (Berg et al., 2009; Robertsen et al., 2003) and to a less extent by IFN-γ (Sun et al., 
2011). Taken together, results indicate that injection of pcDNA3-vhs-G induced a 
systemic IFN response, which in turn stimulated the expression of miR-462 and miR-
731. 
     This was further supported by the observation that injection of fish with type I- or 
type II IFN-encoding plasmid constructs or with the IFN-stimulator and TLR3 agonist 
poly I:C (Richmond and Hamilton, 1969),  resulted in upregulated levels of miR-462, 
miR-731, as well as Mx transcripts at the site of injection. Upregulation of miR-462/731 
levels following poly I:C treatment in cultured rainbow trout liver cells  has been 
previously reported (Schyth et al. manuscript submitted). A highly conserved IFN-
stimulated response element (ISRE) was found in the promoter upstream of the miR-
462/731 cluster locus in teleost fish (Schyth et al., manuscript submitted), accordingly 
supporting the stimulatory role of IFN.  
     Which cell types that express miR-462 and miR-731 are currently not known. At the 
vaccination site the two miRNAs may have been induced in myocytes due to IFN 
induction following vaccine injection. Alternatively, miR-462 and miR-731 could be 
induced in immune cells infiltrating the site of vaccination. Immunization with 
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pcDNA3-vhs-G vaccine has been shown to promote the recruitment of immune cells at 
the site of vaccine administration (Castro et al., 2014; Utke et al., 2008; Lorenzen et al., 
2005; Lorenzen et al., 2002). The increased expression of IFN-γ observed at the site of 
vaccination accordingly suggested the presence of activated NK cells, NKT cells, 
and/or T lymphocytes.       
     Whereas the kinetics of miR-462/731 and Mx expression timely correlated in terms 
of onset, levels of miRNA transcripts remained particularly elevated despite the relative 
decrease of Mx expression 21 dpv (Figure 1A,B). This suggests that in addition to the 
putative roles of miR-462/731 in the early innate immune response, they may 
potentially also be involved in the development of specific adaptive immune responses 
such as the activation and differentiation of immune cells. Apart from the ISRE 
element, the miR-462/731 promoter region thus also contained a gamma IFN activation 
sequence (GAS) and a purine box 1 (PU.1 box: GAGGAAGT) (Schyth et al., 
manuscript submitted). The PU.1 box, a conserved immune-related regulatory element 
in vertebrate (including teleost) genomes, is the binding site of the leukocyte 
differentiation related transcription factor PU.1, which is involved in the regulation of 
hematopoiesis (Mak et al., 2011; Ribas et al., 2008; Anderson et al., 2001; Shintani et 
al., 2000; DeKoter et al., 1998). Isolation of infiltrating cells at the vaccination site and 
subsequent miRNA profiling will be needed to resolve this.  
     Injection of the anti-miRNA-462/731 before challenge of the fish with VHSV tended 
to promote the disease progression (Figure 5). However, the effect was minor and not 
conclusive, possibly due to an excessive challenge dose with the highly virulent VHSV 
isolate and an insufficient challenge dose with the low virulent isolate. Alternatively, 
the persistence of the anti-miRNAs might have been too short to clearly affect the 
miRNAs induced by the subsequent VHSV infection. To increase the chance of having 
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anti-miRNAs present in the fish at the time of miRNA induction, we therefore decided 
to test the effect of anti-miRNAs on poly I:C induced protection against VHSV. 
     Poly I:C has been previously shown to induce the IFN response in teleost fish and 
protects against virus infection in vitro (Verrier et al., 2013) and in vivo (Nishizawa et 
al., 2009; Jensen et al., 2002; Eaton, 1990) shortly after administration, as was also 
demonstrated in this study (Figures 4A and 5). Fish pre-treated with poly I:C were 
injected with anti-miRNAs or mismatch controls and subsequently challenged with the 
highly virulent VSHV strain.  
     Poly I:C treatment slowed down disease progression and decreased mortality 21 dpc 
relative to non-poly I:C-treated groups (Figure 5). Anti-miR-462/731 injection in poly 
I:C-treated fish led to faster disease development and increased mortality compared to 
the poly I:C-treated group that did not receive anti-miRNAs. This demonstrates that 
silencing miR-462/731 with anti-miRNAs counteracted the protective effects of poly 
I:C against VHSV. Anti-miRNA or mismatch control injection to non-poly I:C-treated 
groups showed similar disease development and mortality profiles as the saline/TE-
injected controls. In the poly I:C-treated fish receiving mismatch controls, challenge 
failed in one of the replicate tanks. Mortality comparable to the poly I:C-treated fish 
tanks in the remaining replicate suggested a specific inhibitory effect of the anti-
miRNAs. 
     One basic question related to the observed effect of the anti-miRNAs on virus 
susceptibility is whether the anti-miRNAs are systemically distributed and taken up by 
cells following IP delivery. Efficient delivery remains one of the major challenges in 
the development of nucleic acid-based medicines (Hsu and Uludağ, 2012; Jafari et al., 
2012; Lee and Kataoka, 2012, Xu and Anchordoquy, 2011; Mastrobattista et al., 2007). 
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Reports on systemic effects of antisense oligonucleotides, i.e. anti-miRNAs, in 
mammals suggest that it is possible to specifically inhibit miRNAs in vivo by the 
administration of small chemically-modified, unconjugated or cholesterol-conjugated or 
naked LNA-based anti-miRNAs (Bernardo et al., 2014; Bernardo et al., 2012; 
Hildebrandt-Eriksen et al., 2012; Lanford et al., 2010; Elmen et al., 2008; Esau et al., 
2006; Krützfeldt et al., 2005). Furthermore, a short LNA-based anti-miRNA against 
miR-122 is currently in phase 2 clinical trials for the treatment of HCV infection 
(Janssen et al., 2013). Novel data demonstrate that this LNA-modified DNA 
phosphorothioate antisense oligonucleotide drug called Miravirsen not only blocks the 
mature miR-122 but also interferes with precursor and primary miRNA stages, thereby 
interrupting miRNA biogenesis and the production of the functional mature miRNA 
(Gebert et al., 2014). Although the specific interference with miR-462/731 by the 
administered anti-miRNAs at the molecular level remains to be confirmed from the 
work presented here, current research thus supports that endogenously expressed 
miRNAs can be specifically inhibited by the applied approach. 
     Altogether, the fish trials suggest that the two miRNAs are involved in IFN-
mediated antiviral activities. IFNs are important mediators of immune responses that 
are elicited by the recognition of virus pathogen-associated molecular patterns (PAMPs) 
by host cell receptors. Type I IFNs induce the expression of the cells’ predominantly 
protein-based antiviral resources including the Mx GTPases, adenosine deaminase 
(ADA), protein kinase R (PKR), and the 2’-5’ oligoadenylate synthetase (OAS)/RNAse 
L system, (Schoggins and Rice, 2011; Borden et al., 2007; Samuel 2001). Although 
IFNs have been shown to upregulate expression of cellular miRNAs in human cells 
(Zhang et al., 2013; Scagnolari et al., 2010), the role of these miRNAs, particularly in 
host-pathogen interactions, has not been well established.  
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     Cellular miRNAs induced by IFN-β in human cells have been demonstrated to target 
viral transcripts, thereby contributing towards the antiviral properties of IFN-β 
(Pedersen et al., 2007). Similarly, an IFN-γ-induced miRNA, miR-29a (Schmitt et al., 
2012) has been shown to target the 3’UTR of HIV-1 (Nathans, et al., 2009). The recent 
years have also seen an increasing number of cellular miRNAs reported to be involved 
in antiviral responses against diverse viruses in mammalian cells (Russo and Potenza, 
2011). Some of these miRNAs are IFN-inducible and have been demonstrated to 
directly target viral sequences, while others target host mRNAs that encode proteins 
involved in virus replication, host-virus interactions, signaling, and immune responses 
(Buggele and Horvath, 2013; Buggele et al., 2013; Gao et al., 2013; Sisk et al., 2013; 
Zhang et al., 2013; Terrier et al., 2013; Smith et al., 2012; Pedersen et al., 2007; 
Triboulet et al., 2007). Therefore, the IFN response may potentially use cellular 
miRNAs as RNA-based antiviral effectors in addition to a myriad of well-known 
antiviral proteins.  
    In conclusion, our results suggest that miR-462/731 are involved in IFN-mediated 
antiviral defense in teleost fish and may partly account for the protective effects of poly 
I:C and possibly also the early innate protection mediated by the rhabdovirus G-based 
DNA vaccines. Validated targets of these two miRNAs are currently unknown and 
whether they can directly target VHSV sequences needs further investigation. To our 
knowledge, this is the first report to address expression of specific miRNAs in response 
to DNA vaccination against a fish rhabdovirus and to identify IFN-induced miRNAs 
that may be involved in host-virus interactions and immune responses in teleost fish. 
We speculate that miRNA-mediated RNA interference might play an important role in 
innate antiviral immunity in this highly diverse vertebrate group. Our data may add to a 
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better understanding of the protective immune mechanisms elicited by fish rhabdovirus 
DNA vaccines in fish and how these mechanisms may be regulated.  
 
Acknowledgments 
The authors gratefully acknowledge the kind and able assistance of the staff of the 
National Veterinary Institute, Technical University of Denmark and of the Fish health 
Section, Department of Animal Science, University of Aarhus. Professor Chris 
Secombes and Dr. Jun Zou, University of Aberdeen, Scotland, are thanked for the IFN 
plasmid constructs. This work was supported by the Danish Research Council for 
Technology and Production Sciences (grants no. 26-03-0059 and 274-05-0585); the 
Lundbeck Foundation (grant no. 52/03); the European Commission (contract 
FP6007103 IMAQUANIM); and by the John Birthe Meyer Foundation. 
 
 
 
      
 
 
 
 
 
 
123 
 
References  
Acosta F, Collet B, Lorenzen N, Ellis AE. 2006. Expression of the glycoprotein of viral 
haemorrhagic septicaemia virus (VHSV) on the surface of the fish cell line RTG-P1 
induces type 1 interferon expression in neighbouring cells. Fish Shellfish Immunol. 
21(3):272-8.  
 
Allantaz F, Cheng DT, Bergauer T, Ravindran P, Rossier MF, Ebeling M, Badi L, Reis 
B, Bitter H, D'Asaro M, Chiappe A, Sridhar S, Pacheco GD, Burczynski ME, 
Hochstrasser D, Vonderscher J, Matthes T. 2012. Expression profiling of human 
immune cell subsets identifies miRNA-mRNA regulatory relationships correlated with 
cell type specific expression. PLoS One. 7(1):e29979.  
 
Anderson MK, Sun X, Miracle AL, Litman GW, Rothenberg EV. 2001. Evolution of 
hematopoiesis: Three members of the PU.1 transcription factor family in a cartilaginous 
fish, Raja eglanteria Proc Natl Acad Sci USA 98:553-558. 
Bartel DP. 2004. MicroRNAs: genomics, biogenesis, mechanism, and function. 
116(2):281-97. 
 
Berg K., Svingerud T., Sun B., Robertsen B. 2009. An antiserum against Atlantic 
salmon IFNa1 detects IFN and neutralizes antiviral activity produced by poly I:C 
stimulated cells. Dev. Comp. Immunol. 33:638–645. 
 
Bernard J., Bearzotti-le Berre M., De Kinkelin P. 1985. Viral haemorrhagic septicaemia 
in rainbow trout: Attempt to relate interferon production, antibody synthesis and 
structure of the virus with the mechanism of virulence. Annalles Institute Pasteur. 
136:13–26. 
Bernardo BC, Gao XM, Tham YK, Kiriazis H, Winbanks CE, Ooi JY, Boey EJ, Obad 
S, Kauppinen S, Gregorevic P, Du XJ, Lin RC, McMullen JR. 2014. Silencing of miR-
34a attenuates cardiac dysfunction in a setting of moderate, but not severe, hypertrophic 
cardiomyopathy. PLoS One. 9(2):e90337.  
Bernardo BC, Gao XM, Winbanks CE, Boey EJ, Tham YK, Kiriazis H, Gregorevic P, 
Obad S, Kauppinen S, Du XJ, Lin RC, McMullen JR. 2012. Therapeutic inhibition of 
the miR-34 family attenuates pathological cardiac remodeling and improves heart 
function. Proc Natl Acad Sci U S A. 109(43):17615-20.  
Bonci D, Coppola V, Musumeci M, Addario A, Giuffrida R, Memeo L, D'Urso L, 
Pagliuca A, Biffoni M, Labbaye C, Bartucci M, Muto G, Peschle C, De Maria R. 2008. 
The miR-15a-miR-16-1 cluster controls prostate cancer by targeting multiple oncogenic 
activities. Nat Med. 14(11):1271-7.  
 
Borden EC, Sen GC, Uze G, Silverman RH, Ransohoff RM, Foster GR, Stark GR. 
2007.Interferons at age 50: past, current and future impact on biomedicine. Nat Rev 
Drug Discov. 6(12):975-90. 
 
 
 
124 
 
Boudinot P., Blanco M., de Kinkelin P., Benmansour A. 1998. Combined DNA 
immunization with the glycoprotein gene of viral hemorrhagic septicemia virus and 
infectious hematopoietic necrosis virus induces double-specific protective immunity 
and nonspecific response in rainbow trout. Virology 249:297–306. 
 
Buggele WA, Horvath CM. 2013. MicroRNA profiling of Sendai virus-infected A549 
cells identifies miR-203 as an interferon-inducible regulator of IFIT1/ISG56. J Virol. 
87(16):9260-70.  
 
Buggele WA, Krause KE, Horvath CM. 2013. Small RNA profiling of influenza A 
virus-infected cells identifies miR-449b as a regulator of histone deacetylase 1 and 
interferon beta. PLoS One. 8(9):e76560.  
 
Byon, J.Y.; Ohira, T.; Hirono, I.; Aoki, T. 2006. Comparative immune responses in 
Japanese flounder, Paralichthys olivaceus after vaccination with viral hemorrhagic 
septicemia virus (VHSV) recombinant glycoprotein and DNA vaccine using a 
microarray analysis. Vaccine 24: 921–930. 
 
Byon, J.Y.; Ohira, T.; Hirono, I.; Aoki, T. 2005. Use of a cDNA microarray to study 
immunity against viral hemorrhagic septicemia (VHS) in Japanese flounder 
(Paralichthys olivaceus) following DNA vaccination. Fish Shellfish Immunol. 18: 135–
147. 
 
Castro R, Martínez-Alonso S, Fischer U, Haro NÁ, Soto-Lampe V, Wang T, Secombes 
CJ, Lorenzen N, Lorenzen E, Tafalla C. 2014. DNA vaccination against a fish 
rhabdovirus promotes an early chemokine-related recruitment of B cells to the muscle. 
Vaccine. 32(10):1160-8.  
Chen CZ, Li L, Lodish HF, Bartel DP. 2004. MicroRNAs modulate hematopoietic 
lineage differentiation. Science. 303(5654):83-6.  
Chen PY, Manninga H, Slanchev K, Chien M, Russo JJ, Ju J, Sheridan R, John B, 
Marks DS, Gaidatzis D et al. 2005. The developmental miRNA profiles of zebrafish as 
determined by small RNA cloning Genes Dev 19(11):1288-1293. 
Chen ZY, Lei XY, Zhang QY. 2012. The antiviral defense mechanisms in mandarin 
fish induced by DNA vaccination against a rhabdovirus. Vet Microbiol. 157(3-4):264-
75.  
Creighton CJ, Hernandez-Herrera A, Jacobsen A, Levine DA, Mankoo P, Schultz N, 
Du Y, Zhang Y, Larsson E, Sheridan R, Xiao W, Spellman PT, Getz G, Wheeler DA, 
Perou CM, Gibbs RA, Sander C, Hayes DN, Gunaratne PH; Cancer Genome Atlas 
Research Network. 2012. Integrated analyses of microRNAs demonstrate their 
widespread influence on gene expression in high-grade serous ovarian carcinoma. PLoS 
One. 7(3):e34546.  
 
DeKoter RP, Walsh JC, Singh H. 1998. PU.1 regulates both cytokine-dependent 
proliferation and differentiation of granulocyte/macrophage progenitors EMBO J 
17(15):4456-68. 
125 
 
Eaton W. D. 1990. Antiviral activity in four species of salmonids following exposure to 
poly (I)-poly (C). Dis. Aquat. Org. 9:193–198. 
Elmén J, Lindow M, Schütz S, Lawrence M, Petri A, Obad S, Lindholm M, Hedtjärn 
M, Hansen HF, Berger U, Gullans S, Kearney P, Sarnow P, Straarup EM, Kauppinen S. 
2008. LNA-mediated microRNA silencing in non-human primates. Nature. 
452(7189):896-9.  
Esau C, Davis S, Murray SF, Yu XX, Pandey SK, Pear M, Watts L, Booten SL, 
Graham M, McKay R, Subramaniam A, Propp S, Lollo BA, Freier S, Bennett CF, 
Bhanot S, Monia BP. 2006. miR-122 regulation of lipid metabolism revealed by in vivo 
antisense targeting. Cell Metab. 3(2):87-98. 
Eulalio A, Schulte L, Vogel J. 2012. The mammalian microRNA response to bacterial 
infections. RNA Biol. 9(6):742-50.  
 
Friedman RC, Kai-How Farh KK-H, Burge, and Bartel DP. 2009. Most mammalian 
mRNAs are conserved targets of microRNAs. Genome Res. 19(1): 92–105.  
Gao L, Guo XK, Wang L, Zhang Q, Li N, Chen XX, Wang Y, Feng WH. 2013. 
MicroRNA 181 suppresses porcine reproductive and respiratory syndrome virus 
(PRRSV) infection by targeting PRRSV receptor CD163. J Virol. 87(15):8808-12.  
 
Gebert LF, Rebhan MA, Crivelli SE, Denzler R, Stoffel M, Hall J. 2014. Miravirsen 
(SPC3649) can inhibit the biogenesis of miR-122. Nucleic Acids Res. 42(1):609-21.  
Ghosh Z, Mallick B, and  Chakrabarti J. 2009.
. 
Cellular versus viral microRNAs in 
host–virus interaction. Nucleic Acids Res. 37(4): 1035–1048.  
Hildebrandt-Eriksen, E.S., V. Aarup, R. Persson, H.F. Hansen, M.E. Munk, and H. 
Ørum. 2012. A locked nucleic acid oligonucleotide targeting microRNA 122 is well-
tolerated in cynomolgus monkeys. Nucleic Acid Ther. 22:152–161. 
 
Hsu CY, Uludağ H. 2012. Nucleic-acid based gene therapeutics: delivery challenges 
and modular design of nonviral gene carriers and expression cassettes to overcome 
intracellular barriers for sustained targeted expression. J Drug Target. 20(4):301-28.  
Jafari M, Soltani M, Naahidi S, Karunaratne DN, Chen P. 2012. Nonviral approach for 
targeted nucleic acid delivery. Curr Med Chem. 19(2):197-208. 
Jensen I, Albuquerque A, Sommer AI, Robertsen B. 2002. Effect of poly I : C on the 
expression of Mx proteins and resistance against infection by infectious salmon 
anaemia virus in Atlantic salmon. Fish Shellfish Immunol. 13:311–326. 
 
Jin HK, Takada A, Kon Y, Haller O, Watanabe T. 1999. Identification of the murine 
Mx2 gene: interferon-induced expression of the Mx2 protein from the feral mouse gene 
confers resistance to vesicular stomatitis virus. J Virol. 73(6):4925-30. 
 
Kim CH, Johnson MC, Drennan JD, Simon BE, Thomann E, Leong JA. J Virol. 2000 
74(15):7048-54. DNA vaccines encoding viral glycoproteins induce nonspecific 
immunity and Mx protein synthesis in fish. 
126 
 
Kloosterman WP, Steiner FA, Berezikov E, de Bruijn E, van de Belt J, Verheul M, 
Cuppen E, Plasterk RHA. 2006. Cloning and expression of new microRNAs from 
zebrafish Nucl Acids Res 34(9):2558-2569. 
Krützfeldt J, Rajewsky N, Braich R, Rajeev KG, Tuschl T, Manoharan M, Stoffel M. 
2005. Silencing of microRNAs in vivo with 'antagomirs'. Nature. 438(7068):685-9. 
Epub 2005 Oct 30. 
Kurath G, Garver KA, Corbeil S, Elliott DG, Anderson ED, LaPatra SE. 2006. 
Protective immunity and lack of histopathological damage two years after DNA 
vaccination against infectious hematopoietic necrosis virus in trout Vaccine, 24: 345–
354 
Kurath G. 2008. Biotechnology and DNA vaccines for aquatic animals. Rev Sci Tech. 
27(1):175-96. 
Lanford RE, Hildebrandt-Eriksen ES, Petri A, Persson R, Lindow M, Munk ME, 
Kauppinen S, Ørum H. 2010. Therapeutic silencing of microRNA-122 in primates with 
chronic hepatitis C virus infection. Science. 327(5962):198-201.  
LaPatra, S.E.; Corbeil, S.; Jones, G.R.; Shewmaker, W.D.; Lorenzen, N.; Anderson, 
E.D.; Kurath, G. 2001. Protection of rainbow trout against infectious hematopoietic 
necrosis virus four days after specific or semi-specific DNA vaccination. Vaccine 19, 
4011–4019. 
 
Lee Y, Kataoka. 2012. Delivery of Nucleic Acid Drugs. Nucleic Acid Drugs Advances 
in Polymer Science. 249: 95-134  
 
Li SC, Chan WC, Ho MR, Tsai KW, Hu LY, Lai CH, Hsu CN, Hwang PP, Lin Wc 
2010 Discovery and characterization of medaka miRNA genes by next generation 
sequencing platform BMC Genomics 11(Suppl 4):S8. 
Lim LP, Lau NC, Garrett-Engele P, Grimson A, Schelter JM, Castle J, Bartel DP, 
Linsley PS, Johnson JM. 2005. Microarray analysis shows that some microRNAs 
downregulate large numbers of target mRNAs. Nature.433(7027):769-73.  
Lorenzen E, Einer-Jensen K, Rasmussen JS, Kjaer TE, Collet B, Secombes CJ, 
Lorenzen N. 2009. The protective mechanisms induced by a fish rhabdovirus DNA 
vaccine depend on temperature. Vaccine. 27(29):3870-80.  
Lorenzen E, Lorenzen N, Einer-Jensen K, Brudeseth B, Evensen Ø. 2005. Time course 
study of in situ expression of antigens following DNA-vaccination against VHS in 
rainbow trout (Oncorhynchus mykiss Walbaum) fry Fish Shellfish Immunol, 19: 27–41. 
Lorenzen N, Lorenzen E, Einer-Jensen K, Heppell J, Davis HL. 1999. Genetic 
vaccination of rainbow trout against viral hemorrhagic septicemia virus: small amounts 
of plasmid DNA protect against a heterologous serotype. Virus Res, 63 (1–2): 19–25 
Lorenzen N, Lorenzen E, Einer-Jensen K, Heppell J, Wu T and Davis H. 1998. 
Protective immunity to VHS in rainbow trout (Oncorhynchus mykiss, Walbaum) 
following DNA vaccination. Fish Shellfish Immunol,  8: 261–270. 
127 
 
Lorenzen N, Lorenzen E, Einer-Jensen K, LaPatra SE. 2002. DNA vaccines as a tool 
for analysing the protective immune response against rhabdoviruses in rainbow trout 
Fish & Shellfish Immunology, 12, (5): 439-453 
Lorenzen N, Olesen NJ, Vestergård Jørgensen PE, Etzerodt, M, Holtet TL, Thøgersen 
HC. 1993. Molecular cloning and expression in Escherichia coli of the glycoprotein 
gene of VHS virus, and immunization of rainbow trout with the recombinant protein J. 
Gen. Virol., 74: 623–630 
Lorenzen, N and LaPatra, S. 2005. DNA vaccines for aquacultured fish. Rev Sci Tech, 
24(1): 201–213.  
Lorenzen, N.; Lorenzen, E.; Einer-Jensen, K.; La Patra, S.E. 2002. Immunity induced 
shortly after DNA vaccination of rainbow trout against rhabdoviruses protects against 
heterologous virus but not against bacterial pathogens. Dev. Comp. Immunol. 26, 173–
179. 
 
Mak KS, Funnell APW, Pearson RCM, and Crossley M. 2011. PU.1 and 
Haematopoietic Cell Fate: Dosage Matters. Int J Cell Biol. 2011: 808524.  
Mastrobattista E,  Hennink WE, Schiffelers RM. 2007.
 
Delivery of Nucleic Acids. 
Pharm Res. 24(8): 1561–1563.  
McLauchlan PE, Collet B, Ingerslev E, Secombes CJ, Lorenzen E, Ellis AE. 2003. 
DNA vaccination against viral hemorrhagic septicemia (VHS) in rainbow trout: size, 
dose, route of injection and duration of protection—early protection correlates with Mx 
expression Fish Shellfish Immunol, 15: 39–50 
Mortensen HF, Heuer OE, Lorenzen N, Otte L, Olesen NJ. 1999. Isolation of viral 
haemorrhagic septicaemia virus from wild marine fish species in the Baltic Sea, 
Kattegat, Skagerrak and the North Sea. Virus Res 63:95–106 
Nathans R, Chu CY, Serquina AK, Lu CC, Cao H, Rana TM. 2009. Cellular microRNA 
and P bodies modulate host-HIV-1 interactions. Molecular Cell, 34: 696–709 
Nishizawa T, Takami I, Kokawa Y, Yoshimizu M. 2009. Fish immunization using a 
synthetic double-stranded RNA Poly(I:C), an interferon inducer, offers protection 
against RGNNV, a fish nodavirus. Dis Aquat Organ. 83(2):115-22.  
Olesen, N. J. 1998. Sanitation of viral haemorrhagic septicaemia (VHS). Journal of 
Applied Ichthyology, 14(3-4), 173–177.  
Pedersen IM, Cheng G, Wieland S, Volinia S, Croce CM, Chisari FV, David M. 2007. 
Interferon modulation of cellular microRNAs as an antiviral mechanism. 
449(7164):919-22. 
Ribas L, Roher N, Martinez M, Balasch JC, Donate C, Goetz FW, Iliev D, Planas JV, 
Tort L, MacKenzie S (2008) Characterisation and expression of the transcription factor 
PU.1 during LPS-induced inflammation in the rainbow trout (Oncorhynchus mykiss) 
Fish Shellfish Immunol 24(1):35-45. 
128 
 
Richmond JY, Hamilton LD. 1969. Foot-and-mouth disease virus inhibition induced in 
mice by synthetic double-stranded RNA (polyriboinosinic and polyribocytidylic acids). 
Proceedings of the National Academy of Sciences of the United States of America, 
64:81–86 
Robertsen B., Bergan V., Rokenes T., Larsen R., Albuquerque A. 2003. Atlantic salmon 
interferon genes: cloning, sequence analysis, expression, and biological activity. J. 
Interferon Cytokine Res. 23:601–612. 
 
Russo A, Potenza N. 2011. Antiviral effects of human microRNAs and conservation of 
their target sites. FEBS Lett. 585(16):2551-5.  
Samuel CE. 2001. Antiviral actions of interferons. Clin Microbiol Rev. 14(4):778-809. 
Scagnolari C, Zingariello P, Vecchiet J, Selvaggi C, Racciatti D, Taliani G, Riva E, 
Pizzigallo E, Antonelli G. 2010. Differential expression of interferon-induced 
microRNAs in patients with chronic hepatitis C virus infection treated with pegylated 
interferon alpha. Virol J. 12;7:311.  
Schmitt MJ, Philippidou D, Reinsbach SE, Margue C, Wienecke-Baldacchino A, 
Nashan D, Behrmann I, Kreis S. 2012. Interferon-γ-induced activation of Signal 
Transducer and Activator of Transcription 1 (STAT1) up-regulates the tumor 
suppressing microRNA-29 family in melanoma cells. Cell Communication and 
Signaling, 10: 41 
Schoggins JW, Rice CM. 2011. Interferon-stimulated genes and their antiviral effector 
functions. Curr Opin Virol. 1(6):519-25.  
Shintani S, Terzic J, Sato A, Saraga-Babic M, O'hUigin C, Tichy H, Klein J (2000) Do 
lampreys have lymphocytes? The Spi evidence Proc Natl Acad Sci USA 97(13):7417-
7422. 
Sisk JM, Witwer KW, Tarwater PM, Clements JE. 2013. SIV replication is directly 
downregulated by four antiviral miRNAs. Retrovirology. 10:95.  
Skalsky RL, Cullen BR. 2010. Viruses, microRNAs, and host interactions. Annu Rev 
Microbiol. 64:123-41.  
Smigielska-Czepiel K, van den Berg A, Jellema P, van der Lei RJ, Bijzet J, Kluiver J, 
Boots AM, Brouwer E, Kroesen BJ. 2014. Comprehensive analysis of miRNA 
expression in T-cell subsets of rheumatoid arthritis patients reveals defined signatures 
of naive and memory Tregs. Genes Immun. 15(2):115-25.  
 
Smith JL, Grey FE, Uhrlaub JL, Nikolich-Zugich J, Hirsch AJ. 2012. Induction of the 
cellular microRNA, Hs_154, by West Nile virus contributes to virus-mediated apoptosis 
through repression of antiapoptotic factors. J Virol. 86(9):5278-87.  
 
Staedel C, Darfeuille F. 2013. MicroRNAs and bacterial infection. Cell Microbiol. 
(9):1496-507.  
129 
 
Sun B, Skjæveland I, Svingerud T, Zou J, Jørgensen J, Robertsen B. 2011. Antiviral 
activity of salmonid gamma interferon against infectious pancreatic necrosis virus and 
salmonid alphavirus and its dependency on type I interferon. J Virol. 85(17):9188-98.  
 
Swaminathan S, Murray DD, Kelleher AD. 2013. miRNAs and HIV: unforeseen 
determinants of host-pathogen interaction. Immunol Rev. 254(1):265-80.  
Terrier O, Textoris J, Carron C, Marcel V, Bourdon JC, Rosa-Calatrava M. 2013. Host 
microRNA molecular signatures associated with human H1N1 and H3N2 influenza A 
viruses reveal an unanticipated antiviral activity for miR-146a. J Gen Virol. 94(Pt 
5):985-95.  
 
Triboulet R, Mari B, Lin YL, Chable-Bessia C, Bennasser Y, Lebrigand K, Cardinaud 
B, Maurin T, Barbry P, Baillat V, Reynes J, Corbeau P, Jeang KT, Benkirane M. 2007. 
Suppression of microRNA-silencing pathway by HIV-1 during virus replication. 
Science. 315(5818):1579-82.  
 
Trobridge G. D., Leong J. C. (1995) Characterization of a rainbow trout Mx gene. J. 
Interferon Cytokine Res. 15:691–702. 
 
Utke K, Kock H, Schuetze H, Bergmann SM, Lorenzen N, Einer-Jensen K, Köllner B, 
Dalmo RA, Vesely T, Ototake M, Fischer U. 2008. Cell-mediated immune responses in 
rainbow trout after DNA immunization against the viral hemorrhagic septicemia virus. 
Dev Comp Immunol. 32(3):239-52. 
Utke K, Kock H, Schuetze H, Bergmann SM, Lorenzen N, Einer-Jensen K, Köllner B, 
Dalmo RA, Vesely T, Ototake M, Fischer U. 2008. Cell-mediated immune responses in 
rainbow trout after DNA immunization against the viral hemorrhagic septicemia virus. 
Dev Comp Immunol. 32(3):239-52. 
Verhelst J, Hulpiau P, Saelens X. 2013. Mx proteins: antiviral gatekeepers that restrain 
the uninvited. Microbiol Mol Biol Rev. 77(4):551-66.  
Verjan, N.; Ooi, E.L.; Nochi, T.; Kondo, H.; Hirono, I.; Aoki, T.; Kiyono, H.; Yuki, Y. 
2008. A soluble nonglycosylated recombinant infectous hematopoietic necrosis virus 
(IHNV) G-protein induces IFNs in rainbow trout (Oncorhynchus mykiss). Fish 
Shellfish Immunol. 25, 170–180. 
 
Verrier ER, Langevin C, Tohry C, Houel A, Ducrocq V, Benmansour A, Quillet E, 
Boudinot P. 2012. Genetic resistance to rhabdovirus infection in teleost fish is 
paralleled to the derived cell resistance status. PLoS One. 7(4):e33935.  
 
Verrier, E.R.; Langevin, C.; Benmansour, A.; Boudinot, P. 2011. Early antivirial 
response and virusinduced genes in fish. Dev. Comp. Immunol. 35, 1204-1214. 
 
Wu H, Neilson JR, Kumar P, Manocha M, Shankar P, et al. 2007. miRNA Profiling of 
Naïve, Effector and Memory CD8 T Cells. PLoS ONE 2(10): e1020.  
Xu L, Anchordoquy T. 2011. Drug delivery trends in clinical trials and translational 
medicine: challenges and opportunities in the delivery of nucleic acid-based 
therapeutics. J Pharm Sci. 100(1):38-52.  
130 
 
Xu Z, Chen J, Li X, Ge J, Pan J, Xu X 2013 Identification and characterization of 
microRNAs in channel catfish (Ictalurus punctatus) by using Solexa sequencing 
technology PLoS ONE 8(1):e54174. 
Zhang X, Daucher M, Armistead D, Russell R, Kottilil S. 2013. MicroRNA expression 
profiling in HCV-infected human hepatoma cells identifies potential anti-viral targets 
induced by interferon-α. PLoS One. 8(2):e55733.  
 
Zhang Y, Li YK. 2013. MicroRNAs in the regulation of immune response against 
infections. J Zhejiang Univ Sci B. 14(1):1-7.  
Zou J, Carrington AC, Collet B, Dijkstra JM, Yoshiura Y, Bols N, Secombes CJ. 2005. 
Identification and bioactivities of IFN-gamma in rainbow trout Oncorhynchus mykiss: 
the first Th1-type cytokine characterized functionally in fish J Immunol 175(4):2484-
2494. 
Zou J, Tafalla C, Truckle J, Secombes CJ. 2007. Identification of a second group of 
type I IFNs in fish sheds light on IFN evolution in vertebrates. J Immunol. 179(6):3859-
71. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
131 
 
Figures. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. Expression of miR-462 and miR-731 in the skeletal muscle (site of vaccine 
administration) (A) and in the liver (B) of pcDNA3-vhsG-vaccinated fish at different 
time points post-vaccination determined by quantitative PCR. Fold upregulation values 
were calculated in 6 vaccinates relative to the average of 6 plasmid backbone-injected 
fish. Horizontal bars indicate median values.  
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Figure 2. (A) Expression of Mx in the skeletal muscle (site of vaccination) and in the 
liver of pcDNA3-vhsG-vaccinated fish at different time points post-vaccination 
determined by quantitative PCR. Fold upregulation values were calculated in 6 
vaccinates relative to the mean value of 6 plasmid backbone-injected fish. Horizontal 
bars indicate median values. (B) Type I IFN and IFN-γ expression at the skeletal 
muscle (site of vaccination) of pcDNA3-vhsG-vaccinated fish at different time points 
post-vaccination. Fold upregulation values were measured in a pool of tissue from 6 
vaccinated fish relative to a pool of tissue from 6 plasmid backbone-injected fish.  
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Figure 3. Expression of (A) miR-462 and miR-731 and (B) Mx in the skeletal muscle of 
pcDNA3-IFN1-13 (type I IFN)-, pcDNA3-IFN-G (IFN-γ)-, and poly I:C-injected fish at 
different time points post-injection determined by quantitative PCR. Fold upregulation 
values were measured in a pool of tissue from 6 vaccinated fish relative to a pool of 
tissue from 6 plasmid backbone-injected fish.  
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Figure 4. Development of mortality in fish injected with anti-miR-462/anti-miR-731 
oligonucleotides followed by challenge with a highly virulent VHSV strain (A) or with 
a semi-virulent VHSV isolate (B).   
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Figure 5. Development of mortality in poly I:C-treated fish in which miR-462 and miR-
731 were inhibited using anti-miRNA-specific oligonucleotides and subsequently 
challenged with a highly virulent VHSV strain. Mortality (%) data are presented as 
mean values from two replicate aquaria, except for the poly I:C+mismatch a-miR group 
(*). In this group (*), data from only one aquarium were considered because of the 
failure of virus challenge in the other replicate aquarium.   
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Abstract 
 
          RNA interference (RNAi) is an evolutionarily conserved RNA-mediated cellular 
process that effectively and specifically inhibits gene expression. Small double-stranded 
(ds) RNA molecules with complementarity to mRNA mediate translational inhibition or 
mRNA degradation. Different types of interfering RNAs have been described, the most 
well-known being the 22-nucleotide (nt) small interfering RNAs (siRNAs) with full 
sequence complementarity to their target mRNA and microRNAs (miRNAs) of similar 
size in their mature form, but only complementary to their targets in the 7-nt seed 
region. In invertebrates and plants, siRNAs are important players in the antiviral 
defense and are generated by direct processing of the exogenous ds viral RNA. 
However, in vertebrates, viral dsRNA is recognized by pattern recognition receptors 
which typically activate the IFN system with its broad range of innate antiviral 
mechanisms. Interestingly, accumulating data suggests that this includes IFN induced 
endogenous miRs. Recent reports further revealed that Dicer-processed small RNAs 
derived from viruses can act as small interfering RNAs (siRNAs) to inhibit 
complementary viral RNA also in vertebrates. This review gives an update on our 
current knowledge of RNAi mechanisms involved in antiviral defense in vertebrates.  
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Introduction 
     RNA interference (RNAi) is an evolutionarily conserved phenomenon in which the 
expression of genes is potently knocked down by an RNA-induced degradation or 
silencing of homologous mRNAs in the cytoplasm of eukaryotic cells (Meister & 
Tuschl, 2004; Sharp, 2001). This mechanism posttranscriptionally regulates 
endogenous gene expression but apart from this regulatory role, RNAi also actively 
participates in antiviral defense in fungi, invertebrates, and plants (Guo et al., 2012; 
Han et al., 2011; Ding, 2010; Lu et al., 2005; Segers et al., 2005; Wilkins et al., 2005; 
Baulcombe, 2004); Hamilton and Baulcombe, 1999).  
     Viruses exist in almost all ecosystems and are the most abundant infectious agents 
on Earth. Therefore, organisms have evolved mechanisms to detect viruses and resist 
infection. Whereas RNAi-based viral RNA silencing plays a central role as an antiviral 
defense strategy in invertebrates and plants, the interferon (IFN) system is believed to 
have supplanted RNAi in vertebrates where it predominates as the chief initial antiviral 
protective mechanism (Umbach and Cullen, 2009); Cullen 2006). The IFN response is 
elicited by the recognition of virus components such as dsRNA among other pathogen-
associated molecular patterns (PAMPs) by the host cells’ pattern recognition receptors 
(PRRs) (Akira et al., 2006). Type I IFNs induce the cells’ protein-based antiviral 
defenses that include the myxovirus resistance (Mx) GTPases, adenosine deaminase 
(ADA), protein kinase R (PKR)/EIF2AK2, and the 2’-5’ oligoadenylate synthetase 
(OAS)/RNAse L system, upregulation of MHC class I, and apoptotic pathways, among 
others (Schoggins and Rice, 2011; Borden et al., 2007; Samuel 2001). Induction of the 
IFN response results in cellular RNA degradation, global shutdown of protein synthesis, 
and the death of the virus-infected cells (Pichlmair and Reis e Sousa, 2007). During the 
last decade, it has become evident that RNAi also contributes to antiviral defense 
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mechanisms in mammals in the form of endogenously coded vertebrate 
microribonucleic acids (miRNAs). Some of these miRNAs are IFN-inducible and 
directly target viral transcripts. New data from analysis of the miRNA response to virus 
infection in teleost fish further suggests that otherwise conserved miRNAs have 
evolved into IFN-inducible antiviral defense elements in this primitive branch of 
vertebrates. Finally, the existence of a functional RNAi pathway that directly inhibits 
viruses in mammalian cells was recently reported in two recent papers  showing that  
small RNAs derived from degradation of viral ds RNA function as siRNAs and silence 
complementary viral RNA. The implications for our understanding of the role of RNAi 
in imunnity to viruses are discussed. 
 
The RNAi pathway: gene silencing with siRNAs and miRNAs 
     Naturally occurring small non-coding RNA effectors of RNAi include siRNAs and 
miRNAs. SiRNAs originate from the processing of long dsRNA precursors generated 
by duplex formation of overlapping complementary transcripts (e.g. from repetitive 
sequences) or may, in some organisms, be generated by RNA-dependent RNA 
polymerase action on ssRNA templates (e.g. from viral genomes or transcripts) 
(Meister and Tuschl, 2004). On the other hand, miRNAs are encoded by endogenous 
genes from which they are transcribed, producing transcripts (primary miRNA/pri-
miRNA) containing complementary inverted repeats that fold back on themselves to 
form hairpin loop structures (Ambros, 2004; Bartel, 2004; Lee et al., 2004).   
     Small RNAs mature through the activities of the RNAse III-type endonucleases 
Drosha and Dicer. (Drosha is particularly used to process pri-miRNAs but not long 
dsRNA precursors of siRNAs) (Meister and Tuschl, 2004). 
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     Pri-miRNAs are processed in the nucleus by Drosha and its co-factor Pasha 
(DiGeorge Syndrome Critical Region 8 Protein, DGCR8) into stem-loop structures 
called pre-miRNAs (Gregory et al., 2004; Lee et al., 2003). The pre-miRNAs are 
transported from the nucleus into the cytoplasm by Exportin 5 (Bohnsack et al., 2004), 
where they are further processed by Dicer together with TRBP (Tar RNA binding 
protein) to generate ~22-bp dsRNAs (Skalsky and Cullen, 2010). Long dsRNAs are 
processed like pre-miRNAs by Dicer into 21-24 bp siRNAs (Meister and Tuschl, 2004).   
     The RNAi pathway is triggered by Dicer cropping of dsRNA precursors into short 
siRNA and miRNA duplexes, which despite their different origins, both can be 
incorporated into the RNA-induced silencing complex (RISC) (Ding, 2010; Zamore et 
al., 2000; Bernstein et al., 2001). Upon integration into the RISC of one of the two 
strands (the guide strand), the single-stranded (ss) mature siRNA/miRNA guides the 
RISC complex to destroy matching or near-matching target mRNAs (Hammond et al., 
2000). Complementary sites are usually located in the 3’ untranslated regions (UTRs) 
of target mRNAs and matching between the miRNA seed region (nucleotides 2-7 or 8) 
and the target mRNA results in mRNA degradation and/or translational 
inhibition/repression (Bartel, 2009, 2004; Ambros 2004). The siRNAs usually guide 
RISC to bind perfectly complementary target sites, resulting in mRNA cleavage and 
degradation, whereas miRNAs typically bind to imperfectly matched targets, causing 
translational repression. Cases in which siRNAs and miRNAs shift roles with respect to 
the degree of complementarity of binding site recognition do occur (Meister and 
Tuschl, 2004). MiRNA-mediated gene silencing by RNAi is acknowledged as a crucial 
modulator of the expression of genes involved various biological activities in 
eukaryotes (Bushati and Cohen, 2007; Bartel, 2004). The RNAi pathway is 
schematically outlined in Figure 1. 
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Figure 1. The RNAi pathway. In RNAi, small RNAs guide the regulation of gene 
expression at the post-transcriptional level. Inside the nucleus, Drosha processes 
primary miRNA transcripts into precursor miRNA (pre-miRNA).  The pre-miRNA is 
then exported to the cytoplasm through the export receptor exportin-5. Dicer cleaves the 
pre-miRNA to siRNA-duplexes. The strands of the dsRNA intermediate are separated 
during incorporation into RISC. The mature miRNAs bound to Argonaute (Ago) 
proteins guide the RISC to find matching target mRNAs for cleavage or translational 
suppression. Long dsRNA from exogenous artificial dsRNA, RNA-dependent RNA 
polymerase (RdRP)-generated dsRNAs, genomic sense and antisense transcripts, and 
viral RNAs are processed like pre-miRNAs by Dicer into 21–23 nt duplexes. dsRNA 
stability and Dicer recognition can be regulated by adenosine deaminases (ADARs) and 
the exonuclease ERI-1. The siRNA-containing RISC is formed with the aid from the 
RNA helicase Armitage and R2D2. DCR-1 and DCR-2 are two paralogues of Dicer in 
Drosophila; DCR-1 specially cuts pre-miRNAs, while DCR-2 processes long dsRNA. 
Ago is involved in miRNA-mediated gene silencing, while Ago2 is involved in 
silencing guided by siRNAs.  (Modified from Meister and Tuschl, 2004)  
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RNAi as antiviral defense mechanism in plants and invertebrates 
      In fungi, insects, nematodes, plants, and vertebrates, the central role of RNAi in 
antiviral defense is well characterized (reviewed by Karlikow et al., 2014; Agius et al., 
2012; Ding, 2010; Umbach and Cullen, 2009; Ding and Voinnet, 2007) (Figure 2). In 
these organisms, virus infection elicits the production of virus-derived small RNAs, i.e. 
siRNAs that mediate antiviral RNAi.  
     During the replication of all RNA viruses (excluding retroviruses), viral RNA-
dependent RNA polymerase (RdRP) produces long, perfectly complementary RNA 
duplexes as replication intermediates. DsRNA replication intermediates are PAMPs 
detected and bound by the PRR Dicer that then crops virus dsRNAs into siRNAs that 
guide RISC to target complementary mRNAs. Viral genomes also contain imperfect 
hairpins that can serve as substrates for Dicer activity (Bronkhorst et al., 2013; 
tenOever, 2013). One strand of the siRNA duplex gets loaded into the RISC complex 
and guides RISC to seek out and bind complementary target viral mRNAs and genomic 
and antigenomic viral RNAs, resulting in viral RNA degradation (Ding, 2010; Carthew 
and Sontheimer 2009). 
          DNA viruses may produce dsRNAs by forming secondary structure in their 
transcripts or through sense-antisense pairing of transcripts generated by convergent or 
bidirectional transcription of the genome (Kemp et al., 2013; Bronkhorst et al., 2012; 
Ding and Voinnet, 2007). In this way, substrates for the generation of virus-derived 
siRNAs (vsiRNAs) for RNAi are generated and may play a role in the defense against 
plant DNA viruses (Moissiard and Voinnet, 2006; Blevins et al., 2006). In mammals, 
dsRNA generation from DNA viruses also occurs since TLR3, a dsRNA sensor, is 
activated during infection with dsDNA herpesviruses (Zhang et al., 2007; Tabeta et al., 
2004).     
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Figure 2. The siRNA-guided antiviral RNAi pathway is elicited by long, perfectly 
complementary dsRNAs generated during viral replication. These virus-derived 
dsRNAs are processed by Dicer to generate siRNAs, one strand of which is loaded into 
RISC either directly or after being used as template by cellular RdRP to generate more 
dsRNAs, thus amplifying the silencing effects. Virus-derived siRNAs associated with 
RISC bind target viral mRNAs, resulting in transcript degradation. In plants and 
invertebrates, virus-derived dsRNAs may be released from virus-infected cells, which 
prompts a systemic antiviral state after uptake by other non-infected cells (Modified 
from Umbach and Cullen, 2009).   
 
     In some species of plants and invertebrates, Dicer-generated siRNAs can be used as 
template by cellular RdRP to generate more dsRNAs, thereby augmenting siRNAs that 
could magnify silencing activity. Virus-derived dsRNAs may subsequently be released 
from virus-infected cells, initiating a systemic antiviral state following dsRNA uptake 
by neighboring or distantly located non-infected cells. Systemic RNAi involves the 
import of dsRNA from the extracellular environment and the systemic and long-
distance spread through the whole organism (non-cell-autonomous RNAi) and its 
progeny (Chapman and Carrington, 2007; Jose and Hunter, 2007; Whangbo and Hunter, 
2008).  
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     The highly specific recognition of target viral sequences and the ability to spread 
systemically exhibits certain parallels with vertebrate adaptive immunity which is based 
on the specific recognition of antigenic epitopes followed by systemic release of 
antibodies (Ding, 2010).   
     As counter defense mechanism, plant and animal viruses are known to encode a 
wide spectrum of factors (called viral suppresors of RNA silencing or VSRs) and 
strategies that suppress RNAi (reviewed by Wu et al., 2010). These include VSRs that 
target protein (e.g. Ago) as well as RNA components of the RNAi machinery (Wu et 
al., 2010). For example, tombusviruses produce P19 protein that binds and sequesters 
siRNA duplexes, preventing duplex unwinding and RISC loading. Some viruses encode 
proteins that recruit endogenous RNAi regulators. Others produce defective interfering 
RNAs that lack silencing targets (reviewed by Voinnet, 2005). All these reflect the 
unending evolutionary arms race waged by pathogens and hosts and underscores the 
crucial function of RNAi and its effectiveness as an antiviral defense strategy.   
 
Antiviral RNAi mechanisms in vertebrates 
      As had been shown for many viruses infecting invertebrates and plants, vertebrate 
viruses have also been found to possess components that could help them elude RNA 
silencing (Li and Ding, 2006). For example, influenza and vaccinia viruses produce IFN 
antagonist proteins that suppress RNAi (Li et al., 2004), whereas an adenovirus 
expresses a non-coding RNA (ncRNA) that inhibits the biogenesis of siRNA and 
miRNA (Lu and Cullen 2004). This indicates an RNAi pathway that may operate 
against viruses, although the exact role of these VSRs in an antiviral response in 
mammalian cells remains to be elucidated. Experiments showing the rescue of mutant 
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viruses lacking a functional VSR in RNAi-defective cells are required to support this 
(Wu et al., 2010).  
     Furthermore, various mammalian-infecting viruses are known to be inhibited by 
synthetic siRNAs in experimental RNAi systems (Haasnoot et al., 2007; Saksela, 2003). 
Thus, the antiviral prophylactic and therapeutic potential afforded by exogenous 
siRNAs have been explored in mammalian animal models and cell lines and in humans 
(DeVincenzo, 2012; Barik, 2010; Morris and Rossi, 2006; Ge et al., 2004; Tompkins et 
al., 2004). One clinical trial has provided a first proof of concept of the effectiveness of 
an RNAi-based therapy against a respiratory virus (Alvarez et al., 2009). 
     However, virus-derived siRNAs (vsiRNAs) have been found either at extremely low 
levels or are not detectable in mammalian somatic cells infected with a broad spectrum 
of viruses (Donaszi-Ivanov et al., 2013; Parameswaran et al., 2010; Otsuka et al., 2007; 
Pfeffer et al., 2004). Sindbis virus (SINV) infection is known to be controlled by RNAi 
in insects, but no dicer-generated SINV-derived siRNAs can be identified in SINV-
infected human cells (Donaszi-Ivanov et al., 2013).  
     Thus, whether mammalian cells (and potentially vertebrates in general) employ the 
natural vsiRNA-mediated antiviral RNAi pathway to make cells immune against the 
virus as do invertebrates and plants, has remained questionable (Umbach and Cullen, 
2009). This is partly because in mammalian cells, viral dsRNA triggers the IFN 
response (Akira et al., 2006; Karpala et al., 2005). It is believed that mammalian cells 
have replaced the RNAi pathway with the potent IFN system as the predominant 
protective innate antiviral mechanism (Obbard et al., 2009; Umbach and Cullen, 2009); 
Cullen 2006) and may conceal the effects of the presumed RNAi response provoked by 
virus infection.   
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     Natural antiviral virus-derived siRNA-based RNAi operates in mammalian cells.           
It was only very recently that strong evidence and data have been provided to 
substantiate the existence of a natural RNAi-based mechanism that (as in invertebrates 
and plant) relies on siRNA generation from viral dsRNA, targets viral transcripts, and 
affords protection in vertebrates, particularly in mammalian cells (Maillard et al., 2013) 
and in suckling mice (Li et al., 2013). 
     Maillard and co-workers employed undifferentiated, pluripotent mouse embryonic 
stem cells (mESCs) which are able to survive complete genetic deletion of Dicer and 
Ago and lack an innate immune response. In encephalomyocarditis virus (EMCV)-
infected mESCs, virus-derived small RNAs (vsRNAs) incorporate into the RNA RISC 
loader Argonaute 2 (AGO2) protein and but were not detected in cells deficient in the 
siRNA-generating enzyme Dicer (Maillard et al., 2013). Furthermore, mESCs were 
infected with the wild type Nodamura virus (NoV) which encodes the Dicer inhibitor 
and RNAi suppressor B2 protein. Whereas the NoV mutant (NoV∆B2) that lacks B2 
cannot infect mESCs, its replication was rescued by ectopic expression of either B2 or 
the Ebola virus viral suppressor of RNAi (VSR) protein VP-35, demonstrating that the 
mutant virus is unable to suppress RNAi and hence cannot replicate and establish 
infection (Maillard et al., 2013).  
     On the other hand, wild type NoV caused lethal infection in suckling mice but 
infection with NoV∆B2 resulted in zero mortality and virus clearance (Li et al., 2013). 
Similar innate immune gene expression profiles in mice infected with either the wild 
type or the mutant NoV indicated that virus clearance was due to the RNAi response 
rather than the innate immune reactions. vsRNAs with siRNA characteristics 
accumulated in mice infected with the mutant NoV but not with the wild type virus. 
Therefore, 7-day-old suckling mice lacking IFN responses are able to mount a strong 
149 
 
antiviral RNAi response, preventing infection by viruses that are unable to suppress the 
RNAi system. However, wild type NoV failed to infect adult mice despite having a 
functional RNAi suppressor protein and had been cleared by the IFN system instead (Li 
et al., 2013). Thus, it was confirmed that a natural antiviral RNAi that relies on siRNA 
generation by Dicer action on dsRNA viral replication intermediates operates in 
mammals as it does in plants and invertebrates.            
     Is siRNA-based antiviral RNAi physiologically relevant in mammalian cells? 
Despite the compelling evidence presented in favor of an antiviral function for RNAi in 
mammalian cells and mice, the physiological relevance of siRNA-mediated RNAi 
antiviral response observed by Maillard and co-workers and Li and co-workers has been 
disputed (Cullen et al., 2013).  
     VSR deficiency resulted in virus inhibition by RNAi, strongly emphasizing the 
crucial function of VSRs. Cullen and co-authors (2013) argued that the evidence 
substantiating the functional significance of virus-derived siRNAs both in cells and in 
mice depended exclusively on NoV VSR and on the ability of these vsRNAs to trigger 
an antiviral RNAi response. Cullen et al. (2013) contended that a more convincing data 
would have been the demonstration of the rescue of VSR-deficient mutant virus in 
RNAi-deficient mammalian cells ―but not by mutations that inactivate dsRNA-induced 
IFN responses in mice‖. 
     Other authors (Tanguy and Miska, 2013) reasoned that mammals as accidental hosts 
of the arthropod-vectored NoV are an epidemiological dead-end, thus do not provide 
the selection pressure for the maintenance of functional VSRs, unlike the arthropods 
serving as natural NoV reservoirs. Therefore, animal studies using viruses with only 
mammals as natural hosts are warranted (Tanguy and Miska, 2013).  
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     Results obtained in the two studies also directly contradicted those of one previous 
study in which IFN-deficient mice infected with a VSR-deficient flu virus succumbed 
to infection and died (Garcia-Sastre et al., 1998). In the absence of IFN, a virus unable 
to suppress RNAi would not have been able to cause infection had a functional RNAi 
been operating.      
     Furthermore, at around the same time that the papers of Maillard et al. (2013) and Li 
et al. (2013) came out, one study reported that type I IFN response activation upon virus 
infection in somatic cells reduced the antiviral action of the RNAi pathway (Seo et al., 
2013). The type I IFN antiviral constituents RIG-1/MAVS and RNase L have been 
shown to contribute to the repression of RISC. In non-infected cells, ISG expression is 
inhibited by miRNAs, whereas virus detection by PRRs reduces RISC activity leading 
to heightened ISG expression that increases the protective effect of the IFN response. 
Therefore, antiviral signaling and RNAi pathways appear to regulate each other’s 
activities and unlike its direct role as an antiviral strategy in invertebrates and plants, 
RNAi acts as an inhibitor of the type I IFN response (Seo et al., 2013). Cullen and co-
authors contend that such reciprocal regulatory activities cannot co-exist if RNAi 
functions as an authentic antiviral mechanism in mammalian somatic cells (Cullen et 
al., 2013). In addition, RISC is still inactive at 8 hr post-infection in vivo (Seo et al., 
2013). Hence, the RNAi machinery cannot yet fight the virus at this point of infection, 
which opposes the idea that RNAi operates as a crucial defense strategy against virus 
infection (Cullen et al., 2013).     
     Interestingly, differentiation of mESCs resulted in decreased siRNA generation from 
viral dsRNA (Maillard, et al., 2013), whereas antiviral RNAi activity was observed in 
suckling mice (Li et al., 2013). Therefore it appears that antiviral RNAi acts only in 
certain cell or tissue types in mammals. The mechanism underlying the loss of antiviral 
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RNAi in differentiation cells needs to be elucidated. It would seem that RNAi is more 
relevant as an antiviral defense mechanism in pluripotent stem cells (in which the IFN 
response is not yet active) because it does not entail apoptosis of infected cells as the 
IFN response does.  
 
RNA-based antiviral response mediated by cellular miRNAs in vertebrate cells 
   Because the existence of the invertebrate and plant analogue of a vsiRNA-based 
antiviral immunity in vertebrate cells has long eluded scientists, it was believed that 
endogenous miRNAs are instead engaged as primary effectors of viral silencing in an 
RNAi-based defense (Voinnet, 2005). Unlike the well-elucidated role for siRNAs, the 
role played by cellular miRNAs in antiviral immunity has remained unclear. Emerging 
data show that apart from regulating the expression of host genes, some cellular 
miRNAs also regulate the expression of mammalian virus genes.  
      The importance of RNAi as a defense strategy against virus infection in mammalian 
cells is further suggested by observations that impaired RNAi activity boosts viral 
replication in infected cells. In the absence of Dicer or Drosha, no small RNA effectors 
that guide the RISC machinery are generated. Accordingly, Drosha- or Dicer-deficiency 
in mice (Otsuka et al., 2007) or in cultured cells (Triboulet et al., 2007) prevented 
miRNA production which correlated with more efficient and faster virus replication and 
caused increased vulnerability to virus infection. Some mammalian viruses have further 
been shown to suppress RNAi mechanisms in infected cells. Influenza A virus was thus 
found to target Dicer at both protein and mRNA levels (Matskevich and Moelling, 
2007. It was further shown that HIV-1 actively suppresses the expression of cellular 
miR-17-5p and miR-20a, which target a cellular mRNA whose protein product is used 
by HIV-1 to its advantage (Triboulet et al., 2007). 
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     Cellular miRNAs that directly target viruses. Working on mammalian cells infected 
with the primate-infecting retrovirus, Primate foamy virus 1 (PFV-1), Lecellier and 
collaborators (Lecellier et al., 2005) did not detect virus- derived small RNAs. Instead, 
they found that a cellular miRNA, miR-32, inhibits PFV-1 replication. Silencing miR-
32 with LNA inhibitors resulted in accelerated viral replication rates. The PFV-1 
genome was further shown to contain potential target sites for miR-32 and for a number 
of other human miRNAs. In addition, PFV-1 makes an RNAi inhibitor called Tas 
protein that circumvents the antiviral capability of the RNA silencing pathway and 
further underscores the importance of this pathway in antiviral defense (Lecellier et al., 
2005). Therefore, mammalian cells employ cellular miRNAs rather than take advantage 
of the virus’ own RNA in antiviral RNAi. Lecellier et al. (2005) demonstrated the 
antiviral effect of a human cellular miRNA against a primate virus. Nevertheless, 
whereas the ability of PFV-1 to elicit a similar RNA silencing response required further 
work in a primate cell context, this study was the first to report that a mammalian 
miRNA possesses direct antiviral activity.  
     More recently, an increasing number of vertebrate miRNAs have been reported to 
directly impact gene expression of diverse viruses that infect humans, mice, pig, and 
chicken (see also review by Russo and Potenza, 2011). Table 1 presents those 
vertebrate miRNA whose targets in virus genes have been validated experimentally.    
     Some of these miRNAs target different virus species in the same or in different 
vertebrate hosts (Table 1). It is theoretically possible that such miRNAs may target 
other viruses apart from those that are currently reported and may be shown to have a 
broad range of target viruses, pending new data and further research. One virus species 
could be targeted by several miRNAs, which may allow regulation by multiple 
miRNAs. It would be interesting to know whether each of these miRNAs is sufficient 
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by itself to inhibit the virus or if they exert additive effects to the overall antiviral 
activity. 
     Interestingly, a number of vertebrate miRNAs target DNA viruses (MEV, HBV, 
HPV, ALV, MCMV) (Table 1). Thus far, antiviral RNAi against DNA viruses using 
virus-derived siRNAs have been demonstrated (Kemp et al., 2013; Bronkhorst et al., 
2012), while miRNA-mediated targeting of transcripts produced by vertebrate DNA 
virus has yet to be demonstrated (Skalsky and Cullen, 2010). 
     Moreover, cellular miRNAs target and regulate the replication of retroviruses (HIV-
1, PFV-1, SIV) (Table 1). Retroviruses (unlike other RNA viruses) do not generate 
dsRNA as replication intermediates (which can serve as Dicer substrates), hence virus-
derived siRNAs may not be produced. Accordingly, retrovirus-derived siRNAs have 
not been found in HIV-1- or human T cell leukemia virus type I (HTCLV)-infected 
cells (Lin and Cullen, 2007; Pfeffer et al., 2005). Cellular miRNAs may thus serve as 
relevant effectors in a natural RNA-based antiviral strategy in the absence of virus-
derived siRNAs from retroviruses infecting mammalian cells.  
     The data described above collectively indicate that vertebrate miRNA targeting of 
virus genomes and important virus genes contribute to host antiviral defenses. The 
silencing of virus genes or genomes by cellular miRNAs acting in concert with the 
cells’ many well-known protein-based antiviral resources most likely result in virus 
elimination and clearance of infection.    
     Computational prediction has revealed putative target sites of human cellular 
miRNAs in virus genomes. One study reported that miRNA target sites are mostly 
found in genomes of RNA viruses (Watanabe et al., 2007).  Another report has shown 
that potential miRNA target sites are highly conserved in genomes of selected human-
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infecting viruses (Russo and Potenza, 2011). For a number of human miRNAs and their 
putative targets in the genome of the influenza H1N1 virus, it has been proposed that 
the interaction between cellular miRNA and viral RNA potentially prevents viral 
genome replication instead of silencing gene expression (Zhang et al., 2013), and this 
may apply to other viral RNA-targeting miRNAs as well. A publicly-available database 
called ViTa (http://vita.mbc.nctu.edu.tw/) lists known and putative targets sites of 
chicken, human, mice, and rat miRNAs in various viral genomes (Hsu et al., 2007). 
Experimental validation of these potential miRNA-virus genome interactions will 
reveal the antiviral activities of these cellular miRNAs.  
     There appears to be a selection pressure for certain viruses to conserve miRNA 
binding sites in their genomes despite the high mutation rates, particularly of RNA 
viruses. It has been hypothesized that such sequences may have crucial functions 
(Russo and Potenza, 2011). For example, the miRNA-targeted sequence in an HCV 
mRNA codes for amino acids of the polymerase and surface antigen proteins (Potenza 
et al., 2011). These sequences may also harbor important secondary structures or gene 
regulatory sequences (Russo and Potenza, 2011).     
     Conversely, whether miRNA targeting of viruses is an authentic antiviral response in 
vertebrate cells has been a matter of discussion and arguments against the evolution of 
cellular miRNAs for the specific purpose of antiviral defense have been put forward. 
Umbach and Cullen (2009) contended that many viruses seem to have evolved much 
later than their host species. Next, the high mutation rates of virus polymerases create a 
pool of virus variants (some containing miRNA binding sequences, others lacking 
them) which could be difficult for cellular miRNAs to effectively suppress. 
Furthermore, cellular miRNAs being highly conserved and the virus host range 
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normally narrow make the odds low for miRNAs especially evolving to target a specific 
virus (Umbach and Cullen, 2009).      
     On the other hand, in contrast to the sequence conservation of miRNAs, the high 
mutation rates in viruses lead to more rapid evolution. Mahajan and co-authors (2009) 
reasoned that this should have given rise to virus variants devoid of miRNA target 
sequences as the loss of miRNA target sites will prevent miRNA-mediated virus 
inhibition and is thus an advantage for the virus. The selective pressure that maintains 
miRNA target sites in virus genomes, apart from reasons mentioned earlier (Russo and 
Potenza, 2011), may also be exploited by certain viruses to elude the host immune 
system and to establish chronic infection, as has been proposed for HCV and other 
persistently-infecting viruses (Mahajan et al., 2008). It is proposed that the rather 
―modest‖ effect of miRNAs in inhibiting HCV gene expression would allow the virus 
to institute low level of chronic infection. This, together with the nonexistence of 
miRNA target site-deficient HCV variants and the presence of cellular miRNAs much 
earlier in evolution than HCV is in line with the hypothesis that slowly evolving cellular 
miRNAs may be hijacked by HCV (and potentially other persistently-infecting viruses) 
to survive and persist within the host (Mahajan et al., 2008).  
     Cellular miRNA-virus RNA interaction does not necessarily lead to virus 
suppression. HCV has been known to co-opt the human liver-specific miR-122 in order 
to enhance its own replication (Jopling, 2008). Binding of miR-122 to two conserved 
adjacent sites in the 5’UTR (as opposed to the typical miRNA binding site in the 
3’UTR of target RNAs) of HCV RNA (Jopling 2008; Jopling et al., 2005) stabilizes the 
genome and increases HCV genome replication (Wilson and Huys, 2013). Specifically, 
miRNA protects the HCV RNA against exonuclease cleavage (Li et al., 2013; Wilson 
and Huys, 2013). The interaction between miR-122 and HCV RNA also allows the 
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internal ribosome entry site (IRES) downstream of the miRNA binding site to direct 
and stimulate protein synthesis (Conrad and Niepmann, 2013; Wilson and Huys, 2013). 
It is believed that miR-122 is likely to exert positive regulatory activity on HCV 
miRNA by hitherto unknown mechanisms. Other potential functions for miR-122, the 
stages of HCV life cycle impacted by miR-122, and related viruses that may likewise be 
modulated by miR-122 are discussed by Wilson and Huys (2013). Targeting miR-122 
with miR-122 inhibitors has been a promising strategy for anti-HCV therapy (Lanford 
et al., 2010) and has showed encouraging results in Phase II clinical trials (Janssen et 
al., 2013).      
     However, it can be argued that the virus production-enhancing interaction between 
miR-122 and the HCV genome occurs in an unconventional/non-canonical. As 
described above, miR-122 binds to sites in the 5’ UTR of the HCV RNA, whereas 
canonical miRNA binding that lead to target silencing occurs at the 3’ UTR of the 
target. HCV appears to have usurped miR-122 for its own advantage by its genome 
interacting with the miRNA at sites different from the site that results in gene silencing.   
Cellular miRNAs that target host factors associated with virus-host interactions and 
antiviral defense. Some cellular miRNAs may exert antiviral effects not by directly 
targeting virus sequences but by regulating the expression of host genes whose products 
play roles in cellular processes associated with immune responses and host-virus 
interactions. Such cellular miRNAs whose target host mRNAs have been 
experimentally validated are listed in Table 2.  
     Some miRNAs like miR-125a-5p, -146a, -181 (Tables 1 and 2) have been shown to 
target both viral RNA and host factors. Other virus-targeting miRNAs like miR-29a, -
125b, -146a, -150, -181, -223 (Table 1) have also been previously shown to target 
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cellular mRNAs and have likewise been implicated in immune-relevant roles (reviewed 
by Lindsay, 2007).  
     Of particular interest is miR-146a, which has been known as an important regulator 
of inflammatory responses (Taganov et al., 2006). Its expression is induced in human 
monocytes by microbial LPS and by the pro-inflammatory cytokines TNF-α and IL-1β. 
It is known to target the mRNAs of TNF receptor-associated factor 6 (TRAF6) and IL-1 
receptor-associated kinase 1 (IRAK1). TRAF6 and IRAK1 are important adapters 
downstream of Toll-like and cytokine receptors, hence acts as a negative regulator of 
immune signalling, preventing uninhibited inflammatory responses (Taganov et al., 
2006). miR-146a has been recently shown to be inducible also by IFNβ in human and 
macaque macrophages infected with SIV and targeted regions of the SIV genome (Sisk 
et al., 2013).     
     In addition to those host mRNA targets that have been confirmed experimentally 
(Table 2), potential host targets of differentially regulated miRNAs in virus-infected 
cells have been predicted by computational methods. These include genes that play 
roles in virus entry and replication and in immune-relevant signaling pathways, 
including the Jak-STAT pathway, the MAPK signaling pathway, cytokine-receptor 
interactions, and Fc gamma receptor-mediated endocytosis (Zhang et al., 2013; Buggele 
et al., 2012; Zhao et al, 2012). Functional validation of these putative targets will shed 
light on the precise roles of the relevant miRNAs in host-virus interactions.  
IFN-induced miRNAs. IFNs are known to modulate expression of some cellular 
miRNAs. A number of IFN-β-induced miRNAs in human cells have been shown to 
give significant contribution towards the antiviral properties of IFN-β by targeting 
Hepatitis C virus (HCV) sequences and  inhibiting HCV replication in vitro (Pedersen 
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et al., 2007). The target sequences of such miRNAs were found to be conserved across 
various HCV genotypes (Pedersen et al., 2007). IFN-β and TNF-α stimulated the 
expression of miR-9, -29a, -29b, and -146a that target the genome of SIV in 
macrophages (Sisk et al., 2013). IFNα- and IL-28B-treated human hepatoma cells 
upregulated the miRNA let-7b, which inhibited HCV replication and protein synthesis 
(Cheng et al., 2013).  In human cells, IFN-β induced miR-129-5p, which directly targets 
the transcription factor SP1; such targeting resulted in the downregulation of expression 
of E6 and E7 human papillomavirus oncogenes (Zhang et al., 2013).  
      MiRNAs may thus be a part of the broad range of the antiviral arsenal of IFNs, 
adding to the many protein-based effectors induced by IFNs and contributes to its 
antiviral functions.    
 
RNA-based antiviral mechanisms in teleost fishes? 
     Developing from invertebrates, teleost fish is in evolutionary terms the first group of 
jawed vertebrates and also the first animal group known to have IFN and adaptive 
immune mechanisms as known from higher vertebtates. Teleosts consist of highly 
divergent species that inhabit different aquatic environments and are exposed to a vast 
number of water-borne viruses. These make it interesting to study the role of RNAi in 
the antiviral defense in fish.  
     It is known that a functional RNAi pathway is present and operates in teleost fish, as 
evidenced by the crucial involvement of miRNAs in zebrafish development (Giraldez et 
al., 2006). With a broad range of viruses afflicting different fish species and severely 
impacting aquaculture, the antiviral therapeutic potential of RNAi (using siRNAs or 
shRNAs, dsRNAs) has also been explored in teleost fishes (reviewed by Lima et al., 
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2013; Schyth, 2008) and thus far have been successfully demonstrated in fish cell 
cultures (Kim et al., 2012; Bohle et al., 2011; Kim and Kim, 2011).  
     With the recent demonstration of a functional natural RNAi-based antiviral 
machinery in mammalian cells (discussed in the previous section), it is now clear that 
the basic mechanism of the RNAi pathway is conserved in eukaryotic viral infections.  
It is therefore reasonable to assume that it also broadly operates in other vertebrates, 
including teleost fishes. However, no teleost miRNAs that directly or indirectly target a 
virus in infected fish or cells have been identified thus far. Likewise, no natural fish 
virus-derived siRNAs have been identified.     
     A putative antiviral RNAi in fish is indicated by the induction of Dicer expression in 
rare minnow (Gobiocypris rarus) (Su et al., 2009) and in grass carp (Ctenopharyngodon 
idella) (Shen et al., 2013) infected with Grass carp reovirus. It is likewise suggested by 
the presence of an RNAi antagonist protein in the fish betanodaviruses Greasy grouper 
nervous necrosis virus (GGNNV) (Fenner et al., 2006) and Striped jack nervous 
necrosis virus (SJNNV) (Iwamoto et al., 2005). Fish betanodavirus protein B2 
sequence-independently binds to and sequesters dsRNA, protecting it from cleavage by 
Dicer and enables the accumulation of viral RNA (Fenner et al., 2006). The B2 protein 
when mutated to remove amino acids needed to bind dsRNA has decreased its ability to 
block the silencing of a GFP reporter (Fenner et al., 2007).  
     Furthermore, a fish homologue of a protein involved in cellular dsRNA uptake 
(Duxbury et al., 2005; Feinberg and Hunter 2003; Winston et al., 2002) called systemic 
RNA interference defective protein 1 (SID-1) (called ScSidT2 in mandarin fish, 
Siniperca chuatsi) has been shown to be upregulated in mandarin fish infected with 
Infectious spleen and kidney necrosis virus (ISKNV) (Ren et al., 2011; He et al., 2006) 
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while antiserum neutralization of this protein results in increased ISKNV replication in 
cell culture (Ren et al., 2011). When ScSidT2 was overexpressed in fathead minnow 
(FHM) cells, an increased import of exogenous dsRNA was observed and inhibited 
tiger frog virus replication in these cells (Ren et al., 2011), indicating a role in antiviral 
defense in fish cells. The gene encoding SID-1 is conserved from invertebrates to 
humans (Luo et al., 2013) and SID-1-mediated transport of dsRNA has been implicated 
in systemic RNAi in C. elegans (Calixto et al., 2010; Feinberg and Hunter, 2003; 
Winston et al., 2002). The presence of this protein in fish may indicate that a systemic 
RNAi may operate in fish, as had been shown in C. elegans and plants, although this 
phenomenon has not yet been shown to occur in vertebrates.  
          Research in our lab revealed that two miRNAs, miR-462 and miR-731, currently 
described only in teleost fish, were strongly upregulated in rainbow trout 
(Oncorhynchus mykiss) infected with Viral hemorrhagic septicemia virus (VHSV), a 
fish rhabdovirus (Schyth et al. manuscript submitted) and in fish following the 
administration of a DNA vaccine encoding the glycoprotein (G) gene of VHSV (Bela-
ong et al., manuscript in preparation). These two IFN-inducible miRNAs have been 
shown to be orthologues of conserved ancestral miRNAs found in a cartilaginous fish 
and higher vertebrates. In humans, they are involved in regulation of the cell cycle. 
Silencing miR-462 and miR-731 with specific anti-miRNAs in poly I:C treated fish 
reduced the ability of this TLR3 agonist and IFN inducer to protect fish from lethal 
virus challenge, suggesting their involvement in innate antiviral defense. Whereas these 
miRNAs are conserved across vertebrates in terms of nucleotide sequence, they 
appeared to have functionally evolved into IFN-induced antiviral defense elements in 
the teleost fish (Bela-ong et al. manuscript in preparation; Schyth et al., manuscript 
submitted). Validated cellular as well as putative viral targets of miR-462 and miR-731 
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are currently unknown (Bela-ong et al. manuscript in preparation). As with numerous 
miRNAs in mammalian cells, they may regulate the expression of infection- and 
defense-associated host factors or may directly target viral genomes or transcripts. 
Bioinformatic analysis indicates the presence of potential target sites of these two 
miRNAs in the genome of VHSV. Further studies aimed at characterizing the detailed 
function of these miRNAs in the context of infection is currently underway.   
     Teleost fish miRNAs are presently underrepresented in the miRNA repository 
miRBase (http://mirbase.org) being limited to 8 species, notwithstanding the enormous 
species diversity and the economic importance of fish in both wild fisheries and 
aquaculture. These include miRNAs identified in the model species zebrafish (Danio 
rerio) and medaka (Oryzias latipes) and the aquaculture fish species common carp 
(Cyprinus carpio) and Channel catfish (Ictalurus punctatus).  A total number of 1250 
teleost fish pre-miRNA hairpin sequences and 1044 mature miRNAs are currently listed 
in mirBase (http://mirbase.org, accessed 22 April 2014) and new teleost miRNAs, some 
of them fish-specific, are being discovered.  
     Interestingly, most of miRNAs shown to target viruses or those that have been 
shown to play roles in antiviral responses in higher vertebrates (mostly in mammals) 
(listed in Tables 1 and 2) have homologues in teleost fish, at least in zebrafish according 
to miRbase. Whether these teleost fish homologues perform equivalent functions as 
their mammalian counterparts remains to be analyzed.    
     Research will greatly benefit from teleost miRNA discovery and miRNA profiling in 
virus-infected fish, and functional studies conducted in parallel should pave the way for 
elucidating potential antiviral RNAi pathways in this highly diverse vertebrate group. 
This also entails the development of appropriate cell culture and fish experimental 
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systems (i.e. RNAi-deficient and IFN-deficient cells/fish, VSR-deficient teleost-
infecting viruses) and discovery of teleost-infecting viruses encoding potential VSRs 
and characterization of putative RNAi-blocking activity in teleost systems.  
  
Concluding remarks 
     RNA-based antiviral response is a conserved mechanism that operates in plants,  
invertebrates, and vertebrates. In invertebrates and plants, antiviral RNAi uses the virus’ 
own genetic material to create an antiviral weapon in the form of vsiRNAs which are 
used by the RNAi machinery to destroy the virus’ RNAs. Virus-encoded VSRs that 
inhibit the RNAi machinery and the potent IFN response most likely conceal the effects 
of antiviral RNAi mechanisms in mammalian cells such that its existence here has gone 
unnoticed for some time in mammalian cells. Two very recent reports have identified 
vsiRNAs in mESCs and in suckling mice functioning in antiviral RNAi that appears to 
operate in a context-dependent manner (i.e. only in undifferentiated cells lacking the 
IFN response or in specific tissue types). 
     Emerging data provide strong evidence favoring the antiviral role of cellular 
miRNAs and their contribution to vertebrate immune defense. Together with IFN-
induced effectors, cellular miRNAs may serve in the frontline defense against viruses in 
vertebrate cells and the list of such will most likely increase.  
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Table 1. Vertebrate cellular miRNAs with experimentally validated targets in viral genes. 
miRNA Vertebrate species Target virus Target in viral genome References 
let-7b  Hepatitis C virus (HCV) Conserved coding sequences of NS5B and 5'-
UTR of HCV genome 
Cheng et al., 2012 
miR-9 Human and macaque 
primary macrophages 
Simian immunodeficiency virus 
(SIV) 
Nef/U3 and R regions 
 
Sisk et al., 2013 
 
miR-24 Mice Vesicular stomatitis virus (VSV) large (L) protein and phosphoprotein (P) Otsuka et al., 2007 
miR-28 Human Human immunodeficiency virus 1 
(HIV-1) 
3’ end of RNA Huang et al., 2007; 
Reviewed by Russo and Potenza, 2011 
miR-29a Human and macaque 
primary macrophages 
SIV Nef/U3 and R regions 
 
Sisk et al., 2013 
 
miR-29a Human HIV-1 Nef protein coding sequence; 3’ UTR of 
genomic RNA 
 
Nathans et al., 2009; Ahluwalia et al., 
2008; Reviewed by Russo and Potenza, 
2011 
miR-29b Human and macaque 
primary macrophages 
SIV Nef/U3 and R regions 
 
Sisk et al., 2013 
 
miR-93 Mice VSV large (L) protein and phosphoprotein (P) Otsuka et al., 2007 
miR-
125a-5p 
Human Hepatitis B virus (HBV) Overlapping surface antigen and polymerase 
ORFs 
Potenza et al., 2011; 
Reviewed by Russo and Potenza, 2011 
miR-
125a-5p 
cultured hepatic cells 
 
HBV viral polymerase ORF and the 
overlapping surface antigen ORF 
Potenza et al., 2011 
 
miR-
125b 
Human HIV-1 3’ end of RNA Huang et al., 2007; Reviewed by Russo 
and Potenza, 2011 
miR-
125b 
Human Human papilloma virus Capsid protein L2 coding sequence Nuovo et al., 2010; Reviewed by Russo 
and Potenza, 2011 
miR-
142-3p 
Murine myeloid-
lineage cells (RAW 
264.7) 
North American eastern equine 
encephalitis virus 
3’ UTR of RNA genome Trobaugh et al., 2014 
miR-
146a 
Human and macaque 
primary macrophages 
SIV Nef/U3 and R regions 
 
Sisk et al., 2013 
 
miR-150 Human HIV-1 3’ end of RNA Huang et al., 2007; Reviewed by Russo 
and Potenza, 2011 
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Table 1. Continued……. Vertebrate cellular miRNAs with experimentally validated targets in viral genes. 
miRNA Vertebrate species Target virus Target in viral genome References 
miR-181 Cat (cell line) Mink enteritis virus (MEV) NS1 mRNA Sun et al., 2013 
miR-181 monkey kidney cells  
and pigs 
Porcine reproductive and 
respiratory syndrome virus 
(PRRSV) 
conserved region downstream of ORF4 of 
viral genome 
Guo et al., 2013 
 
 
miR-196 Human HCV Nonstructural protein 5A coding sequence Pedersen et al., 2007; Hou et al., 2010; 
Reviewed by Russo and Potenza, 2011 
miR-
199a-3p 
Human HCV 5’-UTR of genomic RNA Murakami et al., 2009; 
Reviewed by Russo and Potenza, 2011 
miR-
199a-3p 
Human HBV Overlapping surface antigen and polymerase 
ORFs 
Zhang et al., 2010; 
Reviewed by Russo and Potenza, 2011 
miR-210 Human HBV Overlapping surface antigen and polymerase 
ORFs 
Zhang et al., 2010; 
Reviewed by Russo and Potenza, 2011 
miR-223 Human HIV-1 3’-end of RNA Huang et al., 2007; 
Reviewed by Russo and Potenza, 2011 
miR-
296-5p 
Human cells Enterovirus 71 Sites in EV71 genome Zheng et al., 2013 
miR-323 MDCK cell Influenza A virus PB1 gene in virus genome Song et al., 2010 
 
miR-382 Human HIV-1 3’-end of RNA Huang et al., 2007; 
Reviewed by Russo and Potenza, 2011 
miR-448 Human HCV Core protein coding sequence Pedersen et al., 2007; 
Russo and Potenza, 2011 
miR-491 MDCK cells Influenza A virus PB1 gene in virus genome Song et al., 2010 
 
miR-654 MDCK cells Influenza A virus PB1 gene in virus genome Song et al., 2010 
 
miR-
1650 
Chicken cells line) Avian leucosis virus 5’ UTR of viral genome Wang et al., 2013 
 
miR-27a 
and 
miR-27b 
Mice Murine cytomegalovirus  Buck et al., 2010 
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Table 2. Vertebrate cellular miRNAs with validated host factor mRNA targets whose protein products affect virus propagation/replication and antiviral responses. 
miRNA Vertebrate species Infecting virus Host targets References 
miR-17-
5p 
Human (PBMCs) HIV-1 histone acetyltransferase Tat cofactor PCAF Triboulet et al., 2007 
miR-20a Human (PBMCs) HIV-1 histone acetyltransferase Tat cofactor PCAF Triboulet et al., 2007 
miR-122 Human HBV Cyclin G1 Wang et al., 2012 
miR-129-
5p 
Human (HeLa and 
cervical cancer cells) 
HPV Transcription factor SP1 Zhang et al., 2013 
miR-132 primary lymphatic 
endothelial cells 
(LECs) 
Kaposi's sarcoma-associated herpesvirus 
(KSHV) 
p300 transcriptional co-activator; ISGs Lagos et al., 2010 
miR-132 monocytes herpes simplex virus-1 (HSV-1)  Lagos et al., 2010 
miR-132 monocytes human cytomegalovirus (HCMV)  Lagos et al., 2010 
miR-146a Human lung 
epithelial cells 
(A549) 
Influenza A virus Multiple targets involved in Toll-like receptor 
pathway, innate immune response, cytokine 
production, and apoptosis 
Terrier et al., 2013 
 
 
Hs_154 Human cells 
(HEK293T and SK-
N-MC) 
West Nile virus 
 
CCCTC-binding factor (CTCF) 
and epidermal growth factor receptor (EGFR)-
coamplified and overexpressed protein 
(ECOP/VOPP1) 
Smith et al., 2012 
 
miR-181 Pig (blood 
monocytes and 
alveolar 
macrophages 
PRRSV 3’ UTR of CD163 mRNA 
 
Gao et al., 2013 
miR-196 Human HCV 3’ UTR of Bach 1 (basic leucine zipper mammalian 
transcriptional repressor) 
Pedersen et al., 2007; Hou 
et al., 2010; 
Reviewed by Russo and 
Potenza, 2011 
miR-198 monocytes HIV-1 cyclin T1 Sung and Rice, 2009 
miR-203  Human A549 cells Sendai virus IFIT1/ISG56 transcript Buggele and Horvath, 2013 
miR-449b Human A549 cells Influenza A virus histone deacetylase 1 and interferon beta Buggele et al., 2013 
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